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Process for the production of arachidonic acid and/or eicosapentaenoic acid
Description
The present invention relates to a new process for the production of arachidonic acid
and/or eicosapentaenoic acid in plants through the co-expression of a ∆-12-/∆-15-
desaturase, ∆-9-elongase, ∆-8-desaturase and a ∆-5-desaturase and a process for
the production of lipids or oils having an increased content of unsaturated fatty acids,
in particular ω-3 and ω-6 fatty acids having at least two double bonds and a 18 or 20
carbon atom chain length. Preferably the arachidonic acid and eicosapentaenoic acid
are produced in at least a 1:2 ratio.
The invention furthermore relates to the production of a transgenic plants, preferably
a transgenic crop plant, having an increased content of arachidonic acid and/or e i
cosapentaenoic acid, oils or lipids containing Ci8- or C2o- fatty acids with a double
bond in position ∆ . 5 , 8 , 9 , 11, 12, 14, 15 or 17 of the fatty acid produced, respectively
due to the expression of the ∆-12-/∆-15-desaturase, of the ∆-9-elongase, of the ∆-8-
desaturase and of the ∆-5-desaturase in the plant. The expression of the inventive ∆-
12-/∆-15-desaturase leads preferably to linoleic acid and α-linolenic acid as products
having a double bond in the position ∆ . 9 , 12 and 15 of the fatty acid.
The invention additionally relates to specific nucleic acid sequences encoding for pro
teins with ∆-12-/∆-15-desaturase-, ∆-9-elongase-, ∆-8-desaturase- or ∆-5-desaturase-
activity, nucleic acid constructs, vectors and transgenic plants containing said nucleic
acid sequences.
Plants and especially oil crops have been used for centuries as sources for edible and
non-edible products. There are written records and archaeological excavations that oil
crops such as linseed, olive and sesame were widespread use at least six thousand
years ago.
Non-edible products of oilseed crops such as rapeseed were used and included in
lubricants, oil lamps, and cosmetics such as soaps. Oil crops differ in their cultural,
economic and utilization characteristics, for example rapeseed and linseed are
adapted to relatively cool climates, whereas oil palm and coconut are adapted to
warm and damp climates. Some plants are a real oilseed plant that means the main
product of such plants is the oil, whereas in case of others such as cotton or soybean
the oil is more or less a side product. The oils of different plants are basically charac
terized by their individual fatty acid pattern.
Fatty acids and triglycerides have numerous applications in the food industry, animal
nutrition, cosmetics and in the drug sector. Depending on whether they are free satu-
rated or unsaturated fatty acids or triglycerides with an increased content of saturated
or unsaturated fatty acids, they are suitable for the most varied applications; thus, for
example, long chain polyunsaturated fatty acids (= LCPUFAs) are added to infant
formula to increase its nutritional value. The various fatty acids and triglycerides are
mainly obtained from microorganisms such as Mortierella or from oil-producing plants
such as soybean, oilseed rape, sunflower and others, where they are usually obtained
in the form of their triacylglycerides. Alternatively, they are obtained advantageously
from animals, such as fish. The free fatty acids are prepared advantageously by hy
drolysis.
Whether oils with unsaturated or with saturated fatty acids are preferred depends on
the intended purpose; thus, for example, lipids with unsaturated fatty acids, specif i
cally polyunsaturated fatty acids, are preferred in human nutrition since they have a
positive effect on the cholesterol level in the blood and thus on the possibility of heart
disease. They are used in a variety of dietetic foodstuffs or medicaments. In addition
PUFAs are commonly used in food, feed and in the cosmetic industry. Poly unsatu-
rated ω-3- and/or ω-6-fatty acids are an important part of animal feed and human
food. Because of the common composition of human food poly unsaturated ω-3-fatty
acids, which are an essential component of fish oil, should be added to the food to
increase the nutritional value of the food; thus, for example, poly unsaturated fatty
acids such as Docosahexaenoic acid (= DHA, C22 6∆4 7 10 13 16 19)or Eicosapentaenoic
acid (= EPA, C2o5∆5 8 1 1 14 17) are added as mentioned above to infant formula to in
crease its nutritional value. Whereas DHA has a positive effect on the brain develop
ment of babies. The addition of poly unsaturated ω-3-fatty acids is preferred as the
addition of poly unsaturated ω-6-fatty acids like Arachidonic acid (= ARA, C2o4∆5 8 1 1 14 )
to common food have an undesired effect for example on rheumatic diseases such as
rheumatoid arthritis. Poly unsaturated ω-3- and ω-6-fatty acids are precursor of a fam
ily of paracrine hormones called eicosanoids such as prostaglandins which are prod
ucts of the metabolism of Dihomo-γ-linoleic acid, ARA or EPA. Eicosanoids are in-
volved in the regulation of lipolysis, the initiation of inflammatory responses, the regu
lation of blood circulation and pressure and other central functions of the body. Eico-
sanoids comprise prostaglandins, leukotrienes, thromboxanes, and prostacyclins ω-
3-fatty acids seem to prevent artherosclerosis and cardiovascular diseases primarily
by regulating the levels of different eicosanoids. Other Eicosanoids are the thrombox
anes and leukotrienes, which are products of the metabolism of ARA or EPA.
Principally microorganisms such as Mortierella or oil producing plants such as soy
bean, rapeseed or sunflower or algae such as Crypthecodinium or Phaeodactylum are
a common source for oils containing PUFAs, where they are usually obtained in the
form of their triacyl glycerides. Alternatively, they are obtained advantageously from
animals, such as fish. The free fatty acids are prepared advantageously by hydrolysis
with a strong base such as potassium or sodium hydroxide.
Plant oils are in general rich in fatty acids such as monounsaturated fatty acids like
oleic acid or oly unsaturated fatty acids (= PUFA) like linoleic or linolenic acid. LCPU-
FAs like arachidonic acid or eicosapentaenoic acid are rarely found in plants excep
tions are some Nephelium and Salvia species in which arachidonic acid is found and
some Santalum species in which eicosapentaenoic acid is found. The LCPUFA Doco-
sahexaenoic acid is not found in plants. LCPUFAs such as DHA, EPA, ARA, Dihomo-
γ-linoleic acid (C20 3∆8 1 1 14 ) or Docosapentaenoic acid (= DPA, C22 5∆7 10 13 16 19) are not
produced by oil producing plants such as soybean, rapeseed, safflower or sunflower.
A natural sources for said fatty acids are fish for example herring, salmon, sardine,
redfish, eel, carp, trout, halibut, mackerel, pike-perch, tuna or algae.
Approximately 80% of the oils and fats are used in the food industry. Nearly about
84 % of all world wide used vegetable oils are stemming from only six crops/oil crops,
which are soybean, oil palm, rapeseed, sunflower, cottonseed, and groundnut.
On account of their positive properties there has been no shortage of attempts in the
past to make available genes which participate in the synthesis of fatty acids or trig lyc
erides for the production of oils in various organisms having a modified content of
unsaturated fatty acids. Thus, in WO 91/13972 and its US equivalent a ∆-9-
desaturase is described. In WO 93/1 1245 a ∆-15-desaturase and in WO 94/1 1516 a
∆-12-desaturase is claimed. WO 00/34439 discloses a ∆-5- and a ∆-8-desaturase.
Other desaturases are described, for example, in EP-A-O 550 162, WO 94/18337,
WO 97/30582, WO 97/21340, WO 95/18222, EP-A-O 794 250, Stukey et al., J. Biol.
Chem., 265, 1990: 20144-20149, Wada et al., Nature 347, 1990: 200-203 or Huang
et al., Lipids 34, 1999: 649-659. To date, however, the various desaturases have
been only inadequately characterized biochemically since the enzymes in the form of
membrane-bound proteins are isolable and characterizable only with very great diff i
culty (McKeon et al., Methods in Enzymol. 7 1 , 1981 : 275-277, Wang et al., Plant
Physiol. Biochem., 26, 1988: 777-792). Generally, membrane-bound desaturases are
characterized by introduction into a suitable organism, which is then investigated for
enzyme activity by means of analysis of starting materials and products. ∆-6-
Desaturases are described in WO 93/06712, US 5,614,393, US 5614393,
WO 96/21022, WO0021557 and WO 99/271 11 and their application to production in
transgenic organisms is also described, e.g. in WO 9846763, WO 9846764 and
WO 9846765. At the same time the expression of various fatty acid biosynthesis
genes, as in WO 9964616 or WO 9846776, and the formation of poly-unsaturated
fatty acids is also described and claimed. With regard to the effectiveness of the ex
pression of desaturases and their effect on the formation of polyunsaturated fatty ac
ids it may be noted that through expression of a desaturases and elongases as de
scribed to date only low contents of poly-unsaturated fatty acids/lipids, such as by way
of example eicosapentaenoic or arachidonic acid, have been achieved. Therefore, an
alternative and more effective pathway with higher product yield is desirable.
Accordingly, there is still a great demand for new and more suitable genes, which e n
code enzymes, which participate in the biosynthesis of unsaturated fatty acids and
make it possible to produce certain fatty acids specifically on an industrial scale with-
out unwanted byproducts forming. In the selection of genes for biosynthesis two char
acteristics above all are particularly important. On the one hand, there is as ever a
need for improved processes for obtaining the highest possible contents of polyun
saturated fatty acids. Advantageously genes should be as selective as possible and
should if possible have more than one activity in the fatty acid biosynthesis chain.
Accordingly, it is an object of the present invention to provide further genes of desatu-
rase and elongase enzymes for the synthesis of polyunsaturated fatty acids in plants
preferably in oilseed plants and to use them in a commercial process for the produc-
tion of PUFAs especially LCPUFAs. Said process should increase LCPUFA content in
plants as much as possible preferably in seeds of an oil producing plant.
We have found that a process for the production of arachidonic acid or eicosapen-
taenoic acid achieves this object or arachidonic acid and eicosapentaenoic acid in
transgenic plants that produces mature seeds with a content of at least 1 % by weight
of said compounds referred to the total lipid content of said organism, which com
prises the following steps:
a) introduction of at least one nucleic acid sequence in said transgenic plant,
which encodes a polypeptide having a ∆-12-desaturase and ∆-15-desaturase
activity, and
b) introduction of at least one second nucleic acid sequence in said transgenic
plant, which encodes a polypeptide having a ∆-9-elongase activity, and
c) introduction of at least one third nucleic acid sequence in said transgenic plant,
which encodes a polypeptide having a ∆-8-desaturase activity, and
d) introduction of at least a one fourth nucleic acid sequence, which encodes a
polypeptide having a ∆-5-desaturase activity, and
e) cultivating and harvesting of said transgenic plant.
According to the invention the used nucleic acid sequences are isolated nucleic se
quences coding for polypeptides having a ∆-12-desaturase- and ∆-15-desaturase-,
∆9-elongase-, ∆-8 desaturase- or ∆5-desaturase-activity.
Advantageously nucleic acid sequences are used in the abovementioned process of
the invention, which encode polypeptides having ∆-12-desaturase and ∆-15-
desaturase activity, ∆-8-desaturase, ∆-9-elongase or ∆-5-desaturase activity and
which are selected from the group consisting of
a) a nucleic acid sequence depicted in SEQ ID NO: 1, SEQ ID NO: 3 , SEQ ID NO:
5 , SEQ ID NO: 7 , SEQ ID NO: 9 , SEQ ID NO: 11, SEQ ID NO:13, SEQ ID NO:
15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 2 1 and SEQ ID NO: 23, and
b) a nucleic acid sequence, which, as a result of the degeneracy of the genetic
code, can be derived from a polypeptide sequence as depicted in SEQ ID NO:
2 , SEQ ID NO: 4 , SEQ ID NO: 6 , SEQ ID NO: 8 , SEQ ID NO: 10, SEQ ID NO:
12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 18, SEQ ID NO: 20, SEQ ID
NO: 22 or SEQ ID NO: 24 according to the degeneracy of the genetic code,
c) derivatives of the nucleic acid sequences depicted in SEQ ID NO: 1, SEQ ID
NO: 3 , SEQ ID NO: 5 , SEQ ID NO: 7 , SEQ ID NO: 9 , SEQ ID NO: 11, SEQ ID
NO: 13, , SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 2 1 or
SEQ ID NO: 23 which encode polypeptides having at least 50 % homology to
the sequence as depicted in SEQ ID NO: 2 , SEQ ID NO: 4 , SEQ ID NO: 6 , SEQ
ID NO: 8 , SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16,
SEQ ID NO: 18, SEQ ID NO: 20, SEQ ID NO: 22 or SEQ ID NO: 24 and which
polypeptides having ∆-12-desaturase and ∆-15-desaturase activity, ∆-8-
desaturase, ∆-9-elongase or ∆-5-desaturase activity.
In the inventive process the nucleic acid sequence encoding the bifunctional ∆-12-
desaturase- and ∆-15-desaturase-enzyme leads to an increased flux from oleic acid
(C18:1 ∆9) to linolenic acid (C18:3 ∆9 12 15) and thereby to an increase of ω-3-fatty acids
in comparison to the ω-6-fatty acids. Furthermore this bifunctional enzyme acts on
C16-fatty acids having one double bond in the fatty acid molecule as well as on C18-
fatty acids having one double bond in the fatty acid molecule. This leads to a further
increase in flux from precursor fatty acids such as C 18 fatty acids such as oleic acid
towards C18 fatty acids such as linoleic and linolenic acid. This is especially of advan
tage in plants such as oilseed plants having a high content of oleic acid like such as
those from the family of the Brassicaceae, such as the genus Brassica, for example
oilseed rape or canola; the family of the Elaeagnaceae, such as the genus Elaeag-
nus, for example the genus and species Olea europaea, or the family Fabaceae, such
as the genus Glycine, for example the genus and species Glycine max, which are
high in oleic acid. But also in other plants such oilseed plants like Brassica juncea,
Camelina sativa, sunflower or safflower and all other plants mentioned herein this
leads to a higher amount of ω-3-fatty acids. By using said inventive nucleic acid se
quence and the activity of its gene product ω-3-fatty acids to the ω-6-fatty acids are
produced in at least a 1:2 ratio, preferably in at least a 1:3 or 1:4 ratio, more prefera-
bly in at least a 1:5 or 1:6 ratio. That means especially arachidonic acid and ei-
cosapentaenoic acid are produced in at least a 1:2 ratio, preferably in at least a 1:3 or
1:4 ratio, more preferably in at least a 1:5 or 1:6 ratio.
In particular ω-3-fatty acids or ω-6-fatty acids molecules are produced in the inventive
process, arachidonic acid and eicosapentaenoic acid are most preferred produced.
We have found that this object is advantageously achieved by the combined expres
sion of four isolated nucleic acid sequences according to the invention which encode
for polypeptides having the following activities: a polypeptide with ∆-12-desaturase-
and ∆-15-desaturase-activity, a polypeptide with a C18-∆-9-elongase-activity, a poly-
peptide with C20-∆-8-desaturase-activity and a C20-∆-5-desaturase-activity. This o b
jective was achieved in particular by the co-expression of the isolated nucleic acid
sequences according to the invention. C 18 fatty acids with a single double bond in ∆ -
9-position are desaturated a first time to linoleic acid by the ∆-12-desaturase and ∆-
15-desaturase and thereafter a second time to linolenic acid by the same enzyme
advantageously used in the inventive process. The produced C 18 fatty acids linoleic
and linolenic acid both having a double bond in ∆-9-position are than elongated by the
∆-9-elongase, which is advantageously used in the inventive process. By the ∆-8-
desaturase used in the process a double bond in ∆-8-position is introduced into C20
fatty acids. In addition a double bond is introduced into the produced fatty acid mole-
cules in ∆-5-position by the ∆-5-desaturase. The end products of the whole enzymatic
reaction are arachidonic acid and eicosapentaenoic acid.
The ω-3-fatty acids or ω-6-fatty acids, preferably ω-3-fatty acids produced in the proc
ess are advantageously bound in membrane lipids and/or triacylglycerides or mixtures
of different glycerides, but may also occur in the plants as free fatty acids or else
bound in the form of other fatty acid esters.
The fatty acid esters with ω-3-fatty acids or ω-6-fatty acids especially arachidonic acid
and eicosapentaenoic acid molecules can be isolated in the form of an oil or lipid, for
example in the form of compounds such as sphingolipids, phosphoglycerides, lipids,
glycolipids such as glycosphingolipids, phospholipids such as phosphatidylethanola-
mine, phosphatidylcholine, phosphatidylserine, phosphatidylglycerol, phosphatidy-
linositol or diphosphatidylglycerol, monoacylglycerides, diacylglycerides, triacylglyc
erides or other fatty acid esters such as the acetyl-coenzyme A esters from the plants
which have been used for the preparation of the fatty acid esters; preferably, they are
isolated in the form of their diacylglycerides, triacylglycerides and/or in the form of
phosphatidylcholine, especially preferably in the form of the triacylglycerides. In add i
tion to these esters, the LCPUFAs are also present in the plants, advantageously in
the oilseed plants as free fatty acids or bound in other compounds. As a rule, the
various abovementioned compounds (fatty acid esters and free fatty acids) are pre
sent in the plants with an approximate distribution of 80 to 90% by weight of trig lyc
erides, 2 to 5% by weight of diglycerides, 5 to 10% by weight of monoglycerides, 1 to
5% by weight of free fatty acids, 2 to 8% by weight of phospholipids, the total of the
various compounds amounting to 100% by weight.
In the inventive process(es) [the singular shall include the plural and vice versa] the
LCPUFAs are produced in a content of at least 1 % by weight, preferably at least 2 , 3 ,
4 or 5 % by weight, more preferably at least 6 , 7 , 8 , or 9 % by weight, most preferably
10, 20 or 30 % by weight referred to the total lipid content of the plant used in the
process. That means Arachidonic acid and eicosapentaenoic acid are produced in a
content of at least 1 % by weight, preferably at least 2 , 3 , 4 or 5 % by weight, more
preferably at least 6 , 7 , 8 , or 9 % by weight, most preferably 10, 20 or 30 % by weight
referred to the total lipid content. Preferred starting material for the inventive process
is oleic acid (C18:1 ) , which is transformed to the preferred end products ARA or EPA.
As for the inventive process plants are used the product of the process is not a prod
uct of one pure substance per se. It is a mixture of different substances where one or
more compounds are the major product and others are only contained as side prod
ucts. Advantageously the side products shall not exceed 20 % by weight referred to
the total lipid content of the plant, preferably the side products shall not exceed 15 %
by weight, more preferably they shall not exceed 10 % by weight, most preferably
they shall not exceed 5 % by weight. In the event that a mixture of different fatty acids
such as ARA and EPA are the product of the inventive process said fatty acids can be
further purified by method known by a person skilled in the art such as distillation,
extraction, crystallization at low temperatures, chromatography or a combination of
said methods. These chemically pure fatty acids or fatty acid compositions are advan
tageous for applications in the food industry sector, the cosmetic sector and especially
the pharmacological industry sector.
Fatty acid esters or fatty acid mixtures produced by the process according to the in
vention advantageously comprise 6 to 15% of palmitic acid, 1 to 6% of stearic acid, 7
to 85% of oleic acid, 0.5 to 8% of vaccenic acid, 0.1 to 1% of arachic acid, 7 to 25% of
saturated fatty acids, 8 to 85% of monounsaturated fatty acids and 60 to 85% of poly-
unsaturated fatty acids including LCPUFAs, in each case based on 100% and on the
total fatty acid content of the organisms. Advantageous LCPUFAs, which are present
in the fatty acid esters or fatty acid mixtures are preferably at least 1%, 2%, 3%, 4% or
5% by weight of arachidonic acid and/or preferably at least 5%, 6%, 7%, 8%, 9% or
10% by weight of eicosapentaenoic acid, based on the total fatty acid content.
Moreover, the fatty acid esters or fatty acid mixtures which have been produced by
the process of the invention advantageously comprise fatty acids selected from the
group of the fatty acids erucic acid (13-docosaenoic acid), sterculic acid (9,10-
methyleneoctadec-9-enoic acid), malvalic acid (8,9-methyleneheptadec-8-enoic acid),
chaulmoogric acid (cyclopentenedodecanoic acid), furan fatty acid (9,12-epoxyocta-
deca-9,1 1-dienoic acid), vernolic acid (9,10-epoxyoctadec-12-enoic acid), tariric acid
(6-octadecynoic acid), 6-nonadecynoic acid, santalbic acid (t1 1-octadecen-9-ynoic
acid), 6,9-octadecenynoic acid, pyrulic acid (t10-heptadecen-8-ynoic acid), crepenyn-
inic acid (9-octadecen-12-ynoic acid), 13,14-dihydrooropheic acid, octadecen-13-ene-
9,1 1-diynoic acid, petroselenic acid (cis-6-octadecenoic acid), 9c,12t-octadecadienoic
acid, calendulic acid (8t10t12c-octadecatrienoic acid), catalpic acid (9t1 1t13c-
octadecatrienoic acid), eleostearic acid (9c1 1t13t-octadecatrienoic acid), jacaric acid
(8c10t12c-octadecatrienoic acid), punicic acid (9c1 1t13c-octadecatrienoic acid), pari-
naric acid (9c1 1t13t15c-octadecatetraenoic acid), pinolenic acid (all-cis-5,9,12-
octadecatrienoic acid), laballenic acid (5,6-octadecadienallenic acid), ricinoleic acid
(12-hydroxyoleic acid) and/or coriolic acid (13-hydroxy-9c,1 1t-octadecadienoic acid).
The abovementioned fatty acids are, as a rule, advantageously only found in traces in
the fatty acid esters or fatty acid mixtures produced by the process according to the
invention, that is to say that, based on the total fatty acids, they occur to less than
30%, preferably to less than 25%, 24%, 23%, 22% or 2 1%, especially preferably to
less than 20%, 15%, 10%, 9%, 8%, 7%, 6% or 5%, very especially preferably to less
than 4%, 3%, 2% or 1%. In a further preferred form of the invention, these abovemen
tioned fatty acids occur to less than 0.9%, 0.8%, 0.7%, 0.6% or 0.5%, especially pref
erably to less than 0.4%, 0.3%, 0.2%, 0.1 %, based on the total fatty acids. The fatty
acid esters or fatty acid mixtures produced by the process according to the invention
advantageously comprise less than 0.1 %, based on the total fatty acids, and/or no
butyric acid, no cholesterol, no clupanodonic acid (= docosapentaenoic acid,
C22:5∆4 8 12 1521 ) and no nisinic acid (tetracosahexaenoic acid, C23:6∆3 8 12 15 1821 ) .
The isolated nucleic acid sequences used in the process according to the invention
encode proteins or parts of these, where the proteins or the individual protein or parts
thereof comprise(s) an amino acid sequence with sufficient homology to an amino
acid sequence which is shown in the sequences SEQ ID NO: 2 , SEQ ID NO: 4 , SEQ
ID NO: 6 , SEQ ID NO: 8 , SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID
NO: 16, SEQ ID NO: 18, SEQ ID NO: 20, SEQ ID NO: 22 and SEQ ID NO: 24 so that
the proteins or parts thereof retain a ∆-12-desaturase and ∆-15-desaturase-,
∆-9-elongase-, ∆-8-desaturase- and/or ∆-5-desaturase activity. The proteins or parts
thereof which is/are encoded by the nucleic acid molecule(s) preferably retains their
essential enzymatic activity and the ability of participating in the metabolism of
compounds required for the synthesis of cell membranes or lipid bodies in organisms,
advantageously in plants, or in the transport of molecules across these membranes.
Advantageously, the proteins encoded by the nucleic acid molecules have at least
approximately 50%, preferably at least approximately 60% and more preferably at
least approximately 70%, 80% or 90% and most preferably at least approximately
85%, 86%, 87%, 88%, 89%, 90%, 9 1%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%
or more identity with the amino acid sequences shown in SEQ ID NO: 2 , SEQ ID NO:
4 , SEQ ID NO: 6 , SEQ ID NO: 8 , SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14,
SEQ ID NO: 16, SEQ ID NO: 18, SEQ ID NO: 20, SEQ ID NO: 22 and SEQ ID NO:
24. For the purposes of the invention, homology or homologous is understood as
meaning identity or identical, respectively.
The homology was calculated over the entire amino acid or nucleic acid sequence
region. The skilled worker has available a series of programs which are based on
various algorithms for the comparison of various sequences. Here, the algorithms of
Needleman and Wunsch or Smith and Waterman give particularly reliable results. The
program PiIeUp (J. MoI. Evolution., 25, 351-360, 1987, Higgins et al., CABIOS, 5
1989: 151-153) or the programs Gap and BestFit [Needleman and Wunsch (J. MoI.
Biol. 48; 443-453 (1970) and Smith and Waterman (Adv. Appl. Math. 2 ; 482-489
(1981 )], which are part of the GCG software packet [Genetics Computer Group, 575
Science Drive, Madison, Wisconsin, USA 5371 1 (1991 )], were used for the sequence
alignment. The sequence homology values which are indicated above as a
percentage were determined over the entire sequence region using the program GAP
and the following settings: Gap Weight: 50, Length Weight: 3 , Average Match: 10.000
and Average Mismatch: 0.000. Unless otherwise specified, these settings were always
used as standard settings for the sequence alignments.
Moreover, in the process of the invention advantageously nucleic acid sequences are
used which differ from one of the nucleotide sequences shown in SEQ ID NO: 1, SEQ
ID NO: 3 , SEQ ID NO: 5 , SEQ ID NO: 7 , SEQ ID NO: 9 , SEQ ID NO: 11, SEQ ID
NO:13, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 2 1 and SEQ ID
NO: 23 (and parts thereof) owing to the degeneracy of the genetic code and which
thus encode the same ∆-12-desaturase and ∆-15-desaturase, ∆-9-elongase,
∆-8-desaturase or ∆-5-desaturase as those encoded by the nucleotide sequences
shown in SEQ ID NO: 1, SEQ ID NO: 3 , SEQ ID NO: 5 , SEQ ID NO: 7 , SEQ ID NO: 9 ,
SEQ ID NO: 11, SEQ ID NO:13, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19,
SEQ ID NO: 2 1 and SEQ ID NO: 23.
Suitable plants for the production in the process according to the invention are, in
principle all plants that produces mature seeds especially crop plants such as oilseed
plants.
Plants which are suitable are, in principle, all those plants which are capable of sy n
thesizing fatty acids and that produce mature seeds, such as all dicotyledonous or
monocotyledonous plants. Advantageous plants are selected from the group consist
ing of the plant families Anacardiaceae, Asteraceae, Apiaceae, Boraginaceae, Brassi-
caceae, Cannabaceae, Elaeagnaceae, Euphorbiaceae, Fabaceae, Geraniaceae,
Gramineae, Juglandaceae, Leguminosae, Linaceae, Lythrarieae, Malvaceae, Ona-
graceae, Palmae, Poaceae, Rubiaceae, Scrophulariaceae, Solanaceae, Sterculi-
aceae and Theaceae or vegetable plants or ornamentals. More preferred plants are
selected from the group consisting of the plant genera of Pistacia, Mangifera, Anacar-
dium, Calendula, Carthamus, Centaurea, Cichorium, Cynara, Helianthus, Lactuca,
Locusta, Tagetes, Valeriana, Borago, Daucus, Brassica, Camelina, Melanosinapis,
Sinapis, Arabadopsis, Orychophragmus, Cannabis, Elaeagnus, Manihot, Janipha,
Jatropha, Ricinus, Pisum, Albizia, Cathormion, Feuillea, Inga, Pithecolobium, Acacia,
Mimosa, Medicajo, Glycine, Dolichos, Phaseolus, Pelargonium, Cocos, Oleum, Jug-
lans, Wallia, Arachis, Linum, Punica, Gossypium, Camissonia, Oenothera, Elaeis,
Hordeum, Secale, Avena, Sorghum, Andropogon, Holcus, Panicum, Oryza, Zea, Triti-
cum, Coffea, Verbascum, Capsicum, Nicotiana, Solanum, Lycopersicon, Theobroma
and Camellia.
Examples which may be mentioned are the following plants selected from the group
consisting of Anacardiaceae such as the genera Pistacia, Mangifera, Anacardium, for
example the genus and species Pistacia vera [pistachio], Mangifer indica [mango] or
Anacardium occidentale [cashew], Asteraceae, such as the genera Calendula,
Carthamus, Centaurea, Cichorium, Cynara, Helianthus, Lactuca, Locusta, Tagetes,
Valeriana, for example the genus and species Calendula officinalis [common
marigold], Carthamus tinctorius [safflower], Centaurea cyanus [cornflower], Cichorium
intybus [chicory], Cynara scolymus [artichoke], Helianthus annus [sunflower], Lactuca
sativa, Lactuca crispa, Lactuca esculenta, Lactuca scariola L . ssp. sativa, Lactuca
scariola L. var. integrata, Lactuca scariola L . var. integrifolia, Lactuca sativa subsp.
romana, Locusta communis, Valeriana locusta [salad vegetables], Tagetes lucida,
Tagetes erecta or Tagetes tenuifolia [african or french marigold], Apiaceae, such as
the genus Daucus, for example the genus and species Daucus carota [carrot],
Boraginaceae, such as the genus Borago, for example the genus and species Borago
officinalis [borage], Brassicaceae, such as the genera Brassica, Camelina,
Melanosinapis, Sinapis, Arabadopsis, for example the genera and species Brassica
napus, Brassica rapa ssp. [oilseed rape], Sinapis arvensis Brassica juncea, Brassica
juncea var. juncea, Brassica juncea var. crispifolia, Brassica juncea var. foliosa,
Brassica nigra, Brassica sinapioides, Camelina sativa, Melanosinapis communis
[mustard], Brassica oleracea [fodder beet] or Arabidopsis thaliana, Cannabaceae,
such as the genus Cannabis, such as the genus and species Cannabis sativa [hemp],
Elaeagnaceae, such as the genus Elaeagnus, for example the genus and species
Olea europaea [olive], Euphorbiaceae, such as the genera Manihot, Janipha,
Jatropha, Ricinus, for example the genera and species Manihot utilissima, Janipha
manihot, Jatropha manihot, Manihot aipil, Manihot dulcis, Manihot manihot, Manihot
melanobasis, Manihot esculenta [cassava] or Ricinus communis [castor-oil plant],
Fabaceae, such as the genera Pisum, Albizia, Cathormion, Feuillea, Inga,
Pithecolobium, Acacia, Mimosa, Medicajo, Glycine, Dolichos, Phaseolus, soybean, for
example the genera and species Pisum sativum, Pisum arvense, Pisum humile [pea],
Albizia berteriana, Albizia julibrissin, Albizia lebbeck, Acacia berteriana, Acacia
littoralis, Albizia berteriana, Albizzia berteriana, Cathormion berteriana, Feuillea
berteriana, lnga fragrans, Pithecellobium berterianum, Pithecellobium fragrans,
Pithecolobium berterianum, Pseudalbizzia berteriana, Acacia julibrissin, Acacia nemu,
Albizia nemu, Feuilleea julibrissin, Mimosa julibrissin, Mimosa speciosa, Sericanrda
julibrissin, Acacia lebbeck, Acacia macrophylla, Albizia lebbeck, Feuilleea lebbeck,
Mimosa lebbeck, Mimosa speciosa, Medicago sativa, Medicago falcata, Medicago
varia [alfalfa] Glycine max Dolichos soja, Glycine gracilis, Glycine hispida, Phaseolus
max, Soja hispida or Soja max [soybean], Geraniaceae, such as the genera
Pelargonium, Cocos, Oleum, for example the genera and species Cocos nucifera,
Pelargonium grossularioides or Oleum cocois [coconut], Gramineae, such as the
genus Saccharum, for example the genus and species Saccharum officinarum,
Juglandaceae, such as the genera Juglans, Wallia, for example the genera and
species Juglans regia, Juglans ailanthifolia, Juglans sieboldiana, Juglans cinerea,
Wallia cinerea, Juglans bixbyi, Juglans californica, Juglans hindsii, Juglans
intermedia, Juglans jamaicensis, Juglans major, Juglans microcarpa, Juglans nigra or
Wallia nigra [walnut], Leguminosae, such as the genus Arachis, for example the
genus and species Arachis hypogaea [peanut], Linaceae, such as the genera
Adenolinum, for example the genera and species Linum usitatissimum, Linum humile,
Linum austriacum, Linum bienne, Linum angustifolium, Linum catharticum, Linum
flavum, Linum grandiflorum, Adenolinum grandiflorum, Linum lewisii, Linum
narbonense, Linum perenne, Linum perenne var. lewisii, Linum pratense or Linum
trigynum [linseed], Lythrarieae, such as the genus Punica, for example the genus and
species Punica granatum [pomegranate], Malvaceae, such as the genus Gossypium,
for example the genera and species Gossypium hirsutum, Gossypium arboreum,
Gossypium barbadense, Gossypium herbaceum or Gossypium thurberi [cotton],
Onagraceae, such as the genera Camissonia, Oenothera, for example the genera
and species Oenothera biennis or Camissonia brevipes [evening primrose], Palmae,
such as the genus Elaeis, for example the genus and species Elaeis guineensis [oil
palm], Poaceae, such as the genera Hordeum, Secale, Avena, Sorghum,
Andropogon, Holcus, Panicum, Oryza, Zea (maize), Triticum, for example the genera
and species Hordeum vulgare, Hordeum jubatum, Hordeum murinum, Hordeum
secalinum, Hordeum distichon Hordeum aegiceras, Hordeum hexastichon, Hordeum
hexastichum, Hordeum irregulare, Hordeum sativum, Hordeum secalinum [barley],
Secale cereale [rye], Avena sativa, Avena fatua, Avena byzantina, Avena fatua var.
sativa, Avena hybrida [oats], Sorghum bicolor, Sorghum halepense, Sorghum
saccharatum, Sorghum vulgare, Andropogon drummondii, Holcus bicolor, Holcus
sorghum, Sorghum aethiopicum, Sorghum arundinaceum, Sorghum caffrorum,
Sorghum cernuum, Sorghum dochna, Sorghum drummondii, Sorghum durra,
Sorghum guineense, Sorghum lanceolatum, Sorghum nervosum, Sorghum
saccharatum, Sorghum subglabrescens, Sorghum verticilliflorum, Sorghum vulgare,
Holcus halepensis, Sorghum miliaceum, Panicum militaceum [millet], Oryza sativa,
Oryza latifolia [rice], Zea mays [maize] Triticum aestivum, Triticum durum, Triticum
turgidum, Triticum hybernum, Triticum macha, Triticum sativum or Triticum vulgare
[wheat], Rubiaceae, such as the genus Coffea, for example the genera and species
Coffea spp., Coffea arabica, Coffea canephora or Coffea liberica [coffee],
Scrophulariaceae, such as the genus Verbascum, for example the genera and
species Verbascum blattaria, Verbascum chaixii, Verbascum densiflorum, Verbascum
lagurus, Verbascum Iongifolium, Verbascum lychnitis, Verbascum nigrum, Verbascum
olympicum, Verbascum phlomoides, Verbascum phoenicum, Verbascum
pulverulentum or Verbascum thapsus [verbascum], Solanaceae, such as the genera
Capsicum, Nicotiana, Solanum, Lycopersicon, for example the genera and species
Capsicum annuum, Capsicum annuum var. glabriusculum, Capsicum frutescens
[pepper], Capsicum annuum [paprika], Nicotiana tabacum, Nicotiana alata, Nicotiana
attenuata, Nicotiana glauca, Nicotiana langsdorffii, Nicotiana obtusifolia, Nicotiana
quadrivalvis, Nicotiana repanda, Nicotiana rustica, Nicotiana sylvestris [tobacco],
Solanum tuberosum [potato], Solanum melongena [eggplant] Lycopersicon
esculentum, Lycopersicon lycopersicum, Lycopersicon pyriforme, Solanum
integrifolium or Solanum lycopersicum [tomato], Sterculiaceae, such as the genus
Theobroma, for example the genus and species Theobroma cacao [cacao] or
Theaceae, such as the genus Camellia, for example the genus and species Camellia
sinensis [tea].
Plants which are especially advantageously used in the process according to the in
vention are plants which belong to the oil-producing plants, that is to say which are
used for the production of oil, such as oilseed or oil crop plants which comprise large
amounts of lipid compounds, such as peanut, oilseed rape, canola, sunflower, saf-
flower (Carthamus tinctoria), poppy, mustard, hemp, castor-oil plant, olive, sesame,
Calendula, Punica, evening primrose, verbascum, thistle, wild roses, hazelnut, al-
mond, macadamia, avocado, bay, pumpkin/squash, linseed, soybean, pistachios, bo
rage, trees (oil palm, coconut or walnut) or arable crops such as maize, wheat, rye,
oats, triticale, rice, barley, cotton, cassava, pepper, Tagetes, Solanaceae plants such
as potato, tobacco, eggplant and tomato, Vicia species, pea, alfalfa or bushy plants
(coffee, cacao, tea), SaNx species, and perennial grasses and fodder crops. Preferred
plants according to the invention are oil crop plants such as peanut, oilseed rape, ca
nola, sunflower, safflower, poppy, mustard, hemp, castor-oil plant, olive, Calendula,
Punica, evening primrose, pumpkin/squash, linseed, soybean, borage, trees (oil palm,
coconut). Especially preferred are plants which are high in C18:1-, C18:2- and/or
C18:3-fatty acids, such as oilseed rape, canola, Brassica juncea, Camelina sativa,
Orychophragmus, sunflower, safflower, tobacco, verbascum, sesame, cotton, pump
kin/squash, poppy, evening primrose, walnut, linseed, hemp or thistle. Very especially
preferred plants are plants such as rapeseed, canola, safflower, sunflower, poppy,
mustard, hemp, evening primrose, walnut, linseed or hemp. Other preferred plants are
castor bean, sesame, olive, calendula, punica, hazel nut, maize, almond, macadamia,
cotton, avocado, pumpkin, laurel, pistachio, oil palm, peanut, soybean, marigold, cof
fee, tobacco, cacao and borage
For the production of further ω-6- and/or ω-3-fatty acids it is advantageously to intro
duce further nucleic fatty acid sequences, which encode other enzymes of the fatty
acids synthesis chain such as preferably ∆- -elongase(s) and/or ∆-4-desaturase(s)
[for the purposes of the present invention, the plural is understood as comprising the
singular and vice versa]. Other Genes of the fatty acid or lipid metabolism, which can
be introduced are selected from the group consisting of acyl-CoA dehydrogenase(s),
acyl-ACP [= acyl carrier protein] desaturase(s), acyl-ACP thioesterase(s), fatty acid
acyl transferase(s), acyl-CoA:lysophospholipid acyltransferases, fatty acid syn-
thase(s), fatty acid hydroxylase(s), acetyl-coenzyme A carboxylase(s), acyl-coenzyme
A oxidase(s), fatty acid desaturase(s), fatty acid acetylenases, lipoxygenases, triacyl-
glycerol lipases, allenoxide synthases, hydroperoxide lyases or fatty acid elongase(s).
Preferred nucleic acid sequences, which can be used in addition in the inventive
process, are disclosed in the sequence protocol of WO2005/012316 and in Table 1 of
the specification of said application, these sequences are hereby incorporated by ref
erence.
Transgenic plants are to be understood as meaning single plant cells, certain tissues,
organs or parts of plants and their cultures on solid media or in liquid culture, parts of
plants and entire plants such as plant cell cultures, protoplasts from plants, callus cu l
tures or plant tissues such as leafs, stem, shoots, seeds, flowers, roots, tubers etc.
Said transgenic plants can be cultivated for example on solid or liquid culture medium,
in soil or in hydroponics. Plants in the sense of the invention also include plant cells
and certain tissues, organs and parts of plants in all their phenotypic forms such as
anthers, fibers, root hairs, stalks, embryos, calli, cotelydons, petioles, harvested mate
rial, plant tissue, reproductive tissue such as seeds and cell cultures which are derived
from the actual transgenic plant and/or can be used for bringing about the transgenic
plant. In this context, the seed comprises all parts of the seed such as the seed coats,
epidermal cells, seed cells, endosperm or embryonic tissue.
For the purposes of the invention, "transgenic" or "recombinant" means with regard to,
for example, a nucleic acid sequence, an expression cassette (= gene construct) or a
vector comprising the nucleic acid sequence or an organism transformed with the
nucleic acid sequences, gene constructs or vectors as described herein according to
the invention, all those constructions brought about by recombinant methods in which
either
a) the nucleic acid sequence according to the invention, or
b) a genetic control sequence which is operably linked with the nucleic acid
sequence according to the invention, for example a promoter, or
c) a) and b)
are not located in their natural genetic environment or have been modified by
recombinant methods, it being possible for the modification to take the form of, for
example, a substitution, addition, deletion, inversion or insertion of one or more
nucleotide residues. The natural genetic environment is understood as meaning the
natural genomic or chromosomal locus in the original plant or the presence in a
genomic library. In the case of a genomic library, the natural genetic environment of
the nucleic acid sequence is preferably retained, at least in part. The environment
flanks the nucleic acid sequence at least on one side and has a sequence length of at
least 50 bp, preferably at least 500 bp, especially preferably at least 1000 bp, most
preferably at least 5000 bp. A naturally occurring expression cassette - for example
the naturally occurring combination of the natural promoter of the nucleic acid
sequences with the corresponding ∆ 12-desaturase and ∆ 15-desaturase-,
∆-9-elongase-, ∆-8-desaturase- and/or ∆5-desaturase-genes - becomes a transgenic
expression cassette when this expression cassette is modified by non-natural,
synthetic ("artificial") methods such as, for example, mutagenic treatment. Suitable
methods are described, for example, in US 5,565,350 or WO 00/15815.
A transgenic plant for the purposes of the invention is therefore understood as
meaning, as above, that the nucleic acids used in the process are not at their natural
locus in the genome of a plant, it being possible for the nucleic acids to be expressed
homologously or heterologously. However, as mentioned, transgenic also means that,
while the nucleic acids according to the invention are at their natural position in the
genome of a plant, the sequence has been modified with regard to the natural
sequence, and/or that the regulatory sequences of the natural sequences have been
modified. Transgenic is preferably understood as meaning the expression of the
nucleic acids according to the invention at an unnatural locus in the genome, i.e.
homologous or, preferably, heterologous expression of the nucleic acids takes place.
Preferred transgenic organisms are oilseed crops.
After cultivation transgenic plants which are used in the inventive process can be
brought to the market without isolating the ω-6- and/or ω-3-fatty acids preferably the
arachidonic and/or eicosapentaenoic acid. Preferably the ω-6- and/or ω-3-fatty acids
are isolated from the plant in the form of their free fatty acids, their lipids or oils. The
purification can be done by conventional methods such as squeezing and extraction
of the plants or other methods instead of the extraction such as distillation, crystalliza
tion at low temperatures, chromatography or a combination of said methods. Advan
tageously the plants are grinded, heated and/or vaporized before the squeezing and
extraction procedure. As solvent for the extraction solvents such as hexane or other
solvents having a similar extraction behavior are used. The isolated oils are further
purified by acidification with for example phosphoric acid. The free fatty acids are pro
duced from said oils or lipids by hydrolysis. Charcoal or diatom earth is used to re
move dyes from the fluid. In another preferred embodiment of the inventive process
the alkyl ester of the fatty acids are produced from the oils and lipids by transesterifi-
cation with an enzyme of with conventional chemistry. A preferred method is the pro
duction of the alkyl ester in the presence of alcoholates of the corresponding lower
alcohols (C1 to C10 alcohols such as methanol, ethanol, propanol, butanol, hexanol
etc.) such as methanolate or ethanolate. Therefore as the skilled worker knows the
alcohol in the presence of a catalytic amount of a base such as NaOH or KOH is
added to the oils or lipids.
In a preferred form of the inventive process the lipids can be obtained in the usual
manner after the plants have been grown. To this end, the organisms can first be ha r
vested and then disrupted, or they can be used directly. In the case of plant cells,
plant tissue or plant organs, "growing" is understood as meaning, for example, the
cultivation on or in a nutrient medium, or of the intact plant on or in a substrate, for
example in a hydroponic culture, potting compost or on arable land. It is advanta
geous to extract the lipids with suitable solvents such as apolar solvents, for example
hexane, or polar solvents, for example ethanol, isopropanol, or mixtures such as hex-
ane/isopropanol, phenol/chloroform/isoamyl alcohol, at temperatures between O0C
and 8 O0C, preferably between 2 O0C and 5 O0C. As a rule, the biomass is extracted with
an excess of solvent, for example with an excess of solvent to biomass of 1:4. The
solvent is subsequently removed, for example by distillation. The extraction may also
be carried out with supercritical CO2. After the extraction, the remainder of the b io
mass can be removed, for example, by filtration. Standard methods for the extraction
of fatty acids from plants and microorganisms are described in Bligh et al. (Can. J.
Biochem. Physiol. 37, 1959: 9 11-917) or Vick et al. (Plant Physiol. 69, 1982: 1103-
1108).
The crude oil thus obtained can then be purified further, for example by removing
cloudiness by adding polar solvents such as acetone or apolar solvents such as chlo-
roform, followed by filtration or centrifugation. Further purification via columns or other
techniques is also possible.
To obtain the free fatty acids from the triglycerides, the latter are hyrolyzed in the cus
tomary manner, for example using NaOH or KOH.
In the inventive process oils, lipids and/or free fatty acids or fractions thereof are pro-
duced. Said products can be used for the production of feed and food products, cos
metics or pharmaceuticals.
The oils, lipids, LCPUFAs or fatty acid compositions produced according to the
inventive process can be used in the manner with which the skilled worker is familiar
for mixing with other oils, lipids, fatty acids or fatty acid mixtures of animal origin, such
as, for example, fish oils and/or microbial oils such as from Mortierella or
Crypthecodinium. These oils, lipids, fatty acids or fatty acid mixtures, which are
composed of vegetable, microbial and/or animal constituents, may also be used for
the preparation of feedstuffs, foodstuffs, cosmetics or pharmaceuticals.
The term "oil", "lipid" or "fat" is understood as meaning a fatty acid mixture comprising
unsaturated, saturated, preferably esterified, fatty acid(s). The oil, lipid, fat, fatty acid
and/or fatty acid composition is preferably high in polyunsaturated (PUFA and/or
LCPUFA) free and/or, advantageously, esterified fatty acid(s), in particular oleic acid,
linoleic acid, α-linolenic acid, arachidonic acid and/or eicosatetraenoic acid.
Transgenic plants which comprise the LCPUFAs synthesized in the process according
to the invention can also advantageously be marketed directly without there being any
need for the oils, lipids or fatty acids synthesized to be isolated.
However, the LCPUFAs produced in the process according to the invention can also
be isolated from the plants as described above, in the form of their oils, fats, lipids
and/or free fatty acids. Polyunsaturated fatty acids produced by this process can be
obtained by harvesting the crop in which they grow, or from the field. This can be
done via pressing or extraction of the plant parts, preferably the plant seeds. In this
context, the oils, fats, lipids and/or free fatty acids can be obtained by what is known
as cold-beating or cold-pressing without applying heat. To allow for greater ease of
disruption of the plant parts, specifically the seeds, they are previously comminuted,
steamed or roasted. The seeds, which have been pretreated in this manner can
subsequently be pressed or extracted with solvents such as warm hexane. The
solvent is subsequently removed. In the case of microorganisms, the latter are, after
harvesting, for example extracted directly without further processing steps or else,
after disruption, extracted via various methods with which the skilled worker is familiar.
In this manner, more than 96% of the compounds produced in the process can be
isolated. Thereafter, the resulting products are processed further, i.e. refined. In this
process, substances such as the plant mucilages and suspended matter are first
removed. What is known as desliming can be effected enzymatically or, for example,
chemico-physically by addition of acid such as phosphoric acid. Thereafter, the free
fatty acids are removed by treatment with a base, for example sodium hydroxide
solution. The resulting product is washed thoroughly with water to remove the alkali
remaining in the product and then dried. To remove the pigment remaining in the
product, the products are subjected to bleaching, for example using filler's earth or
active charcoal. At the end, the product is deodorized, for example using steam.
The preferred biosynthesis site of the fatty acids, oils, lipids or fats in the plants which
are advantageously used is, for example, in general the seed or cell strata of the
seed, so that seed-specific expression of the nucleic acids used in the process makes
sense. However, it is obvious that the biosynthesis of fatty acids, oils or lipids need
not be limited to the seed tissue, but can also take place in a tissue-specific manner in
all the other parts of the plant, for example in epidermal cells or in the tubers.
In principle, the LCPUFAs produced by the process according to the invention in the
organisms used in the process can be increased in two different ways.
Advantageously, the pool of free polyunsaturated fatty acids and/or the content of the
esterified polyunsaturated fatty acids produced via the process can be enlarged.
Advantageously, the pool of esterified polyunsaturated fatty acids in the transgenic
plants is enlarged by the process according to the invention.
In principle all nucleic acids encoding polypeptides with ∆-8-desaturase, ∆-9-elongase
and/or ∆-5-desaturase activity can be used in the inventive process. Preferably the
nucleic acid sequences can be isolated for example from microorganism or plants
such as fungi like Mortierella, algae like Euglena, Crypthecodinium or Isochrysis, d ia
toms like Phaeodactylum, protozoa like amoeba such as Acanthamoeba or Perkinsus
or mosses like Physcomitrella or Ceratodon, but also non-human animals such as
Caenorhabditis are possible as source for the nucleic acid sequences. Advantageous
nucleic acid sequences according to the invention which encode polypeptides having
a ∆-8-desaturase, ∆-9-elongase and/or ∆-5-desaturase activity are originate from m i
croorganisms or plants, advantageously Phaeodactylum tricornutum, Ceratodon pur-
pureus, Physcomitrella patens, Euglena gracilis, Acanthamoeba castellanii, Perkinsus
marinus or Isochrysis galbana. Thus, the co expression of a C18-specific ∆-12-
desaturase and ∆-15-desaturase, a C18-specific ∆-9 elongase, a C20-specific ∆-8-
desaturase and a C20-specific ∆-5-desaturase leads to the formation of Arachidonic
acid (C20:6n-4, ∆5 , 8 , 11, 14) and/or Eicosapentaenoic acid (C20:3n-5, ∆5 , 8 , 11, 14,
17). Most preferred are the sequences mentioned in the sequence protocol.
In another embodiment the invention furthermore relates to isolated nucleic acid se
quences encoding polypeptides with ∆-12-desaturase and ∆-15-desaturase-, ∆-9-
elongase-, ∆-8-desaturase- and/or ∆-5-desaturase-acitivity.
In one embodiment the invention relates to an isolated nucleic acid sequence which
encodes a polypeptide having a ∆-12-desaturase and ∆-15-desaturase activity se
lected from the group consisting of
a) a nucleic acid sequence depicted in SEQ ID NO: 19, SEQ ID NO: 2 1 or SEQ ID
NO: 23;
b) a nucleic acid sequence, which, as a result of the degeneracy of the genetic
code, can be derived from a polypeptide sequence as depicted in SEQ ID NO:
20, SEQ ID NO: 22 or SEQ ID NO: 24;
c) derivatives of the nucleic acid sequence depicted in SEQ ID NO: 19, SEQ ID
NO: 2 1 or SEQ ID NO: 22 which encode polypeptides having at least 40 % ho
mology to the sequence as depicted in SEQ ID NO: 20, SEQ ID NO: 22 or SEQ
ID NO: 24 and which polypeptides having ∆-12-desaturase and ∆-15-
desaturase activity.
This inventive ∆-12-desaturase and ∆-15-desaturase is able to desaturate C16-fatty
acids having at least one double bond in the fatty acid chain and/or C18-fatty acids
having at least one double bond in the fatty acid chain. Preferably C16- and/or C18-
fatty acids having only one double bond in the fatty acid chain are desaturated. This
activity leads to an increase in flux from precursor fatty acids such as C18-fatty acids
towards C18-fatty acids having more than one double bond in the fatty acid chain
such as linoleic and/or linolenic acid. C18-fatty acids are more preferred in the reac
tion than C16-fatty acids. C18-fatty acids are more than doubled preferred.
In another embodiment the invention relates to an isolated nucleic acid sequence
comprising a nucleotide sequence which encodes a ∆-9-elongase selected from the
group consisting of
a) a nucleic acid sequence depicted in SEQ ID NO: 11;
b) a nucleic acid sequence, which, as a result of the degeneracy of the genetic
code, can be derived from a polypeptide sequence as depicted in SEQ ID NO:
12;
c) derivatives of the nucleic acid sequence depicted in SEQ ID NO: 11 which e n
code polypeptides having at least 70 % homology to the sequence as depicted
in SEQ ID NO: 12 and which polypeptides having ∆-9-elongase activity.
In yet another embodiment the invention relates to an isolated nucleic acid sequence
comprising a nucleotide sequence which encodes a ∆-8-desaturase selected from the
group consisting of
a) a nucleic acid sequence depicted in SEQ ID NO: 3 , SEQ ID NO: 5 or SEQ ID
NO: 7 ;
b) a nucleic acid sequence, which, as a result of the degeneracy of the genetic
code, can be derived from a polypeptide sequence as depicted in SEQ ID NO: 4 ,
SEQ ID NO: 6 or SEQ ID NO: 8 ;
c) derivatives of the nucleic acid sequence depicted in SEQ ID NO: 3 , SEQ ID NO:
5 or SEQ ID NO: 7 which encode polypeptides having at least 70 % homology to
the sequence as depicted in SEQ ID NO: 4 , SEQ ID NO: 6 or SEQ ID NO: 8 and
which polypeptides having ∆-8-desaturase activity.
Further in another embodiment the invention relates to an isolated nucleic acid se
quence comprising a nucleotide sequence which encodes a ∆-5-desaturase selected
from the group consisting of
a) a nucleic acid sequence depicted in SEQ ID NO: 15 or SEQ ID NO: 17;
b) a nucleic acid sequence, which, as a result of the degeneracy of the genetic
code, can be derived from a polypeptide sequence as depicted in SEQ ID NO:
16 or SEQ ID NO: 18;
c) derivatives of the nucleic acid sequence depicted in SEQ ID NO: 15 or SEQ ID
NO: 17 which encode polypeptides having at least 70 % homology to the se-
quence as depicted in SEQ ID NO: 16 or SEQ ID NO: 18 and which polypeptides
having ∆-5-desaturase activity.
By derivative(s) of the sequences according to the invention is meant, for example,
functional homologues of the polypeptides or enzymes encoded by SEQ ID NO: 3 ,
SEQ ID NO: 5 , SEQ ID NO: 7 , SEQ ID NO: 11, SEQ ID NO: 15, SEQ ID NO: 17, SEQ
ID NO: 19, SEQ ID NO: 2 1 or SEQ ID NO: 23 which exhibit the same said specific
enzymatic activity. This specific enzymatic activity allows advantageously the synthe
sis of LCPUFAs of the ω-6- and/or ω-3-pathway of the fatty acid synthesis chain such
as ARA and/or EPA. The said sequences encode enzymes which exhibit ∆-12-
desaturase and ∆-15-desaturase-, ∆-9-elongase-, ∆-8-desaturase- and/or ∆-5-
desaturase-activity.
The enzyme according to the invention, ∆-12-desaturase and ∆-15-desaturase, ∆-9-
elongase, ∆-8-desaturase and/or ∆-5-desaturase, advantageously either elongates
fatty acid chains with 18 carbon atoms (see SEQ ID NO: 11) or introduces a double
bond into fatty acid residues of glycerolipids, free fatty acids or acyl-CoA fatty acids at
position C8-C9 (see SEQ ID NO: 3 , 5 or 7) or at position C5-C6 (see SEQ ID NO: 15 or
17) or at position Ci2-Ci 3 and Ci5-Ci 6 of the fatty acid chain (see SEQ ID NO: 19, 2 1
or 23).
The inventive nucleic acid molecules, for example a nucleic acid molecule with a nu
cleotide sequence of SEQ ID NO: 3 , SEQ ID NO: 5 , SEQ ID NO: 7 , SEQ ID NO: 11,
SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 2 1 or SEQ ID NO: 23
or of a part thereof can be isolated using molecular-biological standard techniques
and the sequence information provided herein. Also, for example a homologous se-
quence or homologous, conserved sequence regions can be identified at the DNA or
amino acid level with the aid of comparative algorithms. They can be used as hybridi
zation probe and standard hybridization techniques (such as, for example, those de
scribed in Sambrook et al., Molecular Cloning: A Laboratory Manual. 2nd ed., Cold
Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press, Cold Spring Harbor,
NY, 1989) for isolating further nucleic acid sequences which can be used in the proc
ess. Moreover, a nucleic acid molecule comprising a complete sequence of SEQ ID
NO: 3 , SEQ ID NO: 5 , SEQ ID NO: 7 , SEQ ID NO: 11, SEQ ID NO: 15, SEQ ID NO:
17, SEQ ID NO: 19, SEQ ID NO: 2 1 or SEQ ID NO: 23 or a part thereof can be iso
lated by polymerase chain reaction, where oligonucleotide primers which are used on
the basis of this sequence or parts thereof (for example a nucleic acid molecule com
prising the complete sequence or part thereof can be isolated by polymerase chain
reaction using oligonucleotide primers which have been generated based on this
same sequence). For example, mRNA can be isolated from cells (for example by
means of the guanidinium thiocyanate extraction method of Chirgwin et al. (1979)
Biochemistry 18:5294-5299) and cDNA by means of reverse transcriptase (for exam
ple Moloney MLV reverse transcriptase, available from Gibco/BRL, Bethesda, MD, or
AMV reverse transcriptase, available from Seikagaku America, Inc., St. Petersburg,
FL). Synthetic oligonucleotide primers for the amplification by means of polymerase
chain reaction can be generated based on one of the sequences shown in SEQ ID
NO: 3 , SEQ ID NO: 5 , SEQ ID NO: 7 , SEQ ID NO: 11, SEQ ID NO: 15, SEQ ID NO:
17, SEQ ID NO: 19, SEQ ID NO: 2 1 or SEQ ID NO: 23 or with the aid of the amino
acid sequences detailed in SEQ ID NO: 4 , SEQ ID NO: 6 , SEQ ID NO: 8 , SEQ ID NO:
12, SEQ ID NO: 16, SEQ ID NO: 18, SEQ ID NO: 20, SEQ ID NO: 22 or SEQ ID NO:
24. A nucleic acid according to the invention can be amplified by standard PCR ampli
fication techniques using cDNA or, alternatively, genomic DNA as template and suit
able oligonucleotide primers. The nucleic acid amplified thus can be cloned into a
suitable vector and characterized by means of DNA sequence analysis. Oligonucleo
tides, which correspond to a desaturase nucleotide sequence can be generated by
standard synthetic methods, for example using an automatic DNA synthesizer.
Homologs of the ∆-12-desaturase and ∆-15-desaturase, ∆-9-elongase,
∆-8-desaturase or ∆-5-desaturase nucleic acid sequences with the sequence SEQ ID
NO: 3 , SEQ ID NO: 5 , SEQ ID NO: 7 , SEQ ID NO: 11, SEQ ID NO: 15, SEQ ID NO:
17, SEQ ID NO: 19, SEQ ID NO: 2 1 or SEQ ID NO: 23 means, for example, allelic
variants with at least approximately 50 or 60%, preferably at least approximately 60 or
70%, more preferably at least approximately 70 or 80%, 90% or 95% and even more
preferably at least approximately 85%, 86%, 87%, 88%, 89%, 90%, 9 1%, 92%, 93%,
94%, 95 %, 96%, 97%, 98%, 99% or more identity or homology with a nucleotide
sequence shown in SEQ ID NO: 3 , SEQ ID NO: 5 , SEQ ID NO: 7 , SEQ ID NO: 11,
SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 2 1 or SEQ ID NO: 23
or its homologs, derivatives or analogs or parts thereof. Furthermore, isolated nucleic
acid molecules of a nucleotide sequence which hybridize with one of the nucleotide
sequences shown in SEQ ID NO: 3 , SEQ ID NO: 5 , SEQ ID NO: 7 , SEQ ID NO: 11,
SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 2 1 or SEQ ID NO: 23
or with a part thereof, for example hybridized under stringent conditions. A part
thereof is understood as meaning, in accordance with the invention, that at least 25
base pairs (= bp), 50 bp, 75 bp, 100 bp, 125 bp or 150 bp, preferably at least 175 bp,
200 bp, 225 bp, 250 bp, 275 bp or 300 bp, especially preferably 350 bp, 400 bp, 450
bp, 500 bp or more base pairs are used for the hybridization. It is also possible and
advantageous to use the full sequence. Allelic variants comprise in particular
functional variants which can be obtained by deletion, insertion or substitution of
nucleotides from/into the sequence detailed in SEQ ID NO: 3 , SEQ ID NO: 5 , SEQ ID
NO: 7 , SEQ ID NO: 11, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO:
2 1 or SEQ ID NO: 23, it being intended, however, that the enzyme activity of the
resulting proteins which are synthesized is advantageously retained for the insertion
of one or more genes. Proteins which retain the enzymatic activity of the ∆-12-
desaturase and ∆-15-desaturase, ∆-9-elongase, ∆-8-desaturase or ∆-5-desaturase,
i.e. whose activity is essentially not reduced, means proteins with at least 10%,
preferably 20%, especially preferably 30%, very especially preferably 40% of the
original enzyme activity in comparison with the protein encoded by SEQ ID NO: 3 ,
SEQ ID NO: 5 , SEQ ID NO: 7 , SEQ ID NO: 11, SEQ ID NO: 15, SEQ ID NO: 17, SEQ
ID NO: 19 , SEQ ID NO: 2 1 or SEQ ID NO: 23. The homology was calculated over the
entire amino acid or nucleic acid sequence region. The skilled worker has available a
series of programs which are based on various algorithms for the comparison of
various sequences. Here, the algorithms of Needleman and Wunsch or Smith and
Waterman give particularly reliable results. The program PiIeUp (J. MoI. Evolution.,
25, 351-360, 1987, Higgins et al., CABIOS, 5 1989: 151-153) or the programs Gap
and BestFit [Needleman and Wunsch (J. MoI. Biol. 48; 443-453 (1970) and Smith and
Waterman (Adv. Appl. Math. 2 ; 482-489 (1981 )], which are part of the GCG software
packet [Genetics Computer Group, 575 Science Drive, Madison, Wisconsin, USA
5371 1 ( 1991 )], were used for the sequence alignment. The sequence homology
values which are indicated above as a percentage were determined over the entire
sequence region using the program GAP and the following settings: Gap Weight: 50,
Length Weight: 3 , Average Match: 10.000 and Average Mismatch: 0.000. Unless
otherwise specified, these settings were always used as standard settings for the
sequence alignments.
Homologs of SEQ ID NO: 3 , SEQ ID NO: 5 , SEQ ID NO: 7 , SEQ ID NO: 11, SEQ ID
NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 2 1 or SEQ ID NO: 23 means
for example also bacterial, fungal and plant homologs, truncated sequences, single-
stranded DNA or RNA of the coding and noncoding DNA sequence.
Homologs of SEQ ID NO: 3 , SEQ ID NO: 5 , SEQ ID NO: 7 , SEQ ID NO: 11, SEQ ID
NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 2 1 or SEQ ID NO: 23 also
means derivatives such as, for example, promoter variants. The promoters upstream
of the nucleotide sequences detailed can be modified by one or more nucleotide
exchanges, by insertion(s) and/or deletion(s) without the functionality or activity of the
promoters being adversely affected, however. It is furthermore possible that the
modification of the promoter sequence enhances their activity or that they are
replaced entirely by more active promoters, including those from heterologous
organisms.
In a further embodiment, derivatives of the nucleic acid molecule according to the
invention represented in SEQ ID NO: 3 , SEQ ID NO: 5 , SEQ ID NO: 7 , SEQ ID NO:
11, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 2 1 or SEQ ID NO:
23 encode proteins with at least 40%, advantageously approximately 50 or 60%,
advantageously at least approximately 60 or 70% and more preferably at least
approximately 70 or 80%, 80 to 90%, 90 to 95% and most preferably at least
approximately 96%, 97%, 98%, 99% or more homology (= identity) with a complete
amino acid sequence of SEQ ID NO: 4 , SEQ ID NO: 6 , SEQ ID NO: 8 , SEQ ID NO:
12, SEQ ID NO: 16, SEQ ID NO: 18, SEQ ID NO: 20, SEQ ID NO: 22 or SEQ ID NO:
24. The homology was calculated over the entire amino acid or nucleic acid sequence
region. The program PiIeUp (J. MoI. Evolution., 25, 351-360, 1987, Higgins et al.,
CABIOS, 5 1989: 151-153) or the programs Gap and BestFit [Needleman and
Wunsch (J. MoI. Biol. 48; 443-453 (1970) and Smith and Waterman (Adv. Appl. Math.
2 ; 482-489 (1981 )], which are part of the GCG software packet [Genetics Computer
Group, 575 Science Drive, Madison, Wisconsin, USA 5371 1 (1991 )], were used for
the sequence alignment. The sequence homology values which are indicated above
as a percentage were determined over the entire sequence region using the program
BestFit and the following settings: Gap Weight: 50, Length Weight: 3 , Average Match:
10.000 and Average Mismatch: 0.000. Unless otherwise specified, these settings
were always used as standard settings for the sequence alignments.
Moreover, the invention comprises nucleic acid molecules which differ from one of the
nucleotide sequences shown in SEQ ID NO: 3 , SEQ ID NO: 5 , SEQ ID NO: 7 , SEQ ID
NO: 11, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 2 1 or SEQ ID
NO: 23 (and parts thereof) owing to the degeneracy of the genetic code and which
thus encode the same ∆-12-desaturase and ∆-15-desaturase, ∆-9-elongase,
∆-8-desaturase or ∆-5-desaturase as those encoded by the nucleotide sequences
shown in SEQ ID NO: 3 , SEQ ID NO: 5 , SEQ ID NO: 7 , SEQ ID NO: 11, SEQ ID NO:
15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 2 1 or SEQ ID NO: 23.
In addition to the ∆-12-desaturase and ∆-15-desaturase, ∆-9-elongase,
∆-8-desaturase or ∆-5-desaturase shown in SEQ ID NO: 3 , SEQ ID NO: 5 , SEQ ID
NO: 7 , SEQ ID NO: 11, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO:
2 1 or SEQ ID NO: 23, the skilled worker will recognize that DNA sequence
polymorphisms which lead to changes in the amino acid sequences of the ∆ -12-
desaturase and ∆-15-desaturase, ∆-9-elongase, ∆-8-desaturase or ∆-5-desaturase
may exist within a population. These genetic polymorphisms in the ∆ -12-desaturase
and ∆-15-desaturase, ∆-9-elongase, ∆-8-desaturase or ∆-5-desaturase gene may
exist between individuals within a population owing to natural variation. These natural
variants usually bring about a variance of 1 to 5% in the nucleotide sequence of the
∆-12-desaturase and ∆-15-desaturase, ∆-9-elongase, ∆-8-desaturase or ∆-5-
desaturase gene. Each and every one of these nucleotide variations and resulting
amino acid polymorphisms in the ∆-12-desaturase and ∆-15-desaturase, ∆-9-
elongase,
∆-8-desaturase or ∆-5-desaturase which are the result of natural variation and do not
modify the functional activity are to be encompassed by the invention.
The nucleic acid sequence(s) according to the invention (for purposes of the applica
tion the singular encompasses the plural and vice versa) or fragments thereof may
advantageously be used for isolating other genomic sequences via homology screen
ing.
The said derivatives may be isolated, for example, from other organisms, eukaryotic
organisms such as plants, especially mosses, algae, dinoflagellates, protozoa or
fungi.
Allele variants include in particular functional variants obtainable by deletion, insertion
or substitution of nucleotides in the sequences depicted in SEQ ID NO: 3 , SEQ ID
NO: 5 , SEQ ID NO: 7 , SEQ ID NO: 11, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO:
19, SEQ ID NO: 2 1 or SEQ ID NO: 23 the enzymatic activity of the derived synthe
sized proteins being retained.
Starting from the DNA sequence described in SEQ ID NO: 3 , SEQ ID NO: 5 , SEQ ID
NO: 7 , SEQ ID NO: 11, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO:
2 1 or SEQ ID NO: 23 or parts of said sequences such DNA sequences can be iso
lated using, for example, normal hybridization methods or the PCR technique from
other eukaryotes such as those identified above for example. These DNA sequences
hybridize under standard conditions with the said sequences. For hybridization use is
advantageously made of short oligonucleotides of the conserved regions of an aver
age length of about 15 to 70 bp, preferably of about 17 to 60 bp, more preferably of
about 19 to 50 bp, most preferably of about 20 to 40 bp, for example, which can be
determined by comparisons with other desaturase or elongase genes in the manner
known to those skilled in the art. The histidine box sequences are advantageously
employed. However, longer fragments of the nucleic acids according to the invention
or the complete sequences may also be used for hybridization. Depending on the
nucleic acid employed: oligonucleotide, longer fragment or complete sequence, or
depending on which type of nucleic acid, DNA or RNA, is used for hybridization these
standard conditions vary. Thus, for example, the melting temperatures of DNA:DNA
hybrids are approximately 100C lower than those of DNA:RNA hybrids of the same
length.
By standard conditions is meant, for example, depending on the nucleic acid in ques
tion temperatures between 420C and 580C in an aqueous buffer solution having a
concentration of between 0.1 and 5 x SSC ( 1 X SSC = 0.15 M NaCI, 15 mM sodium
citrate, pH 7.2) or additionally in the presence of 50 % formamide, such as by way of
example 420C in 5 x SSC, 50 % formamide. Hybridization conditions for DNA:DNA
hybrids are advantageously 0.1 x SSC and temperatures between approximately 2 O0C
and 450C, preferably between approximately 3 O0C and 450C. For DNA:RNA hybrids
the hybridization conditions are advantageously 0.1 x SSC and temperatures between
approximately 3 O0C and 550C, preferably between approximately 450C and 550C.
These specified temperatures for hybridization are melting temperature values calcu
lated by way of example for a nucleic acid having a length of approximately 100 nu-
cleotides and a G + C content of 50 % in the absence of formamide. The experimental
conditions for DNA hybridization are described in relevant genetics textbooks such as
by way of example Sambrook et al., ..Molecular Cloning", Cold Spring Harbor Labora
tory, 1989, and may be calculated by formulae known to those skilled in the art, for
example as a function of the length of the nucleic acids, the nature of the hybrids or
the G + C content. Those skilled in the art may draw on the following textbooks for
further information on hybridization: Ausubel et al. (eds), 1985, Current Protocols in
Molecular Biology, John Wiley & Sons, New York; Hames and Higgins (eds), 1985,
Nucleic Acids Hybridization: A Practical Approach, IRL Press at Oxford University
Press, Oxford; Brown (ed), 1991 , Essential Molecular Biology: A Practical Approach,
IRL Press at Oxford University Press, Oxford.
Furthermore, by derivatives is meant homologues of the sequences SEQ ID NO: 3 ,
SEQ ID NO: 5 , SEQ ID NO: 7 , SEQ ID NO: 11, SEQ ID NO: 15, SEQ ID NO: 17, SEQ
ID NO: 19, SEQ ID NO: 2 1 or SEQ ID NO: 23, for example eukaryotic homologues,
truncated sequences, single-stranded DNA of the encoding and nonencoding DNA
sequence or RNA of the encoding and nonencoding DNA sequence.
In addition, by homologues of the sequences SEQ ID NO: 3 , SEQ ID NO: 5 , SEQ ID
NO: 7 , SEQ ID NO: 11, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO:
2 1 or SEQ ID NO: 23 is meant derivatives such as by way of example promoter vari-
ants. These variants may be modified by one or more nucleotide exchanges, by inser
tion^) and/or deletion(s) without, however, adversely affecting the functionality or eff i
ciency of the promoters. Furthermore, the promoters can have their efficiency in
creased by altering there sequence or be completely replaced by more effective pro
moters even of foreign organisms.
By derivatives is also advantageously meant variants whose nucleotide sequence has
been altered in the region from - 1 to -2000 ahead of the start codon in such a way
that the gene expression and/or the protein expression is modified, preferably in
creased. Furthermore, by derivatives is also meant variants, which have been modi
fied at the 3' end.
The nucleic acid sequences according to the invention which encode a ∆-12-
desaturase and ∆-15-desaturase, a ∆-9-elongase, a ∆- -Sesaturase and/or a ∆-5-
desaturase may be produced by synthesis or obtained naturally or contain a mixture
of synthetic and natural DNA components as well as consist of various heterologous
∆-12-desaturase and ∆-15-desaturase, ∆-9-elongase, ∆- -Sesaturase and/or ∆-5-
desaturase gene segments from different organisms. In general, synthetic nucleotide
sequences are produced with codons, which are preferred by the corresponding host
organisms, plants for example. This usually results in optimum expression of the het
erologous gene. These codons preferred by plants may be determined from codons
having the highest protein frequency, which are expressed in most of the plant spe
cies of interest. An example concerning the bacterium Corynebacterium glutamicum is
provided in Wada et al. (1992) Nucleic Acids Res. 20:21 11-21 18). Such experiments
can be carried out using standard methods and are known to the person skilled in the
art.
Functionally equivalent sequences which encode the ∆-12-desaturase and ∆-15-
desaturase, ∆-9-elongase, ∆- -Sesaturase and/or ∆-5-desaturase gene are those
derivatives of the sequence according to the invention which despite differing nucleo
tide sequence still possess the desired functions, that is to say the enzymatic activity
and specific selectivity of the proteins. That means such functionally equivalent se
quences have an biological or enzymatic activity, which is at least 10%, preferably at
least 20%, 30%, 40% or 50% especially preferably at least 60%, 70%, 80% or 90%
and very especially at least 9 1%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% or
more of the activity of the proteins/enzymes encoded by the inventive sequences.
Thus, functional equivalents include naturally occurring variants of the sequences
described herein as well as artificial ones, e.g. artificial nucleotide sequences adapted
to the codon use of a plant which have been obtained by chemical synthesis.
In addition, artificial DNA sequences are suitable, provided, as described above, they
mediate the desired property, for example an increase in the content of ∆- 1-2 ∆- 1-5
∆- -8and/or ∆-5-double bonds in fatty acids and an elongation of C18-fatty acids hav
ing a ∆-9-double bond in fatty acids, oils or lipids in plants that produce mature seeds
preferably in crop plants by over expression of the ∆-12-desaturase and ∆-15-
desaturase, ∆-9-elongase, ∆- -Sesaturase and/or ∆-5-desaturase gene. Such artificial
DNA sequences can exhibit ∆-12-desaturase and ∆-15-desaturase, ∆-9-elongase, ∆-
-Sesaturase and/or ∆-5-desaturase activity, for example by back-translation of pro-
teins constructed by means of molecular modeling, or be determined by in vitro selec
tion. Possible techniques for in vitro evolution of DNA to modify or improve the DNA
sequences are described in Patten, P.A. et al., Current Opinion in Biotechnology 8 ,
724-733( 1997) or in Moore, J .C. et al., Journal of Molecular Biology 272, 336-347
(1997). Particularly suitable are encoding DNA sequences which are obtained by
back-translation of a polypeptide sequence in accordance with the codon use specific
to the host plant. Those skilled in the art familiar with the methods of plant genetics
can easily determine the specific codon use by computer analyses of other known
genes of the plant to be transformed.
Other suitable equivalent nucleic acid sequences, which may be mentioned are se
quences that encode fusion proteins, a component of the fusion protein being a ∆-12-
desaturase and ∆-15-desaturase, ∆- -Sesaturase and/or ∆-5-desaturase polypeptide
and/or a ∆-9 elongase polypeptide or a functionally equivalent part thereof. The sec
ond part of the fusion protein can be, for example, another polypeptide having enzy-
matic activity or an antigenic polypeptide sequence by means of which it is possible to
demonstrate ∆-12-desaturase and ∆-15-desaturase, ∆-9-elongase, ∆- -Sesaturase
and/or ∆-5-desaturase expression (e.g. myc tag or his tag). Preferably, however, this
is a regulatory protein sequence, such as by way of example a signal sequence for
the endoplasmic reticulum (= ER) which directs the ∆-12-desaturase and ∆-15-
desaturase, ∆- -Sesaturase and/or ∆-5-desaturase protein and/or the ∆-9-elongase
protein to the desired point of action, or regulatory sequences which influence the
expression of the nucleic acid sequence according to the invention, such as promot
ers or terminators. In another preferred embodiment the second part of the fusion
protein is a plastidial targeting sequence as described by Napier J.A. [Targeting of
foreign proteins to the chloroplast, Methods MoI. Biol., 49, 1995: 369 - 376]. A pre
ferred used vector comprising said plastidial targeting sequence is disclosed by Colin
Lazarus [Guerineau F., Woolston S., Brooks L., Mullineaux P. "An expression cas
sette for targeting foreign proteins into chloroplast; Nucleic. Acids Res., Dec 9 , 16
(23), 1988: 11380].
Advantageously, the ∆-12-desaturase and ∆-15-desaturase, ∆-9-elongase, ∆- -8
desaturase and/or ∆-5-desaturase genes in the method according to the invention
may be combined with other genes for fatty acid biosynthesis as described above.
Examples of such genes are the acyl transferases, other desaturases or elongases
such as ∆-4-desaturases or ω-3- and/or ω-6-specific desaturases) and/or such as ∆-
5-elongases to mention only some of them. For in vivo and especially in vitro synthe
sis combination with e.g. NADH cytochrome B5 reductases, which can take up or re-
lease reduction equivalents is advantageous.
By the amino acid sequences according to the invention is meant proteins which con
tain an amino acid sequence depicted in the sequences SEQ ID NO: 4 , SEQ ID NO:
6 , SEQ ID NO: 8 , SEQ ID NO: 12, SEQ ID NO: 16, SEQ ID NO: 18, SEQ ID NO: 20,
SEQ ID NO: 22 or SEQ ID NO: 24 or a sequence obtainable there from by substitu-
tion, inversion, insertion or deletion of one or more amino acid groups (such se
quences are derivatives of SEQ ID NO: 4 , SEQ ID NO: 6 , SEQ ID NO: 8 , SEQ ID NO:
12, SEQ ID NO: 16, SEQ ID NO: 18, SEQ ID NO: 20, SEQ ID NO: 22 or SEQ ID NO:
24), whereas the enzymatic activities of the proteins depicted in SEQ ID NO: 4 , SEQ
ID NO: 6 , SEQ ID NO: 8 , SEQ ID NO: 12, SEQ ID NO: 16, SEQ ID NO: 18, SEQ ID
NO: 20, SEQ ID NO: 22 or SEQ ID NO: 24 being retained or not substantially re
duced, that is they still possess the same enzymatic specificity. By ,,not substantially
reduced" or ,,the same enzymatic activity" is meant all enzymes which still exhibit at
least 10%, 20%, 30%, 40% or 50%, preferably at least 60%, 70%, 80% or 90% pa r
ticularly preferably at least 9 1%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or
more, of the enzymatic activity of the initial enzyme obtained from the wild type source
organism such as organisms of the genus Physcomitrella, Ceratodon, Borago,
Thraustochytrium, Schizochytrium, Phytophtora, Mortierella, Caenorhabditis, Aleuritia,
Muscariodides, Isochrysis, Phaeodactylum, Crypthecodinium, Acanthamoeba or Eu-
glena preferred source organisms are organisms such as the species Euglena
gracilis, Isochrysis galbana, Phaeodactylum tricornutum, Caenorhabditis elegans,
Thraustochytrium , Phytophtora infestans, Ceratodon purpureus, Isochrysis galbana,
Aleuritia farinosa, Muscariodides vialii, Mortierella alpina, Borago officinalis or Phy
scomitrella patens. For the estimation of an enzymatic activity, which is "not substan
tially reduced" or which has the "same enzymatic activity" the enzymatic activity of the
derived sequences are determined and compared with the wild type enzyme activities.
In doing this, for example, certain amino acids may be replaced by others having simi
lar physicochemical properties (space filling, basicity, hydrophobicity, etc.). For exam
ple, arginine residues are exchanged for lysine residues, valine residues for isoleucine
residues or aspartic acid residues for glutamic acid residues. However, one or more
amino acids may also be swapped in sequence, added or removed, or a plurality of
these measures may be combined with one another.
By derivatives is also meant functional equivalents, which in particular also contain
natural or artificial mutations of an originally isolated sequence encoding a ∆-12-
desaturase and ∆-15-desaturase, a ∆-9-elongase, a ∆- -Sesaturase and/or a ∆-5-
desaturase, which continue to exhibit the desired function, that is the enzymatic activ
ity and substrate selectivity thereof is not substantially reduced. Mutations comprise
substitutions, additions, deletions, exchanges or insertions of one or more nucleotide
residues. Thus, for example, the present invention also encompasses those nucleo
tide sequences, which are obtained by modification of the ∆-12-desaturase and ∆-15-
desaturase nucleotide sequence, the ∆-8-desaturase nucleotide sequence, the ∆-5-
desaturase nucleotide sequence and/or the ∆-9-elongase nucleotide sequence used
in the inventive processes. The aim of such a modification may be, e.g., to further
bind the encoding sequence contained therein or also, e.g., to insert further restriction
enzyme interfaces.
Functional equivalents also include those variants whose function by comparison as
described above with the initial gene or gene fragment is weakened (= not substan
tially reduced) or reinforced (= enzyme activity higher than the activity of the initial
enzyme, that is activity is higher than 100%, preferably higher than 110%, 120%,
130%, 140% or 150%, particularly preferably higher than 200% or more).
At the same time the nucleic acid sequence may, for example, advantageously be a
DNA or cDNA sequence. Suitable encoding sequences for insertion into an expres
sion cassette according to the invention include by way of example those which en-
code a ∆-12-desaturase and ∆-15-desaturase, a ∆- -Sesaturase and/or a ∆-5-
desaturase with the sequences described above and lend the host the ability to over
produce fatty acids, oils or lipids having double bonds in the ∆-12-, ∆-15-, ∆-8-position
and ∆-5-position, it being advantageous when at the same time fatty acids having at
least four double bonds are produced. These sequences may be of homologous or
heterologous origin.
By the gene construct (= nucleic acid construct or fragment or expression cassette)
according to the invention is meant the sequences specified in SEQ ID NO: 3 , SEQ ID
NO: 5 , SEQ ID NO: 7 , SEQ ID NO: 11, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO:
19, SEQ ID NO: 2 1 or SEQ ID NO: 23 which result from the genetic code and/or de-
rivatives thereof which are functionally linked with one or more regulation signals ad
vantageously to increase the gene expression and which control the expression of the
encoding sequence in the host cell. These regulatory sequences should allow the
selective expression of the genes and the protein expression. Depending on the host
plant this may mean, for example, that the gene is expressed and/or overexpressed
only after induction or that it is expressed and/or overexpressed immediately. Exam
ples of these regulatory sequences are sequences to which inductors or repressors
bind and in this way regulate the expression of the nucleic acid. In addition to these
new regulation sequences or instead of these sequences the natural regulation of
these sequences ahead of the actual structural genes may still be present and op-
tionally have been genetically modified so that natural regulation was switched off and
the expression of the genes increased. However, the gene construct can also be built
up more simply, that is no additional regulation signals have been inserted ahead of
the nucleic acid sequence or derivatives thereof and the natural promoter with its
regulation has not been removed. Instead of this the natural regulation sequence was
mutated in such a way that no further regulation ensues and/or the gene expression is
heightened. These modified promoters in the form of part sequences (= promoter con
taining parts of the nucleic acid sequences according to the invention) can also be
brought on their own ahead of the natural gene to increase the activity. In addition,
the gene construct may advantageously also contain one or more so-called enhancer
sequences functionally linked to the promoter which allow enhanced expression of the
nucleic acid sequence. At the 3' end of the DNA sequences additional advantageous
sequences may also be inserted, such as further regulatory elements or terminators.
The SEQ ID NO: 3 , SEQ ID NO: 5 , SEQ ID NO: 7 , SEQ ID NO: 11, SEQ ID NO: 15,
SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 2 1 and/or SEQ ID NO: 23 gene may be
present in one or more copies in the gene construct (=expression cassette).
As described above, the regulatory sequences or factors can preferably positively
influence and so increase the gene expression of the introduced genes. Thus, re in
forcement of the regulatory elements advantageously on the transcription level may
be effected by using powerful transcription signals such as promoters and/or enhan
cers. However, in addition reinforcement of translation is also possible, for example by
improving the stability of the mRNA.
Suitable promoters in the expression cassette are in principle all promoters which can
control the expression of foreign genes in microorganisms like protozoa such as
amoeba, ciliates, algae such as green, brown, red or blue algae such as Euglena,
bacteria such as gram-positive or gram-negative bacteria, yeasts such as Saccharo-
myces, Pichia or Schizosaccharomyces or fungi such as Mortierella, Thraustochytrium
or Schizochytrium or plants such as Aleuritia, advantageously in plants or fungi. Such
microorganisms are generally used to clone the inventive genes and possible other
genes of the fatty acid biosynthesis chain for the production of fatty acids according to
the inventive process. Use is preferably made in particular of plant promoters or pro
moters derived from a plant virus. Advantageous regulation sequences for the method
according to the invention are found for example in promoters such as cos, tac, trp,
tet, trp-tet, Ipp, lac, Ipp-lac, laclq T7, T5, T3, gal, trc, ara, SP6, λ-PR or in λ-PL promot
ers which are employed advantageously in gram-negative bacteria. Other advanta
geous regulation sequences are found, for example, in the gram-positive promoters
amy and SPO2, in the yeast or fungal promoters ADC1 , MFa, AC, P-60, CYC1 ,
GAPDH, TEF, rp28, ADH or in the plant promoters CaMV/35S [Franck et al., Cell
2 1( 1980) 285-294], SSU, OCS, Iib4, STLS1 , B33, nos (= Nopalin Synthase Promoter)
or in the ubiquintin or phaseolin promoter. The expression cassette may also contain
a chemically inducible promoter by means of which the expression of the exogenous
∆-12- and ∆-15-,
∆-8- and/or ∆-5-desaturase gene and/or the ∆-9-elongase gene in the microorganism
and/or plant can be controlled advantageously in the plants at a particular time. A d
vantageous plant promoters of this type are by way of example the PRP1 promoter
[Ward et al., Plant.Mol. Biol. 22 (1993), 361-366], a promoter inducible by benzenesul-
fonamide (EP 388 186), a promoter inducible by tetracycline [Gatz et al., (1992) Plant
J. 2 , 397 - 404], a promoter inducible by salicylic acid (WO 95/19443), a promoter
inducible by abscisic acid (EP 335 528) and a promoter inducible by ethanol or cyclo-
hexanone (WO 93/21334). Other examples of plant promoters, which can advanta
geously be used are the promoter of cytosolic FBPase from potato, the ST-LSI pro
moter from potato (Stockhaus et al., EMBO J. 8 (1989) 2445-245), the promoter of
phosphoribosyl pyrophosphate amidotransferase from Glycine max (see also gene
bank accession number U87999) or a nodiene-specific promoter as described in
EP 249 676. Particularly advantageous are those plant promoters, which ensure ex
pression in tissues or plant parts/organs in which fatty acid biosynthesis or the precur-
sor stages thereof occurs, as in endosperm or in the developing embryo for example.
Particularly noteworthy are advantageous promoters, which ensure seed-specific ex
pression such as by way of example the USP promoter or derivatives thereof, the
LEB4 promoter, the phaseolin promoter or the napin promoter. The particularly advan
tageous USP promoter cited according to the invention or its derivatives mediate very
early gene expression in seed development [Baeumlein et al., MoI Gen Genet, 1991 ,
225 (3): 459-67]. Other advantageous seed-specific promoters which may be used for
monocotylodonous or dicotylodonous plants are the promoters suitable for dicotylo-
dons such as napin gene promoters, likewise cited by way of example, from oilseed
rape (US 5,608,152), the oleosin promoter from Arabidopsis (WO 98/45461 ) , the
phaseolin promoter from Phaseolus vulgaris (US 5,504,200), the Bce4 promoter from
Brassica (WO 91/13980) or the leguminous B4 promoter (LeB4, Baeumlein et al.,
Plant J., 2 , 2 , 1992: 233 - 239) or promoters suitable for monocotylodons such as the
promoters of the Ipt2 or Ipt1 gene in barley (WO 95/15389 and W O 95/23230) or the
promoters of the barley hordeine gene, the rice glutelin gene, the rice oryzin gene, the
rice prolamin gene, the wheat gliadin gene, the white glutelin gene, the corn zein
gene, the oats glutelin gene, the sorghum kasirin gene or the rye secalin gene which
are described in WO99/16890.
Furthermore, particularly preferred are those promoters, which ensure the expression
in tissues or plant parts in which, for example, the biosynthesis of fatty acids, oils and
lipids or the precursor stages thereof takes place. Particularly noteworthy are promot
ers, which ensure a seed-specific expression. Noteworthy are the promoter of the
napin gene from oilseed rape (US 5,608,152), the USP promoter from Vicia faba
(USP = unknown seed protein, Baeumlein et al., MoI Gen Genet, 1991 , 225 (3): 459 -
67), the promoter of the oleosin gene from Arabidopsis (WO 98/45461 ) , the phaseolin
promoter (US 5,504,200) or the promoter of the legumin B4 gene (LeB4; Baeumlein et
al., 1992, Plant Journal, 2 (2): 233-9). Other promoters to be mentioned are that of the
Ipt2 or Ipt1 gene from barley (WO 95/15389 and W O 95/23230), which mediate seed-
specific expression in monocotyledonous plants. Other advantageous seed specific
promoters are promoters such as the promoters from rice, corn or wheat disclosed in
WO 99/16890 or Amy32b, Amy6-6 or aleurain (US 5,677,474), Bce4 (rape, US
5,530,149), glycinin (soy bean, EP 571 741), phosphoenol pyruvat carboxylase (soy
bean, JP 06/62870), ADR12-2 (soy bean, WO 98/08962), isocitratlyase (rape, US
5,689,040) or β-amylase (barley, EP 781 849).
As described above, the expression construct (= gene construct, nucleic acid con
struct) may contain yet other genes, which are to be introduced into the microorgan
ism or plant. These genes can be subject to separate regulation or be subject to the
same regulation region as the ∆-12- and ∆-15-desaturase gene and/or the ∆-8- and/or
∆-5-desaturase gene and/or the ∆-9-elongase gene. These genes are by way of ex
ample other biosynthesis genes, advantageously for fatty acid biosynthesis, which
allow increased synthesis. Examples which may be mentioned are the genes for ex
ample of the ∆-9-, ∆-4-desaturase, ∆-5-elongase, α-ketoacyl reductases, α-ketoacyl
synthases, elongases or the various hydroxylases and acyl-ACP thioesterases. The
desaturase and elongase genes are advantageously used in the nucleic acid con
struct.
In principle all natural promoters with their regulation sequences can be used like
those named above for the expression cassette according to the invention and the
method according to the invention. Over and above this, synthetic promoters may also
advantageously be used.
In the preparation of an a gene construct various DNA fragments can be manipulated
in order to obtain a nucleotide sequence, which usefully reads in the correct direction
and is equipped with a correct reading raster. To connect the DNA fragments
(= nucleic acids according to the invention) to one another adaptors or linkers may be
attached to the fragments.
The promoter and the terminator regions can usefully be provided in the transcription
direction with a linker or polylinker containing one or more restriction points for the
insertion of this sequence. Generally, the linker has 1 to 10, mostly 1 to 8 , preferably 2
to 6 , restriction points. In general the size of the linker inside the regulatory region is
less than 100 bp, frequently less than 60 bp, but at least 5 bp. The promoter may be
native or homologous as well as foreign or heterologous to the host organism, for ex-
ample to the host plant. In the 5'-3' transcription direction the expression cassette con
tains the promoter, a DNA sequence which encodes a ∆-12- and ∆-15-desaturase
gene, a ∆-8-desaturase gene, a ∆-5-desaturase gene and/or a ∆-9-elongase gene
and a region for transcription termination. Different termination regions can be ex-
changed for one another in any desired fashion.
Furthermore, manipulations, which provide suitable restriction interfaces or which re
move excess DNA or restriction interfaces can be employed. Where insertions, dele
tions or substitutions, such as transitions and transversions, come into consideration,
in vitro mutagenesis, primer repair, restriction or ligation may be used. In suitable ma-
nipulations such as restriction, chewing back or filling of overhangs for blunt ends
complementary ends of the fragments can be provided for the ligation.
For an advantageous high expression the attachment of the specific ER retention s ig
nal SEKDEL inter alia can be of importance (Schouten, A . et al., Plant MoI. Biol. 30
(1996), 781-792). In this way the average expression level is tripled or even quadru-
pled. Other retention signals, which occur naturally in plant and animal proteins lo
cated in the ER may also be employed for the construction of the cassette. In another
preferred embodiment a plastidial targeting sequence is used as described by Napier
J.A. [Targeting of foreign proteins to the chloroplast, Methods MoI. Biol., 49, 1995:
369 - 376]. A preferred used vector comprising said plastidial targeting sequence is
disclosed by Colin Lazarus [Guerineau F., Woolston S., Brooks L., Mullineaux P. "An
expression cassette for targeting foreign proteins into chloroplast; Nucleic. Acids Res.,
Dec 9 , 16 (23), 1988: 11380].
Preferred polyadenylation signals are plant polyadenylation signals, preferably those
which substantially correspond to T-DNA polyadenylation signals from Agrobacterium
tumefaciens, in particular gene 3 of the T-DNA (octopin synthase) of the Ti plasmid
pTiACH (Gielen et al., EMBO J.3 (1984), 835 et seq.) or corresponding functional
equivalents.
An expression cassette/gene construct is produced by fusion of a suitable promoter
with a suitable ∆ - 12- and ∆ - 15-desaturase DNA sequence, a suitable ∆-8- and/or ∆-5-
desaturase DNA sequence and/or a suitable ∆-9-elongase DNA sequence together
with a polyadenylation signal by common recombination and cloning techniques as
described, for example, in T. Maniatis, E.F. Fritsch and J. Sambrook, Molecular Clon
ing: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
(1989) as well as in TJ. Silhavy, M.L . Berman and L .W . Enquist, Experiments with
Gene Fusions, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1984) and in
Ausubel, F.M. et al., Current Protocols in Molecular Biology, Greene Publishing Assoc
and Wiley-lnterscience (1987).
The DNA sequences encoding the nucleic acid sequences used in the inventive proc
esses such as the ∆-12- and ∆-15-desaturase from Acanthamoeba castellanii or
Perkinsus marinus, ∆-8-desaturase from Euglena gracilis, Acanthamoeba castellanii
or Perkinsus marinus, the ∆-9-elongase from lsochrysis galbana or Acanthamoeba
castellanii and/or the ∆-5-desaturase for example from Thraustrochytrium, Acan
thamoeba castellanii or Perkinsus marinus or other organisms such as Caenorhabditis
elegans, Mortierella alpina, Borage officinalis or Physcomitrella patens contain all the
sequence characteristics needed to achieve correct localization of the site of fatty
acid, lipid or oil biosynthesis. Accordingly, no further targeting sequences are needed
per se. However, such localization may be desirable and advantageous and hence
artificially modified or reinforced so that such fusion constructs are also a preferred
advantageous embodiment of the invention.
Particularly preferred are sequences, which ensure targeting in plastids. Under certain
circumstances targeting into other compartments (reported in: Kermode, Crit. Rev.
Plant Sci. 15, 4 (1996), 285-423) may also be desirable, e.g. into vacuoles, the mito-
chondrium, the endoplasmic reticulum (ER), peroxisomes, lipid structures or due to
lack of corresponding operative sequences retention in the compartment of origin, the
cytosol.
Advantageously, the nucleic acid sequences according to the invention or the gene
construct together with at least one reporter gene are cloned into a gene construct,
which is introduced into the organism via a vector or directly into the genome. This
reporter gene should allow easy detection via a growth, fluorescence, chemical, bio-
luminescence or resistance assay or via a photometric measurement. Examples of
reporter genes which may be mentioned are antibiotic- or herbicide-resistance genes,
hydrolase genes, fluorescence protein genes, bioluminescence genes, sugar or n u
cleotide metabolic genes or biosynthesis genes such as the Ura3 gene, the Ilv2 gene,
the luciferase gene, the β-galactosidase gene, the gfp gene, the 2-desoxyglucose-6-
phosphate phosphatase gene, the β-glucuronidase gene, β-lactamase gene, the neo
mycin phosphotransferase gene, the hygromycin phosphotransferase gene or the
BASTA (= gluphosinate-resistance) gene. These genes permit easy measurement
and quantification of the transcription activity and hence of the expression of the
genes. In this way genome positions may be identified which exhibit differing produc
tivity.
In a preferred embodiment an gene construct comprises upstream, i.e. at the 5' end of
the encoding sequence, a promoter and downstream, i.e. at the 3' end, a polyade-
nylation signal and optionally other regulatory elements which are operably linked to
the intervening encoding sequence for ∆-12- and ∆-15-desaturase, ∆-8-desaturase,
∆-9-elongase and/or ∆-5-desaturase DNA sequence. By an operable linkage is meant
the sequential arrangement of promoter, encoding sequence, terminator and option
ally other regulatory elements in such a way that each of the regulatory elements can
fulfill its function in the expression of the encoding sequence in due manner. The se
quences preferred for operable linkage are targeting sequences for ensuring subcellu
lar localization in plastids. However, targeting sequences for ensuring subcellular lo
calization in the mitochondrium, in the endoplasmic reticulum (= ER), in the nucleus, in
oil corpuscles or other compartments may also be employed as well as translation
promoters such as the 5' lead sequence in tobacco mosaic virus (GaIMe et al., Nucl.
Acids Res. 15 ( 1987), 8693 -871 1) .
An expression cassette/gene construct may, for example, contain a constitutive pro
moter or a tissue-specific promoter (preferably the USP or napin promoter) the gene
to be expressed and the ER retention signal. For the ER retention signal the KDEL
amino acid sequence (lysine, aspartic acid, glutamic acid, leucine) or the KKX amino
acid sequence (lysine-lysine-X-stop, wherein X means every other known amino acid)
is preferably employed.
For expression in a prokaryotic or eukaryotic host organism, for example a microor
ganism such as a fungus or a plant such as an oil crop the expression cassette is ad-
vantageously inserted into a vector such as by way of example a plasmid, a phage or
other DNA which allows optimum expression of the genes in the host organism. Ex
amples of suitable plasmids are: in E. coli pLG338, pACYC184, pBR series such as
e.g. pBR322, pUC series such as pUC18 or pUC19, M113mp series, pKC30, pRep4,
pHS1 , pHS2, pPLc236, pMBL24, pLG200, pUR290, plN-IN 113-B1 , λgt1 1 or pBdCI; in
Streptomyces plJ101 , plJ364, plJ702 or plJ361 ; in Bacillus pUB1 10, pC194 or
pBD214; in Corynebacterium pSA77 or pAJ667; in fungi pALS1 , plL2 or pBB1 16;
other advantageous fungal vectors are described by Romanos, M.A. et al., [(1992)
..Foreign gene expression in yeast: a review", Yeast8 : 423-488] and by van den Hon-
del, C.A.M.J.J. et al. [(1991) ..Heterologous gene expression in filamentous fungi" as
well as in More Gene Manipulations in Fungi [J.W . Bennet & L .L . Lasure, eds.,
pp. 396-428: Academic Press: San Diego] and in ,,Gene transfer systems and vector
development for filamentous fungi" [van den Hondel, C.A.M.J.J. & Punt, P.J. (1991 )
in: Applied Molecular Genetics of Fungi, Peberdy, J.F. et al., eds., pp. 1-28, Cam
bridge University Press: Cambridge]. Examples of advantageous yeast promoters are
2µM, pAG-1 , YEp6, YEpI 3 or pEMBLYe23. Examples of algal or plant promoters are
pLGV23, pGHIac +, pBIN19, pAK2004, pVKH or pDH51 (see Schmidt, R. and
Willmitzer, L., 1988). The vectors identified above or derivatives of the vectors identi
fied above are a small selection of the possible plasmids. Further plasmids are well
known to those skilled in the art and may be found, for example, in the book Cloning
Vectors (Eds. Pouwels P.H. et al. Elsevier, Amsterdam-New York-Oxford, 1985,
ISBN 0 444 904018). Suitable plant vectors are described inter alia in ..Methods in
Plant Molecular Biology and Biotechnology" (CRC Press), Ch. 6/7, pp. 71-1 19. Advan
tageous vectors are known as shuttle vectors or binary vectors which replicate in E.
coli and Agrobacterium.
By vectors is meant with the exception of plasmids all other vectors known to those
skilled in the art such as by way of example phages, viruses such as SV40, CMV,
baculovirus, adenovirus, transposons, IS elements, phasmids, phagemids, cosmids,
linear or circular DNA. These vectors can be replicated autonomously in the host o r
ganism or be chromosomally replicated, chromosomal replication being preferred.
In a further embodiment of the vector the gene construct according to the invention
may also advantageously be introduced into the organisms in the form of a linear
DNA and be integrated into the genome of the host organism by way of heterologous
or homologous recombination. This linear DNA may be composed of a linearized
plasmid or only of the expression cassette as vector or the nucleic acid sequences
according to the invention.
In a further advantageous embodiment the nucleic acid sequence according to the
invention can also be introduced into an organism on its own.
If in addition to the nucleic acid sequence according to the invention further genes are
to be introduced into the organism, all together with a reporter gene in a single vector
or each single gene with a reporter gene in a vector in each case can be introduced
into the organism, whereby the different vectors can be introduced simultaneously or
successively.
The vector advantageously contains at least one copy of the nucleic acid sequences
according to the invention and/or the expression cassette (= gene construct) accord
ing to the invention.
By way of example the plant expression cassette can be installed in the pRT trans
formation vector ((a) Toepfer et al., 1993, Methods Enzymol., 217: 66-78; (b) Toepfer
et al. 1987, Nucl. Acids. Res. 15: 5890 ff.).
Alternatively, a recombinant vector (= expression vector) can also be transcribed and
translated in vitro, e.g. by using the T7 promoter and the T7 RNA polymerase.
Expression vectors employed in prokaryotes frequently make use of inducible sys
tems with and without fusion proteins or fusion oligopeptides, wherein these fusions
can ensue in both N-terminal and C-terminal manner or in other useful domains of a
protein. Such fusion vectors usually have the following purposes: i.) to increase the
RNA expression rate; ii.) to increase the achievable protein synthesis rate; iii.) to in
crease the solubility of the protein; iv.) or to simplify purification by means of a binding
sequence usable for affinity chromatography. Proteolytic cleavage points are also
frequently introduced via fusion proteins, which allow cleavage of a portion of the f u
sion protein and purification. Such recognition sequences for proteases are recog
nized, e.g. factor Xa, thrombin and enterokinase.
Typical advantageous fusion and expression vectors are pGEX [Pharmacia Biotech
Inc; Smith, D.B. and Johnson, K.S. (1988) Gene 67: 31-40], pMAL (New England Bio-
labs, Beverly, MA) and pRIT5 (Pharmacia, Piscataway, NJ) which contains glutathione
S-transferase (GST), maltose binding protein or protein A .
Other examples of E. coli expression vectors are pTrc [Amann et al., (1988) Gene
69:301-315] and pET vectors [Studier et al., Gene Expression Technology: Methods
in Enzymology 185, Academic Press, San Diego, California (1990) 60-89; Stratagene,
Amsterdam, The Netherlands].
Other advantageous vectors for use in yeast are pYepSed (Baldari, et al., (1987)
Embo J. 6:229-234), pMFa (Kurjan and Herskowitz, (1982) Ce// 30:933-943), pJRY88
(Schultz et al., (1987) Gene 54:1 13-123), and pYES derivatives (Invitrogen Corpora-
tion, San Diego, CA). Vectors for use in filamentous fungi are described in: van den
Hondel, C.A.M.J.J. & Punt, PJ. (1991 ) ,,Gene transfer systems and vector develop
ment for filamentous fungi", in: Applied Molecular Genetics of Fungi, J .F. Peberdy, et
al., eds., pp. 1-28, Cambridge University Press: Cambridge.
Alternatively, insect cell expression vectors can also be advantageously utilized, e.g.
for expression in Sf 9 cells. These are e.g. the vectors of the pAc series (Smith et al.
(1983) MoI. Cell Biol. 3:2156-2165) and the pVL series (Lucklow and Summers (1989)
Virology 170:31-39).
Furthermore, plant cells or algal cells can advantageously be used for gene expres
sion. Examples of plant expression vectors may be found in Becker, D., et al. (1992)
,,New plant binary vectors with selectable markers located proximal to the left border",
Plant MoI. Biol. 20: 1195-1 197 or in Bevan, M.W. (1984) ..Binary Agrobacterium vec
tors for plant transformation", Nucl. Acid. Res. 12: 871 1-8721 .
The host plant (= transgenic plant) advantageously contains at least one copy of the
nucleic acid according to the invention and/or of the gene construct according to the
invention.
The introduction of the nucleic acids according to the invention, the gene construct or
the vector into organisms, plants for example, can in principle be done by all of the
methods known to those skilled in the art. The introduction of the nucleic acid se
quences gives rise to recombinant or transgenic plants.
To introduce the nucleic acids used in the process, the latter are advantageously
amplified and ligated in the known manner. Preferably, a procedure following the
protocol for Pfu DNA polymerase or a Pfu/Taq DNA polymerase mixture is followed.
The primers are selected taking into consideration the sequence to be amplified. The
primers should advantageously be chosen in such a way that the amplificate
comprises the entire codogenic sequence from the start codon to the stop codon.
After the amplification, the amplificate is expediently analyzed. For example, a gel-
electrophoretic separation can be carried out, which is followed by a quantitative and
a qualitative analysis. Thereafter, the amplificate can be purified following a standard
protocol (for example Qiagen). An aliquot of the purified amplificate is then available
for the subsequent cloning step. Suitable cloning vectors are mentioned above and
generally known to the skilled worker. These include, in particular, vectors which are
capable of replication in microbial systems, that is to say mainly vectors which ensure
efficient cloning in yeasts or fungi and which make possible the stable transformation
of plants. Those, which must be mentioned, again herein in particular are various
binary and cointegrated vector systems, which are suitable for the T-DNA-mediated
transformation. Such vector systems are, as a rule, characterized in that they
comprise at least the vir genes required for the Agrobacterium-mediated
transformation and the T-DNA-delimiting sequences (T-DNA border). These vector
systems advantageously also comprise further cis-regulatory regions such as
promoters and terminator sequences and/or selection markers, by means of which
suitably transformed organisms can be identified. While in the case of cointegrated
vector systems vir genes and T-DNA sequences are arranged on the same vector,
binary systems are based on at least two vectors, one of which bears vir genes, but
no T-DNA, while a second one bears T-DNA, but no vir gene. Owing to this fact, the
last-mentioned vectors are relatively small, easy to manipulate and to replicate both in
E. coli and in Agrobacterium. These binary vectors include vectors from the series
pBIB-HYG, pPZP, pBecks, pGreen. In accordance with the invention, Bin19, pBI101 ,
pBinAR, pGPTV and pCAMBIA are used by preference. An overview of the binary
vectors and their use is found in Hellens et al, Trends in Plant Science (2000) 5 , 446-
451 . In order to prepare the vectors, the vectors can first be linearized with restriction
endonuclease(s) and then modified enzymatically in a suitable manner. Thereafter,
the vector is purified, and an aliquot is employed for the cloning step. In the cloning
step, the enzymatically cleaved and, if appropriate, purified amplificate is cloned with
vector fragments, which have been prepared in a similar manner, using ligase. In this
context, a particular nucleic acid construct, or vector or plasmid construct, can have
one or else more than one codogenic gene segment. The codogenic gene segments
in these constructs are preferably linked operably with regulatory sequences. The
regulatory sequences include, in particular, plant sequences such as the above-
described promoters and terminator sequences. The constructs can advantageously
be stably propagated in microorganisms, in particular in E. coli and Agrobacterium
tumefaciens, under selective conditions and make possible the transfer of
heterologous DNA into plants or microorganisms.
The nucleic acids used in the process, the inventive nucleic acids and gene
constructs, can be introduced into organisms such as microorganisms or
advantageously plants, advantageously using cloning vectors, and thus be used in
the transformation of plants such as those which are published and cited in: Plant
Molecular Biology and Biotechnology (CRC Press, Boca Raton, Florida), Chapter 6/7,
p. 71-1 19 (1993); F.F. White, Vectors for Gene Transfer in Higher Plants; in:
Transgenic Plants, Vol. 1, Engineering and Utilization, Ed.: Kung and R. Wu,
Academic Press, 1993, 15-38; B. Jenes et al., Techniques for Gene Transfer, in:
Transgenic Plants, Vol. 1, Engineering and Utilization, Ed.: Kung and R. Wu,
Academic Press (1993), 128-143; Potrykus, Annu. Rev. Plant Physiol. Plant Molec.
Biol. 42 (1991 ) , 205-225. Thus, the nucleic acids, the inventive nucleic acids and
nucleic acid constructs, and/or vectors used in the process can be used for the
recombinant modification of a broad spectrum of organisms, advantageously plants,
so that the latter become better and/or more efficient PUFA and/or LCPUFA
producers.
In the case of microorganisms, those skilled in the art can find appropriate methods
for the introduction of the inventive nucleic acid sequences, the gene construct or the
vector in the textbooks by Sambrook, J. et al. (1989) Molecular cloning: A laboratory
manual, Cold Spring Harbor Laboratory Press, by F.M. Ausubel et al. (1994) Current
protocols in molecular biology, John Wiley and Sons, by D.M. Glover et al., DNA Clon-
ing Vol. 1, (1995), IRL Press (ISBN 019-963476-9), by Kaiser et al. (1994) Methods in
Yeast Genetics, Cold Spring Harbor Laboratory Press or Guthrie et al. Guide to Yeast
Genetics and Molecular Biology, Methods in Enzymology, 1994, Academic Press.
The transfer of foreign genes into the genome of a plant is called transformation. In
doing this the methods described for the transformation and regeneration of plants
from plant tissues or plant cells are utilized for transient or stable transformation. Suit
able methods are protoplast transformation by poly(ethylene glycol)-induced DNA
uptake, the ,,biolistic" method using the gene cannon - referred to as the particle bom
bardment method, electroporation, the incubation of dry embryos in DNA solution,
microinjection and gene transfer mediated by Agrobacterium. Said methods are de
scribed by way of example in B. Jenes et al., Techniques for Gene Transfer, in:
Transgenic Plants, Vol. 1, Engineering and Utilization, eds. S.D. Kung and R. Wu,
Academic Press (1993) 128-143 and in Potrykus Annu. Rev. Plant Physiol. Plant
Molec. Biol. 42 (1991 ) 205-225). The nucleic acids or the construct to be expressed is
preferably cloned into a vector, which is suitable for transforming Agrobacterium tume-
faciens, for example pBin19 (Bevan et al., Nucl. Acids Res. 12 (1984) 871 1) . Agro-
bacteria transformed by such a vector can then be used in known manner for the
transformation of plants, in particular of crop plants such as by way of example to
bacco plants, for example by bathing bruised leaves or chopped leaves in an agro-
bacterial solution and then culturing them in suitable media. The transformation of
plants by means of Agrobacterium tumefaciens is described, for example, by Hofgen
and Willmitzer in Nucl. Acid Res. (1988) 16, 9877 or is known inter alia from F.F.
White, Vectors for Gene Transfer in Higher Plants; in Transgenic Plants, Vol. 1, Eng i
neering and Utilization, eds. S.D. Kung and R. Wu, Academic Press, 1993, pp. 15-38.
Agrobacteria transformed by an expression vector according to the invention may
likewise be used in known manner for the transformation of plants such as test plants
like Arabidopsis or crop plants such as cereal crops, corn, oats, rye, barley, wheat,
soybean, rice, cotton, sugar beet, canola, sunflower, flax, hemp, potatoes, tobacco,
tomatoes, carrots, paprika, oilseed rape, tapioca, cassava, arrowroot, tagetes, alfalfa,
lettuce and the various tree, nut and vine species, in particular of oil-containing crop
plants such as soybean, peanut, castor oil plant, sunflower, corn, cotton, flax (lin
seed), oilseed rape, poppy, mustard, sesame, almond, macadamia, olive, calendula,
punica, hazel nut, avocado, pumpkin, walnut, laurel, pistachio, Orychophragmus,
marigold, borage, primrose, canola, evening primrose, hemp, coconut, oil palm, saf-
flower (Carthamus tinctorius), coffee or cocoa bean, e.g. by bathing bruised leaves or
chopped leaves in an agrobacterial solution and then culturing them in suitable media.
For the production of LCPUFAs, for example arachidonic acid and/or eicosapen-
taenoic acid, borage, linseed, sunflower, safflower, Brassica napus, Brassica juncea,
Camelina sativa or Orychophragmus are advantageously suitable.
The genetically modified plant cells may be regenerated by all of the methods known
to those skilled in the art. Appropriate methods can be found in the publications re
ferred to above by S.D. Kung and R. Wu, Potrykus or Hofgen and Willmitzer.
Accordingly, a further aspect of the invention relates to transgenic organisms trans
formed by at least one nucleic acid sequence, expression cassette or vector accord
ing to the invention as well as cells, cell cultures, tissue, parts - such as, for example,
leaves, roots, etc. in the case of plant organisms - or reproductive material derived
from such organisms. The terms ,,host organism", ,,host cell", ..recombinant (host) o r
ganism" and ..transgenic (host) cell" are used here interchangeably. Of course these
terms relate not only to the particular host organism or the particular target cell but
also to the descendants or potential descendants of these organisms or cells. Since,
due to mutation or environmental effects certain modifications may arise in successive
generations, these descendants need not necessarily be identical with the parental
cell but nevertheless are still encompassed by the term as used here.
Suitable organisms or host organisms for the nucleic acid, gene construct or vector
according to the invention are advantageously in principle all plants, which are able to
synthesize fatty acids, especially unsaturated fatty acids or are suitable for the ex
pression of recombinant genes as described above. Further examples which may be
mentioned are plants such as Arabidopsis, Asteraceae such as Calendula or crop
plants such as soybean, peanut, castor oil plant, sunflower, corn, cotton, flax, oilseed
rape, coconut, oil palm, safflower (Carthamus tinctorius) or cocoa bean, bacteria such
as the genus Escherichia, yeasts such as the genus Saccharomyces. Preference is
given to organisms which can naturally synthesize oils in relatively large quantities
such as fungi like Mortierella alpina, Pythium insidiosum or plants such as soybean,
oilseed rape, coconut, oil palm, safflower, flax, castor oil plant, Calendula, peanut,
cocoa bean or sunflower, or yeasts such as Saccharomyces cerevisiae and particular
preference is given to the family of the Brassicaceae such as oilseed rape, soybean,
flax, sunflower, Calendula, Mortierella or Saccharomyces cerevisiae.
Further useful host cells are identified in: Goeddel, Gene Expression Technology:
Methods in Enzymology 185, Academic Press, San Diego, CA (1990).
Usable expression strains, e.g. those exhibiting a relatively low protease activity, are
described in: Gottesman, S., Gene Expression Technology: Methods in Enzymology
185, Academic Press, San Diego, California ( 1990) 119-1 28.
A further object of the invention as described relates to the use of an expression cas
sette containing DNA sequences encoding a ∆-12- and ∆-15-desaturase, a ∆-9-
elongase, a ∆-8-desaturase and/or a ∆-5-desaturase gene or DNA sequences hybrid
izing therewith for the transformation of plant cells, tissues or parts of plants. The aim
of use is to increase the content of fatty acids, oils or lipids having an increased con
tent of double bonds.
In doing so, depending on the choice of promoter, the ∆-12- and ∆-15-desaturase, the
∆-9-elongase, the ∆-8-desaturase and/or the ∆-5-desaturase gene can be expressed
specifically in the leaves, in the seeds, the nodules, in roots, in the stem or other parts
of the plant, preferably in leaves and/or seeds. Those transgenic plants overproducing
fatty acids, oils or lipids according to the invention, the reproductive material thereof,
together with the plant cells, tissues or parts thereof are a further object of the present
invention.
The expression cassette or the nucleic acid sequences according to the invention
containing a ∆-12- and ∆-15-desaturase, a ∆-9-elongase, a ∆-8-desaturase and/or a
∆-5-desaturase gene sequence can, moreover, also be employed for the transforma
tion of the organisms identified by way of example above such as bacteria, cyanobac-
teria, yeasts, filamentous fungi, ciliates and algae with the objective of increasing the
content of fatty acids, oils or lipids according to the invention.
Within the framework of the present invention is the increase of the content of fatty
acids, oils or lipids possessing a higher amount of ω-3-fatty acids in comparison to ω-
6-fatty acids such as eicosapentaenoic acid in comparison to arachidonic acid, due to
functional over expression of the ∆-12- and ∆-15-desaturase, the ∆-9-elongase, the
∆-8-desaturase and/or the ∆-5-desaturase gene in the plant according to the inven-
tion, advantageously in the transgenic oilseed plants according to the invention, by
comparison with the non genetically modified initial plants at least for the duration of
at least one plant generation.
The preferred locus of biosynthesis, of fatty acids, oils or lipids for example, is gener
ally the seed or cell layers of the seed so that a seed-specific expression of the ∆ - 12-
and ∆-15-desaturase, the ∆-9-elongase, the ∆-8-desaturase and/or the ∆-5-
desaturase gene is appropriate. It is, however, obvious that the biosynthesis of fatty
acids, oils or lipids need not be limited to the seed tissue but rather can also occur in
tissue-specific manner in all other parts of the plant - in epidermis cells or in the nod
ules for example.
A constitutive expression of the exogenous ∆ - 12- and ∆ - 15-desaturase, ∆-9-
elongase, ∆-8-desaturase and/or ∆-5-desaturase gene is, moreover, advantageous.
On the other hand, however, an inducible expression may also appear desirable.
The efficiency of the expression of the ∆ - 12- and ∆-15-desaturase, the ∆-9-elongase,
the ∆-8-desaturase and/or the ∆-5-desaturase gene can be determined, for example,
in vitro by shoot meristem propagation. In addition, an expression of the ∆-12- and ∆-
15-desaturase, the ∆-9-elongase, the ∆-8-desaturase and/or the ∆-5-desaturase gene
modified in nature and level and its effect on fatty acid, oil or lipid biosynthesis pe r
formance can be tested on test plants in greenhouse trials.
An additional object of the invention comprises transgenic plants transformed by an
expression cassette containing a ∆-12- and ∆-15-desaturase, a ∆-9-elongase, a ∆-8-
desaturase and/or a ∆-5-desaturase gene sequence according to the invention or
DNA sequences hybridizing therewith, as well as transgenic cells, tissue, parts and
reproduction material of such plants. Particular preference is given in this case to
transgenic crop plants such as by way of example barley, wheat, rye, oats, corn, soy-
bean, rice, cotton, sugar beet, the family of the Brassicaceae such as oilseed rape
and canola, sunflower, flax, hemp, thistle, potatoes, tobacco, tomatoes, tapioca, cas
sava, arrowroot, alfalfa, lettuce and the various tree, nut and vine species.
For the purposes of the invention plants are mono- and dicotyledonous plants that
produce mature seeds.
A further refinement according to the invention are transgenic plants as described
above which contain the nucleic acid sequences, the gene construct and/or vector of
the invention.
The invention is explained in more detail by the following examples.
Examples
Example 1: General cloning methods
The cloning methods, such as by way of example restriction cleavages, agarose gel
electrophoresis, purification of DNA fragments, transfer of nucleic acids to nitrocellu
lose and nylon membranes, linkage of DNA fragments, transformation of Escherichia
coli cells, culture of bacteria and sequence analysis of recombinant DNA, were carried
out as described in Sambrook et al. (1989) (Cold Spring Harbor Laboratory Press:
ISBN 0-87969-309-6).
Example 2 : Sequence analysis of recombinant DNA
Sequencing of recombinant DNA molecules was done using a laser fluorescence
DNA sequencer from the ABI company by the method of Sanger (Sanger et al. (1977)
Proc. Natl. Acad. Sci. USA74, 5463-5467). Fragments resulting from a polymerase
chain reaction were sequenced and checked to prevent polymerase errors in the con
structs to be expressed.
Example 3 : Cloning of the PUFA specific desaturases from Acanthamoeba ca-
stellanii (= SEQ ID NO: 3 , 5 , 15, 19 and 2 1)
Acanthamoeba castellanii (Eukaryota; Protista; Sarcomastigophora; Sarcodina; Rhizo-
podea; Lobosa) is an amoeba species, which is a common species in the soil. Acan
thamoeba castellanii can grow vegetative over a broad temperature range (10 to
32°C). A . castellanii is able to de novo synthesize linoleic acid and C20 n-6 fatty acids.
A . castellanii (ATTC 30010) was grown at 3 O0C on a medium containing 0,75% (w/v)
peptone, 1,5% (w/v) glucose and 0,75% (w/v) yeast extract according to the reference
of Jones et al. [Temperature-induced membrane-lipid adaptation in Acanthamoeba
castellanii. Biochem J. 1993, 290:273-278]. The cell cultures were grown under shak-
ing (200 U/min) and harvested with a centrifuge at 250 x g , 5 min, 4°C, after they have
reached a cell density of 5x1 06- 107 (measured in a Fuchs-Rosenthal Haemozytome-
ter).
The total mRNA was isolated from said harvested cells with the aid of the RNeasy
plant mini Kit (Qiagen). cDNA was synthesized from the total mRNA with the SMART
RACE cDNA amplification kit (Clontech) according to the instructions of the manufac
turer.
For the isolation of new desaturase genes the following degenerated primers were
used for the amplification:
Deg1 :
5'- GGITGG(CZTZA)TIGGICA(TZC) GA(TZC)(GT) (CT)I(GT) (GC)ICA-3'
Deg2:
5'- GG(AZG)AA(TCGA)AG(AZG)TG(AZG)TG(TZC)TC(AZGZT)AT(TZC)TG-S'
The aforementioned primers were used for the amplification in combination with the
3'-adapter-primer of the SMART RACE cDNA amplification kit.
The following protocol was used for the amplification:
a) 2 min at 95°C,
b) 30 sec at 94 0C
30 sec at 55-72°C
2 min at 72 0C
Number of cycles: 30
c) 10 min at 72 0C
PCR amplicons were cloned and sequenced according to the instructions of the
manufacturer (pTOPO, Invitrogen). The sequence information was used for the pro-
duction of full-length clones. For the cloning of the full-length clones 5'- and 3'-specific
primers were synthesized. Said primers were used for the amplification in the SMART
RACE cDNA amplification kit (Clontech) and the amplicons werecloned into the
pTOPO vector (Invitrogen)
Three sequences were identified, which show low similarities to desaturase genes.
In addition according to [Zank et al. 2002, Plant Journal 3 1 :255 268] sequence 9Ac
(∆-9-Elongase from Acanthamoeba, SEQ ID NO: 11) could be identified, which shows
low similarities to elongase genes.
Table 1: Acanthamoeba castellanii desaturase sequences
Example 4 : Cloning of the PUFA specific desaturases from Perkinsus marinus
(= SEQ ID NO: 7 , 17 and 23)
Perkinsus marinus, which belongs to the Protista, is a parasite in seashells. P. mari
nus is able to synthesize LCPUFAs such as arachidonic acid (20:4). The LCPUFAs
are produced according to the present work over the ∆-8-/∆-5-fatty acid pathway (see
figure 1) .
P. marinus was grown at 28°C as disclosed by La Peyre et al. (J: Eurkaryot. Microbiol.
1993, 40: 304 - 310).
The total imRNA was isolated from said harvested cells with the aid of the RNeasy
plant mini Kit (Qiagen). cDNA was synthesized from the total mRNA with the SMART
RACE cDNA amplification kit (Clontech) according to the instructions of the manufac
turer.
For the isolation of new desaturase genes the following degenerated primers were
used for the amplification:
Deg1 :
5'- GGITGG(CZTZA)TIGGICA(TZC) GA(TZC)(GT) (CT)I(GT) (GC)ICA-3'
Deg2:
5'- GG(AZG)AA(TCGA)AG(AZG)TG(AZG)TG(TZC)TC(AZGZT)AT(TZC)TG-S'
The aforementioned primers were used for the amplification in combination with the
3'-adapter-primer of the SMART RACE cDNA amplification kit.
The following protocol was used for the amplification:
d) 2 min at 95°C,
e) 30 sec at 94 0C
30 sec at 55-72°C
2 min at 72 0C
Number of cycles: 30
f ) 10 min at 72 0C
PCR amplicons were cloned and sequenced according to the instructions of the
manufacturer (pTOPO, Invitrogen). The sequence information was used for the pro
duction of full-length clones. For the cloning of the full-length clones 5'- and 3'-specific
primers were synthesized. Said primers were used for the amplification in the SMART
RACE cDNA amplification kit (Clontech) and the amplicons werecloned into the
pTOPO vector (Invitrogen)Three sequences were identified, which show low similari
ties to desaturase genes.
Table 2 : Perkinsus marinus desaturase sequences
Example 5 : Cloning of expression plasmids for the heterologous expression of
A . castellanii and P. marinus genes in yeasts
For the heterologous expression in yeasts the respective sequences were PCR ampli
fied and with the restriction enzymes Kpnl-Sacl the resulting sequences were cloned
into the yeast vector pYES2 (Invitrogen). For the amplification specific primers (see
table 3 below) were used. Only the open reading frames of the PUFA genes were
amplified. In addition restriction cleavage sides were attached to the nucleic acid se
quences. At the 5'-end a Kpnl side and a so named Kozak sequence (Cell, 1986, 44:
283 - 292) was added. To the 3'-end a Sacl side was attached.
Table 3 : Primers for the amplification of the nucleic acid sequences of the desatu-
rases
Composition of the PCR mix (50 µl)
5,00 µL Template cDNA
5,00 µL 10x Puffer (Advantage-Polymerase)+ 25mM MgCI2
5,00 µL 2mM dNTP
1,25 µL each primer ( 10 pmol/ µL of the 5'-ATG as well as of the 3'-stopp primer)
0,50 µL Advantage polymerase
The Advantage polymerase from Clontech was employed.
PCR protocol
Addition temperature: 1 min at 55 0C
Denaturing temperature: 1 min at 94 0C
Elongation temperature: 2 min at 72 0C
Number of cycles: 35
The PCR products and the vector pYES2 were incubated with the restriction enzymes
Kpnl and Sacl for 1 h at 37°C. Afterwards a ligation reaction was done with the Rapid
Ligation Kit (Roche) according to the instructions of the manufacturer. The reaction
mixture was than used for the transformation of E. coli DH5α cells (Invitrogen) again
according to the instructions of the manufacturer. Positive clones were identified with
PCR (reaction scheme as described above). The plasmid DNA was isolated (Qiagen
Dneasy) and the resulting plasmids were checked by sequencing and transformed
with the lithium acetate method into the Saccharomyces strain W303-1A. As a control
the plasmid pYES2 (vector without insert) was transformed in parallel. The trans
formed yeasts were selected on complete minimal dropout uracil medium (CMdum)
agar plates supplemented with 2% glucose, but without uracil.
To express the genes from A . castellanii and P. marinus, precultures consisting of in
each case 5 ml of CMdum dropout uracil liquid medium supplemented with 2% (w/v)
raffinose, but without uracil were initially inoculated with the selected transformants
and incubated for 2 days at 30°C and 200 rpm. Then, 5 ml of CMdum (without uracil)
liquid medium supplemented with 2% of raffinose and 300 µM of various fatty acids
were inoculated with the precultures to an OD6oo θf 0.05. Expression was induced by
the addition of 2% (w/v) of galactose. The cultures were incubated for a further 96
hours at 22°C.
Example 6 : Cloning of expression plasmids for the expression in plants
To transform plants, a further transformation vector based on pBIN19-35S (Bevan M.
(1984) Binary Agrobacterium vectors for plant transformation. Nucl. Acids Res.
18:203) was generated. To this end, BamHI-Xbal cleavage sites were inserted at the
5' and 3' end of the coding sequences, using PCR. The corresponding primer
sequences were derived from the 5' and 3' regions of the respective nucleic acid
sequence (see table 4).
Table 4 : Primers for the expression in plants
Composition of the PCR mix (50 µl):
5.00 µl template cDNA
5.00 µl 10x buffer (Advantage polymerase)+ 25mM MgCI2
5.00 µl 2mM dNTP
1.25 µl of each primer (10 pmol/ µl)
0.50 µl Advantage polymerase
The Advantage polymerase from Clontech was employed.
PCR reaction conditions:
Annealing temperature: 1 min 55°C
Denaturation temperature: 1 min 94°C
Elongation temperature: 2 min 72°C
Number of cycles: 35
The PCR products as well as the vector pBin19-35S were incubated with the
restriction enzymes BamHI and Xbal for 16 hours at 37°C. Afterwards a ligation
reaction was done with the Rapid Ligation Kit (Roche) according to the instructions of
the manufacturer. The reaction mixture was than used for the transformation of E. coli
DH5α cells (Invitrogen) again according to the instructions of the manufacturer.
Positive clones were identified with PCR (reaction scheme as described above) and
the plasmid DNA was isolated (Qiagen Dneasy). The resulting plasmids were checked
by sequencing and transformed by electroporation into Agrobacterium tumefaciens
GC3101 . Afterwards the transformants were plated on 2% YEB Medium agar plates
with kanamycin. Kanamycin tolerant cells were picked and used for the transformation
of Arabidopsis thaliana.
Example 7 : Expression of A . castellanii and P. marinus genes in yeasts
Yeasts which had been transformed with the plasmids pYES2, pYES-12Ac, pYES-
8Ac, pYES2-5Ac, pYES2-9Ac, pYES2-12Pm, pYES2-8Pm and pYES2-5Pm as
described in Example 5 were analyzed as follows:
The yeast cells from the main cultures were harvested by centrifugation (100 x g ,
5 min, 20°C) and washed with 100 imM NaHCO3, pH 8.0 to remove residual medium
and fatty acids. Starting with the yeast cell sediments, fatty acid methyl esters
(FAMEs) were prepared by acid methanolysis. To this end, the cell sediments were
incubated for one hour at 80°C together with 2 ml of 1 N methanolic sulfuric acid and
2% (v/v) of dimethoxypropane. The FAMEs were extracted twice with petroleum ether
(PE). To remove nonderivatized fatty acids, the organic phases were washed in each
case once with 2 ml of 100 mM NaHCθ 3, pH 8.0 and 2 ml of distilled water.
Thereafter, the PE phases were dried with Na2SO4, evaporated under argon and
taken up in 100 µl of PE. The samples were separated on a DB-23 capillary column
(30 m, 0.25 mm, 0.25 µm, Agilent) in a Hewlett-Packard 6850 gas chromatograph
equipped with flame ionization detector. The conditions for the GLC analysis were as
follows: the oven temperature was programmed from 50°C to 250°C with a rate of
5°C/min and finally 10 min at 250°C (holding).
The signals were identified by comparing the retention times with corresponding fatty
acid standards (Sigma). The methodology is described for example in Napier and
Michaelson, 2001 , Lipids. 36 (8):761-766; Sayanova et al., 2001 , Journal of
Experimental Botany. 52 (360):1581-1585, Sperling et al., 2001 , Arch. Biochem.
Biophys. 388 (2):293-298 and Michaelson et al., 1998, FEBS Letters. 439 (3):215-
218.
Example 8 : Functional characterization of the genes of A . castellanii
The substrate activity and specificity of the genes were determined after expression
and after feeding various fatty acids. The substrate specificity of the desaturases after
expressions in yeasts can be determined by feeding various different fatty acids.
Specific examples for the determination of the specificity and activity are disclosed for
example in WO 93/1 1245, WO 94/1 1516, WO 93/06712, US 5,614,393, US5614393,
WO 96/21 022, WO0021 557 und WO 99/271 11, Qiu et al. 2001 , J. Biol. Chem. 276,
31561-31566 for ∆4-desaturases, Hong et al. 2002, Lipids 37,863-868 for ∆5-
desaturases. WO2005/012316 teaches such a method for example in example 18 in
more detail.
a) Characterization of the gene 12Ac:
First the construct pYES-12Ac was tested in yeasts without feeding fatty acids. Aston
ishingly it was shown in comparison to the control vector pYES2 (vector without insert)
that even without feeding fatty acids new fatty acids are detectable in the yeasts (Fig-
ure 2 A and B).
Figure 2 A and B show a comparison of the fatty acid profile between the control (con
struct pYES2 without insert, Figure 2A) and the construct pYES2-12Ac (Figure 2B),
which contains the Acanthamoeba castellanii gene for the ∆-12-/∆-15-desaturase.
The fatty acids are marked. The new fatty acids synthesized are in case of construct
pYES2-12Ac (2B) the fatty acids C16:2, C16:3, C18:2 and C18:3, whereas the un
usual fatty acids 16:2n-4 and 16:3n-1 are formed for the C 16 fatty acids. For the C 18
fatty acids linoleic and linolenic acid (18:2n-6 and 18:2n-3) are formed.
According to the new synthesized fatty acids it is possible to identify the gene product
of the nucleic acid sequence as a ∆-12-desaturase. The enzyme is able to desaturate
C18:1 and C16:1 as substrate to the corresponding C18:2 and C16:2 fatty acids. The
conversion rate of C18:1 (40,0%) is higher than the rate of the C16:1 (15,8%) conver
sion. That means the conversion rate of C18:1 is more than double than the conver
sion rate of the C16:1 .
The conversion rate of the desaturase was calculated according to the following for-
mula:
Substrate
(Substrate + Product) x 100
The result of the formula is given as percentage value.
Furthermore the enzyme shows in addition a clear ∆-15-desaturase-activity. That
means also that products of the ∆-12-desaturase reaction, which are C16:2 and/or
C18:2 are further desaturated to C16:3 and/or C 18:3.
b) Characterization of the gene 8Ac:
According to different sequence alignments (Blast) performed with the sequence SEQ
ID NO: 3 (8Ac sequence) with different data bases (NCBI-BLAST:
http://www.ncbi.nlm.nih.gov/BLAST/) the encoded protein sequence is most likely a
putative ∆-5-desaturase.
Sequences with significant similarities (bits) Value
gi| 16033740|gb|AAL1 331 1. 1 1 delta-5 fatty acid desaturase [P... 176 1e-42
gi|50882495|gb|AAT85663.1 | polyunsaturated fatty acid delta... 170 6e-41
gi|4150956|dbj|BAA37090.1 1 delta 5 fatty acid desaturase [D... 156 9e-37
gi|23894018|emb|CAD53323.1 | delta 5 fatty acid desaturase [... 156 1e-36
gi|33466346|gb|AAQ1 9605.1 1 delta-4 fatty acid desaturase [E... 150 7e-35
gi|5263169|dbj|BAA81814.1 | fatty acid desaturase [Dictyoste... 149 1e-34
gi|25956288|gb|AAN75707.1 | delta 4-desaturase [Thraustochyt... 142 1e-32
gi|25956290|gb|AAN75708.1 1 delta 4-desaturase [Thraustochyt... 139 1e-31
gi|25956294|gb|AAN75710.1 | delta 4-desaturase [Thraustochyt... 139 1e-31
gi|25956292|gb|AAN75709.1 | delta 4-desaturase [Thraustochyt... 138 2e-31
gi|20069125|gb|AAM09688.1 | delta-4 fatty acid desaturase [T... 138 3e-31
gi|39545945|gb|AAR28035.1 | delta-5 desaturase [Mortierella ... 136 9e-31
gi|3859488|gb|AAC72755.1 1 delta-5 fatty acid desaturase [Mo... 135 2e-30
gi|41017070|sp|O74212|FAD5_MORAP Delta-5 fatty acid desatur... 130 7e-29
gi|48854274|ref|ZP_00308437.1 | COG3239: Fatty acid desatura... 114 4e-24
gi|48854276|ref|ZP_00308439.1 | COG3239: Fatty acid desatura... 114 7e-24
According to this putative activity different fatty acids were fed (18:2, 18:3, 20:3n-6,
20:4n-3). None of said fatty acids were desaturated by the enzyme. This result clearly
shows that the protein encoded by the 8Ac gene has neither a ∆-5-desaturase activity
nor a ∆-6-desaturase activity.
Unexpectedly after feeding of the fatty acids 20:2n-6 und 20:3n-3 it could be shown,
that the 8Ac sequence encodes a ∆-8-desaturase (see figures 3 A , 3 B, 4 A and 4 B).
Figure 3 A and B shows the fatty acid profile of yeasts transformed with the construct
pYES2 as control (Figure 3 A) and pYES2-8Ac (Figure 3 B) and fed with the fatty acid
C20:2A11 14 . The respective fatty acids are market.
Figure 4 A and B shows the fatty acid profile of yeast transformed with the construct
pYES2 (Figure 4 A) as control and pYES2-8Ac (Figure 4 B) and fed with the fatty acid
C20:3A11 14 17 . The respective fatty acids are market.
The protein encoded by 8Ac sequence is therefore a ∆-8-desaturase. The conversion
rates for the fatty acids C20:2 and C20:3 are 15,2% and 17,5% respectively. This is
absolutely astonishing as the 8Ac sequence, which has some similarities to "front-
end" desaturases, has a different conserved region of the characteristic Cyt b5 motiv
His-Pro-Gly-Gly (HPGG), which is necessary for building the Heme domain. In general
mutations in said domain lead to depletion of the enzymatic acitivty (Sayanova et al.
1999, Plant Physiol 121 (2):641-646). The amino acid sequence of this new ∆-8-
desaturase shows unexpected differences to known "front-end" desaturases. Instead
of the HPGG motive this desaturase shows the motive HPAG, which is due to an
alanine in position 44 of the sequence. Sayanova et al. 1999, Plant Physiol
121(2):641-646 has shown that such a change of the motive from HPPG to HPAG
leads to inactive enzymes. Therefore the activity of the new ∆-8-desaturase is even
more astonishing.
For the further improvement of the activity of the ∆-8-desaturase, the sequence of the
enzyme was mutagenized. The following primer.
8AcMf CAAGTACCACCCGGGCGGCAGCAGGGCCA and
8AcMr TGGCCCTGCTGCCGCCCGGGTGGTACTTG
were used together with the site directed mutagenesis Kit (Stratagene) for the
mutagenesis according to the instructions of the manufacturer of the ∆-8-desaturase.
The mutagenesis was afterwards checked by sequencing. Due to the mutagenesis
the nucleotide sequences 124-CACCCGGCCGGC was changed to 124-
CACCCGGGCGGC, which leads to a change from Alanine to Glycine in position 44 of
the nucleic acid sequence shown in SEQ ID NO: 3 . The resulting sequence is shown
in SEQ ID NO: 5 . As already described for the sequence of 8Ac the mutated se
quence 8AcM was also cloned into the vector pYES2 and transformed into yeast.
Yeast transformed either with the vector pYES-8Ac or pYES2-8AcM were grown and
fed in parallel with different fatty acids (see table 5). The results of the feeding are
shown in table 5 . The mutated enzyme 8AcM shows in comparison to the wild type
enzyme 8Ac an increased activity towards the fatty acid C20:2. This is a two fold in
crease of the activity. The mutation has no influence of the activity with the fatty acid
C20:3 as substrate. This clearly shows that with the mutation the activity of the ∆-8-
desaturase can be influenced in a very specific manner.
Table 5 . Fatty acid conversion rate of yeasts transformed with pYES-8Ac or
pYES2-8AcM
The mutated ∆-8-desaturase 8AcM and its derivatives are especially useful alone or in
combination with the ∆-12- and ∆-15-desaturase, the ∆-9-elongase and the ∆-5-
desaturase for the synthesis of arachidonic acid.
c) Characterization of the gene 5Pm:
The constructs pYES2 and pYES-5Pm were transformed into yeasts grown in paralell
as described. Afterwards 250 µM of different fatty acids were fed. During this feeding
experiments it can be shown that fatty acids such as C16:0, C16:1 , C18:0, C18:1 ,
C18:2n-6, C20:2n-6 or C22:4n-6 are not desaturated by the protein encoded by the
5Pm sequence. Whereas the substrate C20:3n-6 was desaturated by the enzyme
(see figures 5 A and 5 B). Figures 5 A and 5 B clearly shows that the enzyme pro
duces arachidonic acid during the transformation of the fatty acid substrate C20:3n-6.
No new fatty acid is produced by the control (Figure 5 A). The desaturation of the fatty
acid substrate C20:3n-6 to arachidonic acid is due to a ∆-5-desaturase activity, which
is encoded by the 5Pm sequence (SEQ ID NO: 17). The conversion rate calculated
according to the equation mentioned above is 15,4%.
Figure 5 A and 5 B shows the comparison of the fatty acid profile of yeasts trans
formed with the construct pYES2 as control and fed with the fatty acid C20:3n-6 (Fig
ure 5 A) and with the construct pYES2-5Pm fed with the fatty acid C20:3n-6 (Figure 5
B). The fatty acids are marked. The new synthesized fatty acid is C20:4n-6 (arachi-
donic acid).
d) Characterization of the genes 5Ac, 9Ac, 12Pm und 8Pm:
According to sequence comparisons it was able to identify the sequences 5Ac, 12Pm
and 8Pm as desaturases having a ∆-5-desaturase, ∆-12-desaturase and ∆-8-
desaturase activity. For the sequence 9Ac we were able to show a ∆ -9-elongase ac-
tivity.
In combination with the 12Ac and 8Ac gene the complete set of enzymes from A . cas-
tellanii, which is necessary for the synthesis for arachidonic (C20:4n-6) or eicosapen-
taenoic acid could be identified. In addition further genes for the synthesis of said
aforementioned fatty acids are isolated from P. marinus. With the aid of said genes
the PUFA and/or LCPUFA content can be further improved. For the synthesis of ara
chidonic acid or eicosapentaenoic acid said genes can be introduced in plants or m i
croorganism (see example 8).
Example 8 : Generation of transgenic plants
a) Generation of transgenic oilseed rape plants (modified method of Moloney et al.,
1992, Plant Cell Reports, 8:238-242)
Binary vectors in Agrobacterium tumefaciens C58C1 :pGV2260 or Escherichia coli
(Deblaere et al, 1984, Nucl. Acids. Res. 13, 4777-4788) can be used for generating
transgenic oilseed rape plants. To transform oilseed rape plants (Var. Drakkar, NPZ
Nordeutsche Pflanzenzucht, Hohenlieth, Germany), a 1:50 dilution of an overnight
culture of a positively transformed agrobacterial colony in Murashige-Skoog medium
(Murashige and Skoog 1962 Physiol. Plant. 15, 473) supplemented with 3% sucrose
(3MS medium) is used. Petiols or hypocotyls of freshly germinated sterile oilseed rape
plants (in each case approx. 1 cm2) are incubated with a 1:50 agrobacterial dilution for
5-10 minutes in a Petri dish. This is followed by 3 days of coincubation in the dark at
25°C on 3MS medium supplemented with 0.8% Bacto agar. The cultures are then
grown for 3 days at 16 hours light/8 hours dark and the cultivation is continued in a
weekly rhythm on MS medium supplemented with 500 mg/l Claforan (cefotaxim
sodium), 50 mg/l kanamycin, 20 µM benzylaminopurine (BAP), now supplemented
with 1.6 g/l of glucose. Growing shoots are transferred to MS medium supplemented
with 2% sucrose, 250 mg/l Claforan and 0.8% Bacto agar. If no roots develop after
three weeks, 2-indolebutyric acid was added to the medium as growth hormone for
rooting.
Regenerated shoots are obtained on 2MS medium supplemented with kanamycin and
Claforan; after rooting, they are transferred to compost and, after growing on for two
weeks in a controlled-environment cabinet or in the greenhouse, allowed to flower,
and mature seeds are harvested and analyzed by lipid analysis for elongase and/or
desaturasse expression, such as ∆-12- and ∆-15-desaturase, ∆-8-desaturase, ∆-
9-elongase or ∆-5-desaturase activity. In this manner, lines with elevated contents of
PUFAs and/or LCPUFAs can be identified.
b) Generation of transgenic linseed plants
Transgenic linseed plants can be generated for example by the method of Bell et al.,
1999, In Vitro Cell. Dev. Biol.-Plant. 35(6):456-465 by means of particle
bombardment. In general, linseed was transformed by an agrobacteria-mediated
transformation, for example by the method of Mlynarova et al. (1994), Plant Cell
Report 13: 282-285.
c) Generation of transgenic Arabidopsis plants
Binary plasmids were transferred to A . tumefaciens strainGV3101 by electroporation
and kanamycin-resistant colonies were selected in all cases. Wildtype CoIO or trans
genic line CA1-9, containing the coding region of / . galbana elongating activity,
IgASEI [Qi, B., Beaudoin, F., Fraser, T., Stobart, A.K., Napier, J.A. and Lazarus, CM.
(2002) Identification of a cDNA encoding a novel C18-D9 polyunsaturated fatty acid-
specific elongating activity from the docosahexaenoic acid (DHA)-producing micro-
alga, lsochrysis galbana. FEBS Lett. 510, 159-65] was used as the host for transfor
mation with A . castellanii ∆8-desaturase gene. A . tumefaciens-mediated transforma
tion was performed as described in Bechthold et al. [(1993) In planta Agrobacterium-
mediated gene transfer by infiltration of Arabidopsis thaliana plants. CR. Acad. Sci.
Ser. Ill Sci.Vie., 316, 1194-1 199.] and seeds from dipped plants were spread on Mu-
rashige and Skoog medium containing 50 µg ml 1 kanamycin.
Example 9 : Lipid extraction from leafs
The effect of the genetic modification in plants, fungi, algae, ciliates or on the
production of a desired compound (such as a fatty acid) can be determined by
growing the modified microorganisms or the modified plant under suitable conditions
(such as those described above) and analyzing the medium and/or the cellular
components for the elevated production of desired product (i.e. of the lipids or a fatty
acid). These analytical techniques are known to the skilled worker and comprise
spectroscopy, thin-layer chromatography, various types of staining methods,
enzymatic and microbiological methods and analytical chromatography such as high-
performance liquid chromatography (see, for example, Ullman, Encyclopedia of
Industrial Chemistry, Vol. A2, p. 89-90 and p. 443-613, VCH: Weinheim (1985);
Fallon, A., et al., (1987) "Applications of HPLC in Biochemistry" in: Laboratory
Techniques in Biochemistry and Molecular Biology, Vol. 17; Rehm et al. (1993)
Biotechnology, Vol. 3 , Chapter III: "Product recovery and purification", p. 469-714,
VCH: Weinheim; Belter, P.A., et al. (1988) Bioseparations: downstream processing for
Biotechnology, John Wiley and Sons; Kennedy, J.F., and Cabral, J.M.S. (1992)
Recovery processes for biological Materials, John Wiley and Sons; Shaeiwitz, J.A.,
and Henry, J .D. (1988) Biochemical Separations, in: Ullmann's Encyclopedia of
Industrial Chemistry, Vol. B3; Chapter 11, p. 1-27, VCH: Weinheim; and Dechow, F.J.
(1989) Separation and purification techniques in biotechnology, Noyes Publications).
In addition to the abovementioned processes, plant lipids are extracted from plant
material as described by Cahoon et al. (1999) Proc. Natl. Acad. Sci. USA 96
(22): 12935-1 2940 and Browse et al. (1986) Analytic Biochemistry 152:141-145. The
qualitative and quantitative analysis of lipids or fatty acids is described by Christie,
William W., Advances in Lipid Methodology, Ayr/Scotland: Oily Press (Oily Press Lipid
Library; 2); Christie, William W., Gas Chromatography and Lipids. A Practical Guide -
Ayr, Scotland: Oily Press, 1989, Repr. 1992, IX, 307 pp. (Oily Press Lipid Library; 1) ;
"Progress in Lipid Research, Oxford: Pergamon Press, 1 (1952) - 16 (1977) under the
title: Progress in the Chemistry of Fats and Other Lipids CODEN.
One example is the analysis of fatty acids (abbreviations: FAME, fatty acid methyl
ester; GC-MS, gas liquid chromatography/mass spectrometry; TAG, triacylglycerol;
TLC, thin-layer chromatography).
The unambiguous detection for the presence of fatty acid products can be obtained
by analyzing recombinant organisms using analytical standard methods: GC, GC-MS
or TLC, as described on several occasions by Christie and the references therein
(1997, in: Advances on Lipid Methodology, Fourth Edition: Christie, Oily Press,
Dundee, 119-169; 1998, Gaschromatographie-Massenspektrometrie-Verfahren [Gas
chromatography/mass spectrometric methods], Lipide 33:343-353).
The material to be analyzed can be disrupted by sonication, grinding in a glass mill,
liquid nitrogen and grinding or via other applicable methods. After disruption, the
material must be centrifuged. The sediment is resuspended in distilled water, heated
for 10 minutes at 100°C, cooled on ice and recentrifuged, followed by extraction for
one hour at 90°C in 0.5 M sulfuric acid in methanol with 2% dimethoxypropane, which
leads to hydrolyzed oil and lipid compounds, which give transmethylated lipids. These
fatty acid methyl esters are extracted in petroleum ether and finally subjected to a GC
analysis using a capillary column (Chrompack, WCOT Fused Silica, CP-Wax-52 CB,
25 µm, 0.32 mm) at a temperature gradient of between 170°C and 240°C for
20 minutes and 5 minutes at 240°C. The identity of the resulting fatty acid methyl
esters must be defined using standards, which are available from commercial sources
(i.e. Sigma).
Plant material is initially homogenized mechanically by comminuting in a pestle and
mortar to make it more amenable to extraction.
This is followed by heating at 100°C for 10 minutes and, after cooling on ice, by
resedimentation. The cell sediment is hydrolyzed for one hour at 90°C with 1 M
methanolic sulfuric acid and 2% dimethoxypropane, and the lipids are
transmethylated. The resulting fatty acid methyl esters (FAMEs) are extracted in
petroleum ether. The extracted FAMEs are analyzed by gas liquid chromatography
using a capillary column (Chrompack, WCOT Fused Silica, CP-Wax-52 CB, 25 m,
0.32 mm) and a temperature gradient of from 170°C to 240°C in 20 minutes and 5
minutes at 240°C. The identity of the fatty acid methyl esters is confirmed by
comparison with corresponding FAME standards (Sigma). The identity and position of
the double bond can be analyzed further by suitable chemical derivatization of the
FAME mixtures, for example to give 4,4-dimethoxyoxazoline derivatives (Christie,
1998) by means of GC-MS.
Leaf material from transgenic Arabidopsis thaliana CoIO and super-transformants of
transgenic line CA1-9 both transformed with the construct pBIN1935S-8Ac were
analyzed ba gas chromatography of methyl ester derivates as described above.
Identities were confirmed by GC-MS and co-migration with authentic standards. The
conversion rates are shown in the following table 6 :
Table 6 : Conversion rate with AcD8 (delta-8-desaturase from Acanthamoeba
castellanii) of different substrates
Figure 6 shows the result with the line CA1-9. In the double transgenic Arabidopsis a
clear activity of Ac8 can be shown by the conversion of the present 20:2A11 14 or
20:3∆1 1 14 17 into 20:3∆8 1 1 14 or 20:4∆8 1 1 14 17 , the precursors of arachidonic acid or
eicosapentaenoic acid.
Additionally Acyl-CoA profiles were done from the Arabidopsis leaves of Arabidopsis
wild type (Figure 7 A), Arabidopsis ∆9elo (Figure 7 B) and Arabidopsis ∆9elo∆8des
(Figure 7 C) using the method of Larson et al. [Plant J. 2002 Nov;32(4):519-27].
Results from the measurements are shown in Figure 7 and demonstrate again the
functionality of 8Ac in plants.
Equivalents:
Many equivalents of the specific embodiments according to the invention described
herein can be identified or found by the skilled worker resorting simply to routine
experiments. These equivalents are intended to be within the scope of the patent
claims.
What is claimed is:
1. A process for the production of arachidonic acid or eicosapentaenoic acid or
arachidonic acid and eicosapentaenoic acid in transgenic plants that produce
mature seeds with a content of at least 1 % by weight of said compounds re-
ferred to the total lipid content of said organism which comprises the following
steps:
a) introduction of at least one nucleic acid sequence in said transgenic plant,
which encodes a polypeptide having a ∆-12-desaturase- and ∆-15-
desaturase-activity, and
b) introduction of at least one second nucleic acid sequence in said transgenic
plant, which encodes a polypeptide having a ∆-9-elongase-activity, and
c) introduction of at least one third nucleic acid sequence in said transgenic
plant, which encodes a polypeptide having a ∆-8-desaturase-activity, and
d) introduction of at least a one fourth nucleic acid sequence, which encodes a
polypeptide having a ∆-5-desaturase-activity, and
e) cultivating and harvesting of said transgenic plant.
2 . The process as claimed in claim 1, wherein the nucleic acid sequences which
encode polypeptides having ∆-12-desaturase and ∆-15-desaturase activity, ∆-
8-desaturase, ∆-9-elongase or ∆-5-desaturase activity are selected from the
group consisting of
a) a nucleic acid sequence depicted in SEQ ID NO: 1, SEQ ID NO: 3 , SEQ ID
NO: 5 , SEQ ID NO: 7 , SEQ ID NO: 9 , SEQ ID NO: 11, SEQ ID NO:13,
SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 2 1 and
SEQ ID NO: 23, and
b) a nucleic acid sequence, which, as a result of the degeneracy of the ge
netic code, can be derived from a polypeptide sequence as depicted in
SEQ ID NO: 2 , SEQ ID NO: 4 , SEQ ID NO: 6 , SEQ ID NO: 8 , SEQ ID NO:
10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 18,
SEQ ID NO: 20, SEQ ID NO: 22 or SEQ ID NO: 24 according to the de
generacy of the genetic code,
c) derivatives of the nucleic acid sequences depicted in SEQ ID NO: 1, SEQ
ID NO: 3 , SEQ ID NO: 5 , SEQ ID NO: 7 , SEQ ID NO: 9 , SEQ ID NO: 11,
SEQ ID NO: 13, , SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ
ID NO: 2 1 or SEQ ID NO: 23 which encode polypeptides having at least 50
% homology to the sequence as depicted in SEQ ID NO: 2 , SEQ ID NO: 4 ,
SEQ ID NO: 6 , SEQ ID NO: 8 , SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID
NO: 14, SEQ ID NO: 16, SEQ ID NO: 18, SEQ ID NO: 20, SEQ ID NO: 22
or SEQ ID NO: 24 and which polypeptides having ∆-12-desaturase and ∆-
15-desaturase activity, ∆-8-desaturase, ∆-9-elongase or ∆-5-desaturase
activity.
3 . The process as claimed in claim 1 or 2 , wherein the transgenic plant that pro
duces mature seeds is an oilseed plant.
4 . The process as claimed in claim 1 or 2 , wherein the transgenic plant that pro
duces mature seeds is selected from the group consisting of the plant families
of Anacardiaceae, Asteraceae, Apiaceae, Boraginaceae, Brassicaceae, Can-
nabaceae, Elaeagnaceae, Euphorbiaceae, Fabaceae, Geraniaceae,
Gramineae, Juglandaceae, Leguminosae, Linaceae, Lythrarieae, Malvaceae,
Onagraceae, Palmae, Poaceae, Rubiaceae, Scrophulariaceae, Solanaceae,
Sterculiaceae and Theaceae.
5 . The process as claimed in claim 1 or 2 , wherein the transgenic plant that pro
duces mature seeds is selected from the group consisting of the plant genera of
Pistacia, Mangifera, Anacardium, Calendula, Carthamus, Centaurea, Cichorium,
Cynara, Helianthus, Lactuca, Locusta, Tagetes, Valeriana, Borago, Daucus,
Brassica, Camelina, Melanosinapis, Sinapis, Arabadopsis, Orychophragmus,
Cannabis, Elaeagnus, Manihot, Janipha, Jatropha, Ricinus, Pisum, Albizia, Ca-
thormion, Feuillea, Inga, Pithecolobium, Acacia, Mimosa, Medicajo, Glycine,
Dolichos, Phaseolus, Pelargonium, Cocos, Oleum, Juglans, Wallia, Arachis,
Linum, Punica, Gossypium, Camissonia, Oenothera, Elaeis, Hordeum, Secale,
Avena, Sorghum, Andropogon, Holcus, Panicum, Oryza, Zea, Triticum, Coffea,
Verbascum, Capsicum, Nicotiana, Solanum, Lycopersicon, Theobroma and
Camellia.
6 . The process as claimed in any of the claims 1 to 5 , wherein the transgenic plant
is selected from the group consisting of rapeseed, poppy, mustard, hemp, cas-
tor bean, sesame, olive, calendula, punica, hazel nut, maize, almond, macada-
mia, cotton, avocado, pumpkin, walnut, laurel, pistachio, primrose, canola, eve
ning primrose, oil palm, peanut, linseed, soybean, safflower, marigold, coffee,
tobacco, cacao, sunflower and borage.
7 . The process as claimed in any of the claims 1 to 6 , wherein the arachidonic acid
or eicosapentaenoic acid or arachidonic acid and eicosapentaenoic acid is iso
lated in the form of their oils, lipids of free fatty acids.
8 . The process as claimed in any of the claims 1 to 7 , wherein arachidonic acid
and eicosapentaenoic acid is produced in at least a 1:2 ratio.
9 . The process as claimed in any of the claims 1 to 8 , wherein the arachidonic acid
and eicosapentaenoic acid are produced in a content of at least 5 % by weight
referred to the total lipid content.
10. The process as claimed in any of the claims 1 to 9 , wherein the ∆-12-
desaturase- and ∆-15-desaturase used in the process desaturates C16 or C18-
fatty acids having one double bond in the fatty acid chain or C16 and C18-fatty
acids having one double bond in the fatty acid chain.
11. An isolated nucleic acid sequence which encodes a polypeptide having a ∆ -12-
desaturase and ∆-15-desaturase activity selected from the group consisting of
a) a nucleic acid sequence depicted in SEQ ID NO: 19, SEQ ID NO: 2 1 or
SEQ ID NO: 23;
b) a nucleic acid sequence, which, as a result of the degeneracy of the ge
netic code, can be derived from a polypeptide sequence as depicted in
SEQ ID NO: 20, SEQ ID NO: 22 or SEQ ID NO: 24;
c) derivatives of the nucleic acid sequence depicted in SEQ ID NO: 19, SEQ
ID NO: 2 1 or SEQ ID NO: 22 which encode polypeptides having at least 40
% homology to the sequence as depicted in SEQ ID NO: 20, SEQ ID NO:
22 or SEQ ID NO: 24 and which polypeptides having ∆-12-desaturase and
∆-15-desaturase activity.
12. An isolated nucleic acid sequence comprising a nucleotide sequence which
encodes a ∆-9-elongase selected from the group consisting of
a) a nucleic acid sequence depicted in SEQ ID NO: 11;
b) a nucleic acid sequence, which, as a result of the degeneracy of the ge-
netic code, can be derived from a polypeptide sequence as depicted in
SEQ ID NO: 12;
c) derivatives of the nucleic acid sequence depicted in SEQ ID NO: 11 which
encode polypeptides having at least 70 % homology to the sequence as
depicted in SEQ ID NO: 12 and which polypeptides having ∆-9-elongase
activity.
13. An isolated nucleic acid sequence comprising a nucleotide sequence which
encodes a ∆-8-desaturase selected from the group consisting of
a) a nucleic acid sequence depicted in SEQ ID NO: 3 , SEQ ID NO: 5 or SEQ
ID NO: 7 ;
b) a nucleic acid sequence, which, as a result of the degeneracy of the ge
netic code, can be derived from a polypeptide sequence as depicted in
SEQ ID NO: 4 , SEQ ID NO: 6 or SEQ ID NO: 8 ;
c) derivatives of the nucleic acid sequence depicted in SEQ ID NO: 3 , SEQ
ID NO: 5 or SEQ ID NO: 7 which encode polypeptides having at least 70 %
homology to the sequence as depicted in SEQ ID NO: 4 , SEQ ID NO: 6 or
SEQ ID NO: 8 and which polypeptides having ∆-8-desaturase activity.
14. An isolated nucleic acid sequence comprising a nucleotide sequence which
encodes a ∆-5-desaturase selected from the group consisting of
a) a nucleic acid sequence depicted in SEQ ID NO: 15 or SEQ ID NO: 17;
b) a nucleic acid sequence, which, as a result of the degeneracy of the g e
netic code, can be derived from a polypeptide sequence as depicted in
SEQ ID NO: 16 or SEQ ID NO: 18;
c) derivatives of the nucleic acid sequence depicted in SEQ ID NO: 15 or
SEQ ID NO: 17 which encode polypeptides having at least 70 % homology
to the sequence as depicted in SEQ ID NO: 16 or SEQ ID NO: 18 and
which polypeptides having ∆-5-desaturase activity.
15. A polypeptide encoded by an isolated nucleic acid sequence as claimed in
claims 11 to 14.
16. A gene construct comprising an isolated nucleic acid having the sequence SEQ
ID NO: 3 , SEQ ID NO: 5 , SEQ ID NO: 7 , SEQ ID NO: 11, SEQ ID NO: 15, SEQ
ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 2 1 or SEQ ID NO: 23 as claimed in
claims 11 to 14, where the nucleic acid is functionally linked to one or more
regulatory signals.
17. A gene construct as claimed in claim 16, whose gene expression is increased
by the regulatory signals.
18. A vector comprising a nucleic acid as claimed in claims 11 to 14 or a gene con
struct as claimed in claim 17.
19. A transgenic plant comprising at least one nucleic acid as claimed in claims 11
to 14, a gene construct as claimed in claim 17 or a vector as claimed in claim
18.
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SEQUENCE LISTING
<110> Rothamsted Research
















atg aag tea aag cgc caa gcg ctt ccc ctt aca att gat gga aca aca 48
Met Lys Ser Lys Arg Gin Ala Leu Pro Leu Thr lie Asp Gly Thr Thr
1 5 10 15
tat gat gtg tct gcc tgg gtc aat ttc cac cct ggt ggt gcg gaa att 96
Tyr Asp val ser Ala Trp val Asn Phe His Pro Gly Gly Ala Glu lie
20 25 30
ata gag aat tac caa gga agg gat gcc act gat gcc ttc atg gtt atg 144
lie Glu Asn Tyr Gin Gly Arg Asp Ala Thr Asp Ala Phe Met Val Met
35 40 45
cac tct caa gaa gcc ttc gac aag etc aag cgc atg ccc aaa ate aat 192
His Ser Gin Glu Ala Phe Asp Lys Leu Lys Arg Met Pro Lys lie Asn
50 55 60
ccc agt tct gag ttg cca ccc cag get gca gtg aat gaa get caa gag 240
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Pro Ser Ser Glu Leu Pro Pro Gin Ala Ala VaI Asn Glu Ala Gin Glu
65 70 75 80
gat ttc egg aag etc cga gaa gag ttg ate gca act ggc atg ttt gat 288
Asp Phe Arg Lys Leu Arg Glu Glu Leu lie Ala Thr Gly Met Phe Asp
85 90 95
gcc tec ccc etc tgg tac tea tac aaa ate age ace aca ctg ggc ctt 336
Ala Ser Pro Leu Trp Tyr Ser Tyr Lys lie Ser Thr Thr Leu Gly Leu
100 105 110
gga gtg ctg ggt tat ttc ctg atg gtt cag tat cag atg tat ttc att 384
Gly VaI Leu Gly Tyr Phe Leu Met VaI Gin Tyr Gin Met Tyr Phe lie
115 120 125
ggg gca gtg ttg ctt ggg atg cac tat caa cag atg ggc tgg ctt tct 432
Gly Ala val Leu Leu Gly Met His Tyr Gin Gin Met Gly Trp Leu ser
130 135 140
cat gac att tgc cac cac cag act ttc aag aac egg aac tgg aac aac 480
His Asp lie Cys His His Gin Thr Phe Lys Asn Arg Asn Trp Asn Asn
145 150 155 160
etc gtg gga ctg gta ttt ggc aat ggt ctg caa ggt ttt tec gtg aca 528
Leu val Gly Leu val Phe Gly Asn Gly Leu Gin Gly Phe ser val Thr
165 170 175
tgc tgg aag gac aga cac aat gca cat cat teg gca ace aat gtt caa 576
Cys Trp Lys Asp Arg His Asn Ala His His Ser Ala Thr Asn Val Gin
180 185 190
ggg cac gac cct gat att gac aac etc ccc etc tta gcc tgg tct gag 624
Gly His Asp Pro Asp lie Asp Asn Leu Pro Leu Leu Ala Trp ser Glu
195 200 205
gat gac gtc aca egg gcg tea ccg att tec cgc aag etc att cag ttc 672
Asp Asp Val Thr Arg Ala Ser Pro lie Ser Arg Lys Leu lie Gin Phe
210 215 220
cag cag tat tat ttc ttg gtc ate tgt ate ttg ttg egg ttc att tgg 720
Gin Gin Tyr Tyr Phe Leu Val lie Cys lie Leu Leu Arg Phe lie Trp
225 230 235 240
tgt ttc cag age gtg ttg ace gtg cgc agt ctg aag gac aga gat aac 768
Cys Phe Gin Ser Val Leu Thr Val Arg Ser Leu Lys Asp Arg Asp Asn
245 250 255
caa ttc tat cgc tct cag tat aag aag gag gcc att ggc etc gcc ctg 816
Gin Phe Tyr Arg Ser Gin Tyr Lys Lys Glu Ala lie Gly Leu Ala Leu
260 265 270
cat tgg aca ttg aag gcc ctg ttc cac tta ttc ttt atg ccc age ate 864
His Trp Thr Leu Lys Ala Leu Phe His Leu Phe Phe Met Pro Ser lie
275 280 285
etc aca teg ctg ttg gta ttt ttc gtt teg gag ctg gtt ggc ggc ttc 912
Leu Thr Ser Leu Leu Val Phe Phe Val Ser Glu Leu Val Gly Gly Phe
290 295 300
ggc att gcg ate gtg gtg ttc atg aac cac tac cca ctg gag aag ate 960
Gly lie Ala lie Val Val Phe Met Asn His Tyr Pro Leu Glu Lys lie
305 310 315 320
ggg gac teg gtc tgg gat ggc cat gga ttc teg gtt ggc cag ate cat 1008
Gly Asp Ser Val Trp Asp Gly His Gly Phe Ser Val Gly Gin lie His
325 330 335
gag ace atg aac att egg cga ggg att ate aca gat tgg ttt ttc gga 1056
Glu Thr Met Asn lie Arg Arg Gly lie lie Thr Asp Trp Phe Phe Gly
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340 345 350
ggc ttg aac tac cag ate gag cac cat ttg tgg ccg ace etc cct cgc 1104
Gly Leu Asn Tyr Gin lie Glu His His Leu Trp Pro Thr Leu Pro Arg
355 360 365
cac aac ctg aca gcg gtt age tac cag gtg gaa cag ctg tgc cag aag 1152
His Asn Leu Thr Ala val ser Tyr Gin val Glu Gin Leu cys Gin Lys
370 375 380
cac aac ctg ccg tat egg aac ccg ctg ccc cat gaa ggg ttg gtc ate 1200
His Asn Leu Pro Tyr Arg Asn Pro Leu Pro His Glu Gly Leu Val lie
385 390 395 400
ctg ctg cgc tat ctg gcg gtg ttc gcc egg atg gcg gag aag caa ccc 1248
Leu Leu Arg Tyr Leu Ala Val Phe Ala Arg Met Ala Glu Lys Gin Pro
405 410 415
gcg ggg aag get eta taa 1266







Met Lys Ser Lys Arg Gi n Ala Leu Pro Leu Thr lie Asp Gly Thr Thr
1 5 10 15
Tyr Asp Val Ser Ala Trp Val Asn Phe Hi s Pro Gly Gly Al a Gl u lie
20 25 30
l i e Gl u Asn Tyr Gi n Gly Arg Asp Ala Thr Asp Ala Phe Met Val Met
35 40 45
Hi s Ser Gi n Gl u Ala Phe Asp Lys Leu Lys Arg Met Pro Lys lie Asn
50 55 60
Pro Ser Ser Gl u Leu Pro Pro Gi n Ala Ala Val Asn Gl u Al a Gi n Gl u
65 70 75 80
Asp Phe Arg Lys Leu Arg Gl u Gl u Leu lie Al a Thr Gly Met Phe Asp
8 5 90 95
Al a Ser Pro Leu Trp Tyr Ser Tyr Lys lie Ser Thr Thr Leu Gly Leu
100 105 110
Gly Val Leu Gly Tyr Phe Leu Met Val Gi n Tyr Gi n Met Tyr Phe lie
115 120 125
Gly Ala Val Leu Leu Gly Met Hi s Tyr Gi n Gi n Met Gly Trp Leu Ser
130 135 140
Phoeni xτ empl8528 .tmp .txt
His Asp lie Cys His His Gin Thr Phe Lys Asn Arg Asn Trp Asn Asn
145 150 155 160
Leu VaI Gly Leu VaI Phe Gly Asn Gly Leu Gin Gly Phe Ser VaI Thr
165 170 175
Cys Trp Lys Asp Arg His Asn Ala His His Ser Ala Thr Asn VaI Gin
180 185 190
Gly His Asp Pro Asp lie Asp Asn Leu Pro Leu Leu Ala Trp Ser Glu
195 200 205
Asp Asp VaI Thr Arg Ala Ser Pro lie Ser Arg Lys Leu lie Gin Phe
210 215 220
Gin Gin Tyr Tyr Phe Leu VaI lie Cys lie Leu Leu Arg Phe lie Trp
225 230 235 240
Cys Phe Gin Ser VaI Leu Thr VaI Arg Ser Leu Lys Asp Arg Asp Asn
245 250 255
Gin Phe Tyr Arg Ser Gin Tyr Lys Lys Glu Ala lie Gly Leu Ala Leu
260 265 270
His Trp Thr Leu Lys Ala Leu Phe His Leu Phe Phe Met Pro Ser lie
275 280 285
Leu Thr Ser Leu Leu VaI Phe Phe VaI Ser Glu Leu VaI Gly Gly Phe
290 295 300
Gly H e Ala H e VaI VaI Phe Met Asn His Tyr Pro Leu Glu Lys H e
305 310 315 320
Gly Asp Ser VaI Trp Asp Gly His Gly Phe Ser VaI Gly Gin lie His
325 330 335
Glu Thr Met Asn lie Arg Arg Gly lie lie Thr Asp Trp Phe Phe Gly
340 345 350
Gly Leu Asn Tyr Gin lie Glu His His Leu Trp Pro Thr Leu Pro Arg
355 360 365
His Asn Leu Thr Ala VaI Ser Tyr Gin VaI Glu Gin Leu Cys Gin Lys
370 375 380
His Asn Leu Pro Tyr Arg Asn Pro Leu Pro His Glu Gly Leu VaI lie
385 390 395 400
Leu Leu Arg Tyr Leu Ala val Phe Ala Arg Met Ala Glu Lys Gin Pro
405 410 415
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atg gtc etc aca ace ccg gcc etc aac ctg aag aag gaa cga acg teg 48
Met VaI Leu Thr Thr Pro Al a Leu Asn Leu Lys Lys Gl u Arg Thr Se r
1 5 10 15
ttc ace cag gag gag ctt tec aag etc tgg gtc ctt cac ggc cag gtg 96
Phe Thr Gi n Gl u Gl u Leu Se r Lys Leu Trp VaI Leu Hi s Gl y Gi n VaI
20 25 30
tac gat ttc ace gac ttt gtc aag tac cac ccg gcc ggc age agg gcc 144
Tyr Asp Phe Thr Asp Phe VaI Lys Tyr Hi s Pro Al a Gl y Se r Arg Al a
35 40 45
ate ctg etc ggc cgt ggc cgt gat tgt ace gtg etc ttc gag tec tac 192
l i e Leu Leu Gl y Arg Gl y Arg Asp Cys Thr VaI Leu Phe Gl u Se r Ty r
50 55 60
cac aca gtc ctg cct tec gat get ctt etc gag aag tac cgc gtc tct 240
Hi s Thr VaI Leu Pro Se r Asp Al a Leu Leu Gl u Lys Ty r Arg VaI Se r
65 70 75 80
get ccc aac gcc aag etc gag gag age egg tea gcc aag ctg ttc teg 288
Al a Pro Asn Al a Lys Leu Gl u Gl u Se r Arg Se r Al a Lys Leu Phe Se r
85 90 95
ttc gag gag ggt age ttc tac cga ace etc aag cag cga acg cgc gag 336
Phe Gl u Gl u Gl y Se r Phe Tyr Arg Thr Leu Lys Gi n Arg Thr Arg Gl u
100 105 110
tac ttc aag ace aac aac ctg age ace aag gcc ace acg atg gag gtc 384
Tyr Phe Lys Thr Asn Asn Leu Se r Thr Lys Al a Thr Th r Met Gl u VaI
115 120 12 5
ate tac ttc gtg gcc ace ate etc age ate tac ttc tgc acg tgg gcc 432
l i e Ty r Phe VaI Al a Thr l i e Leu Se r l i e Ty r Phe Cys Thr Trp Al a
130 135 140
gcc ttc gtg cag ggt tec etc ate gcc get gtc ctt cac gga gtg ggc 480
Al a Phe VaI Gi n Gl y Se r Leu l i e Al a Al a VaI Leu Hi s Gl y VaI Gl y
145 150 155 160
cgt gcg ate tgt ate ata caa ccg act cat gcg act teg cac tac gcc 528
Arg Al a l i e Cys l i e l i e Gi n Pro Thr Hi s Al a Thr Se r Hi s Ty r Al a
165 170 175
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atg ttc cgc tea gtg tgg etc aac cag tgg gcc tac agg ate tec atg 576
Met Phe Arg Ser VaI Trp Leu Asn Gin Trp Ala Tyr Arg lie Ser Met
180 185 190
gcc gtc age gga teg teg ccg gcc cag tgg ace ace aag cac gtc ate 624
Ala VaI Ser Gly Ser Ser Pro Ala Gin Trp Thr Thr Lys His VaI lie
195 200 205
aac cat cac gtc gag ace aac ctg tgc ccc ace gat gac gac ace atg 672
Asn His His VaI G lu Thr Asn Leu Cys Pro Thr Asp Asp Asp Thr Met
210 215 220
tac ccc ate aag cgc ate ctg cac gag ttc cct cgt ctg ttc ttc cac 720
Tyr Pro lie Lys Arg lie Leu His G lu Phe Pro Arg Leu Phe Phe His
225 230 235 240
aag tac cag cac ate tac ate tgg ctg gtg tac ccc tac ace ace ate 768
Lys Tyr Gin His lie Tyr lie Trp Leu VaI Tyr Pro Tyr Thr Thr lie
245 250 255
ttg tgg cac ttc tec aac ctg gcc aag etc gcc etc ggc gcc get cgc 816
Leu Trp His Phe Ser Asn Leu Ala Lys Leu Ala Leu Gly Ala Ala Arg
260 265 270
ggt cag atg tac gag ggt ate gcc aag gtg age caa gag ace teg ggt 864
Gly Gin Met Tyr Glu Gly lie Ala Lys VaI Ser Gin Glu Thr Ser Gly
275 280 285
gac tgg gtg gag acg gcc atg acg ctg ttc ttc ttc acg ttc tec cgt 912
Asp Trp VaI Glu Thr Ala Met Thr Leu Phe Phe Phe Thr Phe Ser Arg
290 295 300
ctg ctg ctg ccc ttc ctg tgc ctg ccc ttc ace acg gcc gcc gcg gtg 960
Leu Leu Leu Pro Phe Leu Cys Leu Pro Phe Thr Thr Ala Ala Ala VaI
305 310 315 320
ttc ctg etc tec gag tgg ace tgc teg ace tgg ttc gcg ctg cag ttc 1008
Phe Leu Leu Ser Glu Trp Thr Cys Ser Thr Trp Phe Ala Leu Gin Phe
325 330 335
gcc gtg age cac gag gtc gac gag tgc gtc gag cac gag aag teg gtc 1056
Ala VaI Ser His Glu VaI Asp Glu Cys VaI Glu His Glu Lys Ser VaI
340 345 350
etc gac ace etc aag gcc aac gag gcc aag ggc ate gtc aac cag ggc 1104
Leu Asp Thr Leu Lys Ala Asn Glu Ala Lys Gly lie VaI Asn Gin Gly
355 360 365
ggc etc gtc gac tgg ggc gcg cac cag gtt egg gcc teg cac aac tac 1152
Gly Leu VaI Asp Trp Gly Ala His Gin VaI Arg Ala Ser His Asn Tyr
370 375 380
tct gcc gac tec ctg ctg teg etc cac ttc age ggt ggc etc aac ctt 1200
Ser Ala Asp Ser Leu Leu Ser Leu His Phe Ser Gly Gly Leu Asn Leu
385 390 395 400
cag ate gag cac cac etc ttc ccc tec gtc cac tac act cac tac cct 1248
Gin lie Glu His His Leu Phe Pro Ser VaI His Tyr Thr His Tyr Pro
405 410 415
gcc ccg tec aag att gtg cag cag acg tgc aag gag ttc aac ttg ccc 1296
Ala Pro Ser Lys lie VaI Gin Gin Thr Cys Lys Glu Phe Asn Leu Pro
420 425 430
tgc act ctg teg ccg teg atg atg ggt gcc gtg ace aag cac tac cac 1344
Cys Thr Leu ser Pro ser Met Met Gly Ala val Thr Lys His Tyr His
435 440 445
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cag etc aag aag atg ggt get gag aac tga 1374





<213> Acanthamoeba caste! lanii
<400> 4
Met VaI Leu Thr Thr Pro Ala Leu Asn Leu Lys Lys Gl u Arg Thr Ser
1 5 10 15
Phe Thr Gi n Gl u Gl u Leu Ser Lys Leu Trp VaI Leu Hi s Gl y Gi n VaI
20 25 30
Tyr Asp Phe Thr Asp Phe VaI Lys Tyr Hi s Pro Ala Gly Ser Arg Ala
35 40 45
l i e Leu Leu Gly Arg Gly Arg Asp Cys Thr VaI Leu Phe Gl u Ser Tyr
50 55 60
Hi s Thr VaI Leu Pro Ser Asp Ala Leu Leu Gl u Lys Tyr Arg VaI Ser
65 70 75 80
Al a Pro Asn Ala Lys Leu Gl u Gl u Ser Arg Ser Ala Lys Leu Phe Ser
8 5 90 95
Phe Gl u Gl u Gly Ser Phe Tyr Arg Thr Leu Lys Gi n Arg Thr Arg Gl u
100 105 110
Tyr Phe Lys Thr Asn Asn Leu Ser Thr Lys Al a Thr Thr Met Gl u VaI
115 120 125
l i e Tyr Phe val Ala Thr lie Leu ser lie Tyr Phe cys Thr Trp Ala
130 135 140
Al a Phe VaI Gi n Gly Ser Leu lie Ala Ala VaI Leu Hi s Gly VaI Gly
145 150 155 160
Arg Ala lie cys lie l i e Gi n Pro Thr Hi s Al a Thr ser Hi s Tyr Ala
165 170 175
Met Phe Arg Ser VaI Trp Leu Asn Gi n Trp Al a Tyr Arg l i e Ser Met
180 185 190
Al a VaI Ser Gly Ser Ser Pro Ala Gi n Trp Thr Thr Lys Hi s VaI lie
195 200 205
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Asn His His VaI G lu Thr Asn Leu Cys Pro Thr Asp Asp Asp Thr Met
210 215 220
Tyr Pro lie Lys Arg lie Leu His G lu Phe Pro Arg Leu Phe Phe His
225 230 235 240
Lys Tyr Gin His lie Tyr lie Trp Leu VaI Tyr Pro Tyr Thr Thr lie
245 250 255
Leu Trp His Phe Ser Asn Leu Ala Lys Leu Ala Leu Gly Ala Ala Arg
260 265 270
Gly Gin Met Tyr Glu Gly lie Ala Lys val ser Gin Glu Thr ser Gly
275 280 285
Asp Trp VaI Glu Thr Ala Met Thr Leu Phe Phe Phe Thr Phe Ser Arg
290 295 300
Leu Leu Leu Pro Phe Leu cys Leu Pro Phe Thr Thr Ala Ala Ala val
305 310 315 320
Phe Leu Leu Ser Glu Trp Thr Cys Ser Thr Trp Phe Ala Leu Gin Phe
325 330 335
Ala val ser His Glu val Asp Glu cys val Glu His Glu Lys Ser val
340 345 350
Leu Asp Thr Leu Lys Ala Asn Glu Ala Lys Gly lie Val Asn Gin Gly
355 360 365
Gly Leu Val Asp Trp Gly Ala His Gin Val Arg Ala Ser His Asn Tyr
370 375 380
Ser Ala Asp Ser Leu Leu Ser Leu His Phe Ser Gly Gly Leu Asn Leu
385 390 395 400
Gin lie Glu His His Leu Phe Pro Ser Val His Tyr Thr His Tyr Pro
405 410 415
Ala Pro Ser Lys lie Val Gin Gin Thr Cys Lys Glu Phe Asn Leu Pro
420 425 430
Cys Thr Leu Ser Pro Ser Met Met Gly Ala Val Thr Lys His Tyr His
435 440 445












atg gtc etc aca ace ccg gcc etc aac ctg aag aag gaa cga acg teg 48
Met VaI Leu Thr Thr Pro Ala Leu Asn Leu Lys Lys Glu Arg Thr Ser
1 5 10 15
ttc ace cag gag gag ctt tec aag etc tgg gtc ctt cac ggc cag gtg 96
Phe Thr Gin Glu Glu Leu Ser Lys Leu Trp VaI Leu His Gly Gin VaI
20 25 30
tac gat ttc ace gac ttt gtc aag tac cac ccg ggc ggc age agg gcc 144
Tyr Asp Phe Thr Asp Phe VaI Lys Tyr His Pro Gly Gly Ser Arg Ala
35 40 45
ate ctg etc ggc cgt ggc cgt gat tgt ace gtg etc ttc gag tec tac 192
lie Leu Leu Gly Arg Gly Arg Asp Cys Thr VaI Leu Phe Glu Ser Tyr
50 55 60
cac aca gtc ctg cct tec gat get ctt etc gag aag tac cgc gtc tct 240
His Thr VaI Leu Pro Ser Asp Ala Leu Leu Glu Lys Tyr Arg VaI Ser
65 70 75 80
get ccc aac gcc aag etc gag gag age egg tea gcc aag ctg ttc teg 288
Ala Pro Asn Ala Lys Leu Glu Glu Ser Arg Ser Ala Lys Leu Phe Ser
85 90 95
ttc gag gag ggt age ttc tac cga ace etc aag cag cga acg cgc gag 336
Phe Glu Glu Gly Ser Phe Tyr Arg Thr Leu Lys Gin Arg Thr Arg Glu
100 105 110
tac ttc aag ace aac aac ctg age ace aag gcc ace acg atg gag gtc 384
Tyr Phe Lys Thr Asn Asn Leu Ser Thr Lys Ala Thr Thr Met Glu VaI
115 120 125
ate tac ttc gtg gcc ace ate etc age ate tac ttc tgc acg tgg gcc 432
lie Tyr Phe val Ala Thr lie Leu ser lie Tyr Phe cys Thr Trp Ala
130 135 140
gcc ttc gtg cag ggt tec etc ate gcc get gtc ctt cac gga gtg ggc 480
Ala Phe VaI Gin Gly Ser Leu lie Ala Ala VaI Leu His Gly VaI Gly
145 150 155 160
cgt gcg ate tgt ate ata caa ccg act cat gcg act teg cac tac gcc 528
Arg Ala lie cys lie lie Gin Pro Thr His Ala Thr ser His Tyr Ala
165 170 175
atg ttc cgc tea gtg tgg etc aac cag tgg gcc tac agg ate tec atg 576
Met Phe Arg Ser VaI Trp Leu Asn Gin Trp Ala Tyr Arg lie Ser Met
180 185 190
gcc gtc age gga teg teg ccg gcc cag tgg ace ace aag cac gtc ate 624
Ala VaI Ser Gly Ser Ser Pro Ala Gin Trp Thr Thr Lys His VaI lie
195 200 205
aac cat cac gtc gag ace aac ctg tgc ccc ace gat gac gac ace atg 672
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Asn His His VaI G lu Thr Asn Leu Cys Pro Thr Asp Asp Asp Thr Met
210 215 220
tac ccc ate aag cgc ate ctg cac gag ttc cct cgt ctg ttc ttc cac 720
Tyr Pro lie Lys Arg lie Leu His G lu Phe Pro Arg Leu Phe Phe His
225 230 235 240
aag tac cag cac ate tac ate tgg ctg gtg tac ccc tac ace ace ate 768
Lys Tyr Gin His lie Tyr lie Trp Leu VaI Tyr Pro Tyr Thr Thr lie
245 250 255
ttg tgg cac ttc tec aac ctg gee aag etc gee etc ggc gee get cgc 816
Leu Trp His Phe Ser Asn Leu Ala Lys Leu Ala Leu Gly Ala Ala Arg
260 265 270
ggt cag atg tac gag ggt ate gee aag gtg age caa gag ace teg ggt 864
Gly Gin Met Tyr Glu Gly lie Ala Lys val ser Gin Glu Thr ser Gly
275 280 285
gac tgg gtg gag acg gee atg acg ctg ttc ttc ttc acg ttc tec cgt 912
Asp Trp VaI Glu Thr Ala Met Thr Leu Phe Phe Phe Thr Phe Ser Arg
290 295 300
ctg ctg ctg ccc ttc ctg tgc ctg ccc ttc ace acg gee gcc gcg gtg 960
Leu Leu Leu Pro Phe Leu cys Leu Pro Phe Thr Thr Ala Ala Ala val
305 310 315 320
ttc ctg etc tec gag tgg ace tgc teg ace tgg ttc gcg ctg cag ttc 1008
Phe Leu Leu Ser Glu Trp Thr Cys Ser Thr Trp Phe Ala Leu Gin Phe
325 330 335
gcc gtg age cac gag gtc gac gag tgc gtc gag cac gag aag teg gtc 1056
Ala val ser His Glu val Asp Glu cys val Glu His Glu Lys ser val
340 345 350
etc gac ace etc aag gcc aac gag gcc aag ggc ate gtc aac cag ggc 1104
Leu Asp Thr Leu Lys Ala Asn Glu Ala Lys Gly lie Val Asn Gin Gly
355 360 365
ggc etc gtc gac tgg ggc gcg cac cag gtt egg gcc teg cac aac tac 1152
Gly Leu Val Asp Trp Gly Ala His Gin Val Arg Ala Ser His Asn Tyr
370 375 380
tct gcc gac tec ctg ctg teg etc cac ttc age ggt ggc etc aac ctt 1200
Ser Ala Asp Ser Leu Leu Ser Leu His Phe Ser Gly Gly Leu Asn Leu
385 390 395 400
cag ate gag cac cac etc ttc ccc tec gtc cac tac act cac tac cct 1248
Gin lie Glu His His Leu Phe Pro Ser Val His Tyr Thr His Tyr Pro
405 410 415
gcc ccg tec aag att gtg cag cag acg tgc aag gag ttc aac ttg ccc 1296
Ala Pro Ser Lys lie Val Gin Gin Thr Cys Lys Glu Phe Asn Leu Pro
420 425 430
tgc act ctg teg ccg teg atg atg ggt gcc gtg ace aag cac tac cac 1344
Cys Thr Leu Ser Pro Ser Met Met Gly Ala Val Thr Lys His Tyr His
435 440 445
cag etc aag aag atg ggt get gag aac tga 1374
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<213> Acanthamoeba castellanii
<400> 6
Met val Leu Thr Thr Pro Ala Leu Asn Leu Lys Lys Gl u Arg Thr ser
1 5 10 15
Phe Thr G n Gl u Gl u Leu Ser Lys Leu Trp VaI Leu Hi s Gl y Gi n VaI
20 25 30
Tyr Asp Phe Thr Asp Phe VaI Lys Tyr Hi s Pro Gly Gly Ser Arg Ala
35 40 45
l i e Leu Leu Gly Arg Gly Arg Asp Cys Thr VaI Leu Phe Gl u Ser Tyr
50 55 60
Hi s Thr VaI Leu Pro Ser Asp Ala Leu Leu Gl u Lys Tyr Arg VaI Ser
65 70 75 80
Al a Pro Asn Ala Lys Leu Gl u Gl u Ser Arg Ser Ala Lys Leu Phe Ser
8 5 90 95
Phe Gl u Gl u Gly Ser Phe Tyr Arg Thr Leu Lys Gi n Arg Thr Arg Gl u
100 105 110
Tyr Phe Lys Thr Asn Asn Leu Ser Thr Lys Al a Thr Thr Met Gl u VaI
115 120 125
l i e Tyr Phe VaI Ala Thr lie Leu Ser lie Tyr Phe Cys Thr Trp Ala
130 135 140
Al a Phe VaI Gi n Gly Ser Leu lie Ala Ala VaI Leu Hi s Gly VaI Gly
145 150 155 160
Arg Ala lie Cys lie l i e Gi n Pro Thr Hi s Al a Thr Ser Hi s Tyr Ala
165 170 175
Met Phe Arg Ser VaI Trp Leu Asn Gi n Trp Al a Tyr Arg l i e Ser Met
180 185 190
Al a VaI Ser Gly Ser Ser Pro Ala Gi n Trp Thr Thr Lys Hi s VaI lie
195 200 205
Asn Hi s Hi s VaI Gl u Thr Asn Leu Cys Pro Thr Asp Asp Asp Thr Met
210 215 220
Tyr Pro lie Lys Arg l i e Leu Hi s Gl u Phe Pro Arg Leu Phe Phe Hi s
225 230 235 240
Lys Tyr Gi n Hi s lie Tyr lie Trp Leu VaI Tyr Pro Tyr Thr Thr lie
245 250 255
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Leu Trp His Phe Ser Asn Leu Ala Lys Leu Ala Leu Gly Ala Ala Arg
260 265 270
Gly Gin Met Tyr Glu Gly lie Ala Lys VaI Ser Gin Glu Thr Ser Gly
275 280 285
Asp Trp VaI Glu Thr Ala Met Thr Leu Phe Phe Phe Thr Phe Ser Arg
290 295 300
Leu Leu Leu Pro Phe Leu Cys Leu Pro Phe Thr Thr Ala Ala Ala VaI
305 310 315 320
Phe Leu Leu Ser Glu Trp Thr Cys Ser Thr Trp Phe Ala Leu Gin Phe
325 330 335
Ala VaI Ser His Glu VaI Asp Glu Cys VaI Glu His Glu Lys Ser VaI
340 345 350
Leu Asp Thr Leu Lys Ala Asn Glu Ala Lys Gly lie VaI Asn Gin Gly
355 360 365
Gly Leu VaI Asp Trp Gly Ala His Gin VaI Arg Ala Ser His Asn Tyr
370 375 380
Ser Ala Asp Ser Leu Leu Ser Leu His Phe Ser Gly Gly Leu Asn Leu
385 390 395 400
Gin lie Glu His His Leu Phe Pro Ser VaI His Tyr Thr His Tyr Pro
405 410 415
Ala Pro Ser Lys lie VaI Gin Gin Thr Cys Lys Glu Phe Asn Leu Pro
420 425 430
Cys Thr Leu Ser Pro Ser Met Met Gly Ala VaI Thr Lys His Tyr His
435 440 445
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<223> Delta-8-Desaturase
<400> 7
atg tct tct ctt ace etc tac aga ggc ccc ttt tec cga atg gtg etc 48
Met ser se r Leu Thr Leu Tyr Arg Gl y Pro Phe ser Arg Met val Leu
1 5 10 15
cct cgt cag gaa ate tgc ate gat ggt cgc ata tac gat gtc act gag 96
Pr o Arg G n Gl u l i e Cys l i e Asp Gl y Arg l i e Tyr Asp VaI Thr Gl u
20 25 30
ttc ate aat cgt cat cca ggt ggt aag att ate etc ttc caa gtt ggt 144
Phe l i e As pi Arg Hi s Pro Gl y Gl y Lys l i e l i e Leu Phe Gi n VaI Gl y
35 40 45
get gat gee act gat get ttt cgt gag ttt cat get ggc agt gag aag 192
Al a Asp Al a Thr Asp Al a Phe Arg Gl u Phe Hi s Al a Gl y Se r Gl u Lys
50 55 60
gca gag aag ate etc aaa ace eta cca tec cgt gat gat gac ggt act 240
Al a Gl u Lys l i e Leu Lys Thr Leu Pr o Se r Arg Asp Asp Asp Gl y Th r
65 70 75 80
ttc ctt cct tea ace caa cgc tec ate atg gat gat ttc aaa cgc eta 288
Phe Leu Pro Se r Thr Gi n Arg Se r l i e Met As p Asp Phe Lys Arg Leu
85 90 95
aga gat gac etc gtc age aga ggt gtc ttc aag cca age gtc atg cat 336
Arg Asp Asp Leu VaI Se r Arg Gl y VaI Phe Lys Pro Se r VaI Met Hi s
100 105 110
gtt gta tac cgc tgc ttg gaa gtc gtt get etc tat etc att ggc ttc 384
VaI VaI Ty r Arg Cys Leu Gl u VaI VaI Al a Leu Tyr Leu l i e Gl y Phe
115 120 12 5
tat ttg get ctg tgc ace agt aat gtg tac gtt ggg tgt get gta ctt 432
Tyr Leu Al a Leu Cys Thr Se r Asn VaI Ty r VaI Gl y Cys Al a VaI Leu
130 135 140
ggt gta get caa ggt cgt get ggt tgg ttg atg cat gaa gga ggt cat 480
Gl y VaI Al a Gi n Gl y Arg Al a Gl y Tr p Leu Met Hi s Gl u Gl y Gl y Hi s
145 150 155 160
cac tct ctg act ggt aac tgg aaa gtt gac cag ttc etc caa gaa eta 528
Hi s Se r Leu Thr Gl y Asn Trp Lys VaI Asp Gi n Phe Leu Gi n Gl u Leu
165 170 175
ttt ttc ggc att ggt tgt ggt atg tea get gcg tgg tgg cgc aat gca 576
Phe Phe Gl y l i e Gl y Cys Gl y Met Se r Al a Al a Trp Trp Arg Asn Al a
180 185 190
cac aac aag cat cac get get cct cag cat tta ggg aaa gat gtt gat 624
Hi s Asn Lys Hi s Hi s Al a Al a Pro Gi n Hi s Leu Gl y Lys Asp VaI Asp
19 5 200 205
etc gag aca ttg cct ctg gtc gee ttc aat aag gee gta ctt cga ggc 672
Leu Gl u Th r Leu Pro Leu VaI Al a Phe Asn Lys Al a VaI Leu Arg Gl y
210 215 220
cgt eta ccg tct gtc tgg ate aga tea caa get gtg tgc ttt gca ccg 720
Arg Leu Pro Se r VaI Trp l i e Arg Se r Gi n Al a VaI Cys Phe Al a Pro
225 230 235 240
ata tea aca eta ctg gta teg ttc ttt tgg caa ttc tac eta cac ccg 768
l i e Se r Th r Leu Leu VaI Se r Phe Phe Trp Gi n Phe Ty r Leu Hi s Pro
245 250 255
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agg cat att att agg aca ggt cga cga atg gag tct ttc tgg eta etc 816
Arg His lie lie Arg Thr Gly Arg Arg Met Glu Ser Phe Trp Leu Leu
260 265 270
gta cgc tac tta gtt att gtg tac etc ggg ttc age tat gga ttg gta 864
VaI Arg Tyr Leu VaI lie VaI Tyr Leu Gly Phe Ser Tyr Gly Leu VaI
275 280 285
teg gtc ttg tta tgt tac ate gca agt gtg cat gtt ggt ggt atg tac 912
Ser VaI Leu Leu Cys Tyr lie Ala Ser VaI His VaI Gly Gly Met Tyr
290 295 300
ate ttt gta cac ttc get eta tea cat aca cat tta cct gtc att aac 960
lie Phe VaI His Phe Ala Leu Ser His Thr His Leu Pro VaI lie Asn
305 310 315 320
cag cat ggt aga get aac tgg ttg gaa tac gca tct aag cac aca gtt 1008
Gin His Gly Arg Ala Asn Trp Leu G lu Tyr Ala Ser Lys His Thr VaI
325 330 335
aat gtg tea act aac aat tat ttc gtc aca tgg etc atg agt tat ttg 1056
Asn VaI Ser Thr Asn Asn Tyr Phe VaI Thr Trp Leu Met Ser Tyr Leu
340 345 350
aat tat caa ata gag cat cat etc ttc ccg tea tgt ccc cag ttt aga 1104
Asn Tyr Gin lie G lu His His Leu Phe Pro Ser Cys Pro Gin Phe Arg
355 360 365
ttc cct ggt tac gtc agt atg agg gtt cga gaa ttt ttt cat aag cat 1152
Phe Pro Gly Tyr VaI Ser Met Arg VaI Arg Glu Phe Phe His Lys His
370 375 380
gga ttg aag tat aac gag gtc ggc tat eta cat gca etc aat etc aca 1200
Gly Leu Lys Tyr Asn Glu VaI Gly Tyr Leu His Ala Leu Asn Leu Thr
385 390 395 400
ttt tea aat ctg get get gtt gcc ata gtg gaa tag 1236







Met Se r Se r Leu Thr Leu Tyr Arg Gl y Pro Phe Se r Arg Met VaI Leu
1 5 10 15
Pr o Arg Gi n Gl u l i e Cys l i e As p Gl y Arg l i e Tyr As p VaI Thr Gl u
20 25 30
Phe l i e As n Arg Hi s Pro Gl y Gl y Lys l i e l i e Leu Phe Gi n VaI Gl y
35 40 45
Al a Asp Al a Thr Asp Al a Phe Arg Gl u Phe Hi s Al a Gl y Se r Gl u Lys
50 55 60
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Ala Glu Lys lie Leu Lys Thr Leu Pro Ser Arg Asp Asp Asp Gly Thr
65 70 75 80
Phe Leu Pro Ser Thr Gin Arg Ser lie Met Asp Asp Phe Lys Arg Leu
85 90 95
Arg Asp Asp Leu VaI Ser Arg Gly VaI Phe Lys Pro Ser VaI Met His
100 105 110
VaI VaI Tyr Arg Cys Leu Glu VaI VaI Ala Leu Tyr Leu lie Gly Phe
115 120 125
Tyr Leu Ala Leu Cys Thr Ser Asn VaI Tyr VaI Gly Cys Ala VaI Leu
130 135 140
Gly VaI Ala Gin Gly Arg Ala Gly Trp Leu Met His Glu Gly Gly His
145 150 155 160
His Ser Leu Thr Gly Asn Trp Lys VaI Asp Gin Phe Leu Gin Glu Leu
165 170 175
Phe Phe Gly lie Gly Cys Gly Met Ser Ala Ala Trp Trp Arg Asn Ala
180 185 190
His Asn Lys His His Ala Ala Pro Gin His Leu Gly Lys Asp VaI Asp
195 200 205
Leu Glu Thr Leu Pro Leu VaI Ala Phe Asn Lys Ala VaI Leu Arg Gly
210 215 220
Arg Leu Pro ser val Trp lie Arg ser Gin Ala val cys Phe Ala Pro
225 230 235 240
lie Ser Thr Leu Leu Val Ser Phe Phe Trp Gin Phe Tyr Leu His Pro
245 250 255
Arg His lie lie Arg Thr Gly Arg Arg Met Glu ser Phe Trp Leu Leu
260 265 270
Val Arg Tyr Leu Val lie Val Tyr Leu Gly Phe Ser Tyr Gly Leu Val
275 280 285
Ser val Leu Leu cys Tyr lie Ala ser val His val Gly Gly Met Tyr
290 295 300
lie Phe Val His Phe Ala Leu Ser His Thr His Leu Pro Val lie Asn
305 310 315 320
Gin His Gly Arg Ala Asn Trp Leu Glu Tyr Ala Ser Lys His Thr Val
325 330 335
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Asn VaI Ser Thr Asn Asn Tyr Phe VaI Thr Trp Leu Met Ser Tyr Leu
340 345 350
Asn Tyr Gin lie G lu His His Leu Phe Pro Ser Cys Pro Gin Phe Arg
355 360 365
Phe Pro Gly Tyr VaI Ser Met Arg VaI Arg Glu Phe Phe His Lys His
370 375 380
Gly Leu Lys Tyr Asn Glu VaI Gly Tyr Leu His Ala Leu Asn Leu Thr
385 390 395 400









<223> Del ta-9- El ongase
<400> 9
atg gcc etc gca aac gac gcg gga gag cgc ate tgg gcg get gtg ace 48
Met Ala Leu Ala Asn Asp Ala Gly Glu Arg lie Trp Ala Ala Val Thr
1 5 10 15
gac ccg gaa ate etc att ggc ace ttc teg tac ttg eta etc aaa ccg 96
Asp Pro Glu lie Leu lie Gly Thr Phe Ser Tyr Leu Leu Leu Lys Pro
20 25 30
ctg etc cgc aat tec ggg ctg gtg gat gag aag aag ggc gca tac agg 144
Leu Leu Arg Asn Ser Gly Leu Val Asp Glu Lys Lys Gly Ala Tyr Arg
35 40 45
acg tec atg ate tgg tac aac gtt ctg ctg gcg etc ttc tct gcg ctg 192
Thr Ser Met lie Trp Tyr Asn Val Leu Leu Ala Leu Phe Ser Ala Leu
50 55 60
age ttc tac gtg acg gcg ace gcc etc ggc tgg gac tat ggt acg ggc 240
Ser Phe Tyr Val Thr Ala Thr Ala Leu Gly Trp Asp Tyr Gly Thr Gly
65 70 75 80
gcg tgg ctg cgc agg caa ace ggc gac aca ccg cag ccg etc ttc cag 288
Ala Trp Leu Arg Arg Gin Thr Gly Asp Thr Pro Gin Pro Leu Phe Gin
85 90 95
tgc ccg tec ccg gtt tgg gac teg aag etc ttc aca tgg ace gcc aag 336
Cys Pro ser Pro val Trp Asp ser Lys Leu Phe Thr Trp Thr Ala Lys
100 105 110
Phoeni xτ empl8528 .tmp .txt
gca ttc tat tac tec aag tac gtg gag tac etc gac acg gcc tgg ctg 384
Ala Phe Tyr Tyr Ser Lys Tyr VaI G lu Tyr Leu Asp Thr Ala Trp Leu
115 120 125
agg gtc tec ttt etc cag gcc ttc cac cac ttt ggc gcg ccg tgg gat 432
Arg VaI Ser Phe Leu Gin Ala Phe His His Phe Gly Ala Pro Trp Asp
130 135 140
gtg tac etc ggc att egg ctg cac aac gag ggc gta tgg ate ttc atg 480
VaI Tyr Leu Gly H e Arg Leu His Asn Glu Gly VaI Trp H e Phe Met
145 150 155 160
ttt ttc aac teg ttc att cac ace ate atg tac ace tac tac ggc etc 528
Phe Phe Asn Ser Phe lie His Thr lie Met Tyr Thr Tyr Tyr Gly Leu
165 170 175
ace gcc gcc ggg tat aag ttc aag gcc aag ccg etc ate ace gcg atg 576
Thr Ala Ala Gly Tyr Lys Phe Lys Ala Lys Pro Leu lie Thr Ala Met
180 185 190
cag ate tgc cag ttc gtg ggc ggc ttc ctg ttg gtc tgg gac tac ate 624
Gin lie Cys Gin Phe VaI Gly Gly Phe Leu Leu VaI Trp Asp Tyr lie
195 200 205
aac gtc ccc tgc ttc aac teg gac aaa ggg aag ttg ttc age tgg get 672
Asn VaI Pro Cys Phe Asn Ser Asp Lys Gly Lys Leu Phe Ser Trp Ala
210 215 220
ttc aac tat gca tac gtc ggc teg gtc ttc ttg etc ttc tgc cac ttt 720
Phe Asn Tyr Ala Tyr VaI Gly Ser VaI Phe Leu Leu Phe Cys His Phe
225 230 235 240
ttc tac cag gac aac ttg gca acg aag aaa teg gcc aag gcg ggc aag 768
Phe Tyr Gin Asp Asn Leu Ala Thr Lys Lys Ser Ala Lys Ala Gly Lys
245 250 255







Met Al a Leu Al a Asn As p Al a Gl y Gl u Arg l i e Trp Al a Al a VaI Th r
1 5 10 15
Asp Pr o Gl u l i e Leu l i e Gl y Th r Phe s e r Ty r Leu Leu Leu Lys Pro
20 25 30
Leu Leu Arg Asn Se r Gl y Leu VaI Asp Gl u Lys Lys Gl y Al a Ty r Arg
35 40 45
Thr Se r Met l i e Trp Tyr Asn VaI Leu Leu Al a Leu Phe Se r Al a Leu
50 55 60
Phoeni xτempl8528 .tmp .txt
Ser Phe Tyr VaI Thr Ala Thr Ala Leu Gly Trp Asp Tyr Gly Thr Gly
65 70 75 80
Ala Trp Leu Arg Arg Gin Thr Gly Asp Thr Pro Gin Pro Leu Phe Gin
85 90 95
Cys Pro Ser Pro VaI Trp Asp Ser Lys Leu Phe Thr Trp Thr Ala Lys
100 105 110
Ala Phe Tyr Tyr Ser Lys Tyr VaI G lu Tyr Leu Asp Thr Ala Trp Leu
115 120 125
Arg val ser Phe Leu Gin Ala Phe His His Phe Gly Ala Pro Trp Asp
130 135 140
VaI Tyr Leu Gly lie Arg Leu His Asn Glu Gly VaI Trp lie Phe Met
145 150 155 160
Phe Phe Asn ser Phe lie His Thr lie Met Tyr Thr Tyr Tyr Gly Leu
165 170 175
Thr Ala Ala Gly Tyr Lys Phe Lys Ala Lys Pro Leu lie Thr Ala Met
180 185 190
Gin lie cys Gin Phe val Gly Gly Phe Leu Leu val Trp Asp Tyr lie
195 200 205
Asn Val Pro Cys Phe Asn Ser Asp Lys Gly Lys Leu Phe Ser Trp Ala
210 215 220
Phe Asn Tyr Ala Tyr Val Gly Ser Val Phe Leu Leu Phe Cys His Phe
225 230 235 240











Phoeni xτempl8528 .tmp .txt
<400> 11
atg gcg get gcg acg gcg acg acg gca acg acg gcg gtg atg gag caa 48
Met Ala Ala Ala Thr Ala Thr Thr Ala Thr Thr Ala VaI Met G lu Gin
1 5 10 15
gtg ccc att acg gag gcc ate ttc egg ccg gac etc tgg gtc gga egg 96
VaI Pro lie Thr Glu Ala lie Phe Arg Pro Asp Leu Trp VaI Gly Arg
20 25 30
gac cag tgg gag gcg aat gcc gtg age ttc gta tgg agg tac tgg tgg 144
Asp Gin Trp Glu Ala Asn Ala VaI Ser Phe VaI Trp Arg Tyr Trp Trp
35 40 45
ttc ttc ctg gtg atg ggc gtg gca tac ctg ccc ate ate ttc ggc etc 192
Phe Phe Leu VaI Met Gly VaI Ala Tyr Leu Pro lie lie Phe Gly Leu
50 55 60
aag tac tgg atg aag gat cgt ccg gcc ttc aac etc cgt egg ccg etc 240
Lys Tyr Trp Met Lys Asp Arg Pro Ala Phe Asn Leu Arg Arg Pro Leu
65 70 75 80
ate ttg tgg aat ate ttc atg gcg acg ttc teg ace gcc ggc ttc ctg 288
lie Leu Trp Asn lie Phe Met Ala Thr Phe Ser Thr Ala Gly Phe Leu
85 90 95
teg ate gtc tac ccc etc ate gag aac tgg gtc tac ccc ggc ggc ggc 336
Ser lie VaI Tyr Pro Leu lie Glu Asn Trp VaI Tyr Pro Gly Gly Gly
100 105 110
etc ace ccg cat gag ttc ate tgc teg gcc age tac tec tac aag ttt 384
Leu Thr Pro His Glu Phe lie Cys Ser Ala Ser Tyr Ser Tyr Lys Phe
115 120 125
ggt gat tgc gcc ate tgg gtg ttc etc ttc aac atg teg aag ate etc 432
Gly Asp Cys Ala lie Trp VaI Phe Leu Phe Asn Met Ser Lys lie Leu
130 135 140
gag ttc gtc gac ace ate ttc ate gtc ccc agg aag ace cac etc ggc 480
Glu Phe val Asp Thr lie Phe lie val Pro Arg Lys Thr His Leu Gly
145 150 155 160
ttc etc cac tac tac cac cac ate ate ace tac tec ttc tgc etc tac 528
Phe Leu His Tyr Tyr His His lie lie Thr Tyr Ser Phe Cys Leu Tyr
165 170 175
gcc ggc cag tac atg cac cac tac aac tgt ggc ggc tat ttc ttc tgc 576
Ala Gly Gin Tyr Met His His Tyr Asn cys Gly Gly Tyr Phe Phe cys
180 185 190
etc atg aac ttc ttc gtc cac ggc ate atg tac ttc tac tac get etc 624
Leu Met Asn Phe Phe Val His Gly lie Met Tyr Phe Tyr Tyr Ala Leu
195 200 205
cgc tec atg ggc ttc cgt ccc tec ttc gat att ggc ate ace ttc etc 672
Arg ser Met Gly Phe Arg Pro ser Phe Asp lie Gly lie Thr Phe Leu
210 215 220
cag att ttg caa atg gtg etc ggc gtg gcc ate ate ace ate tec gcc 720
Gin lie Leu Gin Met Val Leu Gly Val Ala lie lie Thr lie Ser Ala
225 230 235 240
ggc tgc gag aag gtg gac ccc ate gga acg ace ttc ggc tac ttt att 768
Gly Cys Glu Lys Val Asp Pro lie Gly Thr Thr Phe Gly Tyr Phe lie
245 250 255
tat ttc teg ttc ttc gtc etc ttc tgc aag ttc ttc tac tac cgc tac 816
Phoeni xτ empl8528 .tmp .txt
Tyr Phe Ser Phe Phe VaI Leu Phe Cys Lys Phe Phe Tyr Tyr Arg Tyr
260 265 270
ate gcc acg ccc gcc aag aag ccc gag gcc gcc gcc aag teg cca gcc 864
lie Ala Thr Pro Ala Lys Lys Pro Glu Ala Ala Ala Lys Ser Pro Ala
275 280 285
ace aag ccc aag agg aag cac gac taa 891





<213> Acanthamoeba caste! lanii
<400> 12
Met Al a Al a Al a Thr Al a Thr Th r Al a Thr Th r Al a val Met Gl u Gi n
1 5 10 15
VaI Pr o l i e Thr Gl u Al a l i e Phe Ar g Pro As p Leu Trp VaI Gl y Arg
20 25 30
Asp Gi n Trp Gl u Al a As n Al a val s e r Phe val Trp Arg Tyr Trp Trp
35 40 45
Phe Phe Leu Val Met Gl y Val Al a Tyr Leu Pro l i e l i e Phe Gl y Leu
50 55 60
Lys Ty r Trp Met Lys As p Arg Pro Al a Phe As n Leu Arg Arg Pr o Leu
65 70 75 80
l i e Leu Trp Asn l i e Phe Met Al a Thr Phe Se r Thr Al a Gl y Phe Leu
85 90 95
Se r l i e Val Tyr Pro Leu l i e Gl u Asn Trp Val Tyr Pro Gl y Gl y Gl y
100 105 110
Leu Thr Pro Hi s Gl u Phe l i e Cys Se r Al a Se r Tyr Se r Tyr Lys Phe
115 120 12 5
Gl y Asp Cys Al a l i e Trp Val Phe Leu Phe As n Met Se r Lys l i e Leu
130 135 140
Gl u Phe Val Asp Thr l i e Phe l i e Val Pro Arg Lys Th r Hi s Leu Gl y
145 150 155 160
Phe Leu Hi s Tyr Ty r Hi s Hi s l i e l i e Thr Ty r Se r Phe Cys Leu Ty r
165 170 175
Al a Gl y Gi n Tyr Met Hi s Hi s Ty r Asn Cys Gl y Gl y Ty r Phe Phe Cys
Phoeni xτ empl8 528. tmp . txt
180 185 190
Leu Met Asn Phe Phe VaI Hi s Gl y l i e Met Ty r Phe Tyr Tyr Al a Leu
195 200 205
Arg ser Met Gl y Phe Arg Pro se r Phe Asp l i e Gl y l i e Thr Phe Leu
210 215 220
Gi n l i e Leu Gi n Met VaI Leu Gl y VaI Al a l i e l i e Th r l i e Se r Al a
225 230 235 240
Gl y Cys Gl u Lys VaI Asp Pro l i e Gl y Thr Th r Phe Gl y Tyr Phe l i e
245 250 255
Tyr Phe Se r Phe Phe VaI Leu Phe Cys Lys Phe Phe Tyr Tyr Arg Ty r
260 265 270
l i e Al a Th r Pro Al a Lys Lys Pro Gl u Al a Al a Al a Lys Se r Pro Al a
275 280 285





<213> Thrau st rochyt r i urn
<220>
<221> CDS
<222> (l) . . (132O)
<223> Del ta- 5- Desatu rase
<400> 13
atg ggc aag ggc age gag ggc cgc age gcg gcg cgc gag atg acg gcc 48
Met Gl y Lys Gl y Se r Gl u Gl y Arg Se r Al a Al a Arg Gl u Met Thr Al a
1 5 10 15
gag gcg aac ggc gac aag egg aaa acg att ctg ate gag ggc gtc ctg 96
Gl u Al a Asn Gl y Asp Lys Arg Lys Thr l i e Leu l i e Gl u Gl y val Leu
20 25 30
tac gac gcg acg aac ttt aag cac ccg ggc ggt teg ate ate aac ttc 144
Tyr Asp Al a Thr Asn Phe Lys Hi s Pro Gl y Gl y Se r l i e l i e Asn Phe
35 40 45
ttg ace gag ggc gag gcc ggc gtg gac gcg acg cag gcg tac cgc gag 192
Leu Thr Gl u Gl y Gl u Al a Gl y VaI Asp Al a Th r Gi n Al a Tyr Arg Gl u
50 55 60
ttt cat cag egg tec ggc aag gcc gac aag tac etc aag teg ctg ccg 240
Phoeni xτempl8528 .tmp .txt
Phe His Gin Arg Ser Gly Lys Ala Asp Lys Tyr Leu Lys Ser Leu Pro
65 70 75 80
aag ctg gat gcg tec aag gtg gag teg egg ttc teg gee aaa gag cag 288
Lys Leu Asp Ala Ser Lys VaI G u Ser Arg Phe Ser Ala Lys G lu Gin
85 90 95
gcg egg cgc gac gcc atg acg cgc gac tac gcg gcc ttt cgc gag gag 336
Ala Arg Arg Asp Ala Met Thr Arg Asp Tyr Ala Ala Phe Arg G lu Glu
100 105 110
etc gtc gcc gag ggg tac ttt gac ccg teg ate ccg cac atg att tac 384
Leu VaI Ala Glu Gly Tyr Phe Asp Pro Ser lie Pro His Met lie Tyr
115 120 125
cgc gtc gtg gag ate gtg gcg etc ttc gcg etc teg ttc tgg etc atg 432
Arg val val Glu lie val Ala Leu Phe Ala Leu ser Phe Trp Leu Met
130 135 140
tec aag gcc teg ccc ace teg etc gtg ctg ggc gtg gtg atg aac ggc 480
Ser Lys Ala Ser Pro Thr Ser Leu Val Leu Gly Val Val Met Asn Gly
145 150 155 160
att gcg cag ggc cgc tgc ggc tgg gtc atg cac gag atg ggc cac ggg 528
lie Ala Gin Gly Arg cys Gly Trp val Met His Glu Met Gly His Gly
165 170 175
teg ttc acg ggc gtc ate tgg etc gac gac egg atg tgc gag ttc ttc 576
Ser Phe Thr Gly Val lie Trp Leu Asp Asp Arg Met Cys Glu Phe Phe
180 185 190
tac ggc gtc ggc tgc ggc atg age ggg cac tac tgg aag aac cag cac 624
Tyr Gly val Gly Cys Gly Met ser Gly His Tyr Trp Lys Asn Gin His
195 200 205
age aag cac cac gcc gcg ccc aac cgc etc gag cac gat gtc gat etc 672
Ser Lys His His Ala Ala Pro Asn Arg Leu Glu His Asp Val Asp Leu
210 215 220
aac acg ctg ccc ctg gtc gcc ttt aac gag cgc gtc gtg cgc aag gtc 720
Asn Thr Leu Pro Leu Val Ala Phe Asn G lu Arg Val Val Arg Lys Val
225 230 235 240
aag ccg gga teg ctg ctg gcg etc tgg ctg cgc gtg cag gcg tac etc 768
Lys Pro Gly Ser Leu Leu Ala Leu Trp Leu Arg Val Gin Ala Tyr Leu
245 250 255
ttt gcg ccc gtc teg tgc ctg etc ate ggc ctt ggc tgg acg etc tac 816
Phe Ala Pro Val Ser Cys Leu Leu lie Gly Leu Gly Trp Thr Leu Tyr
260 265 270
ctg cac ccg cgc tac atg ctg cgc ace aag egg cac atg gag ttc gtc 864
Leu His Pro Arg Tyr Met Leu Arg Thr Lys Arg His Met Glu Phe Val
275 280 285
tgg ate ttc gcg cgc tac att ggc tgg ttc teg etc atg ggc get etc 912
Trp lie Phe Ala Arg Tyr lie Gly Trp Phe Ser Leu Met Gly Ala Leu
290 295 300
ggc tac teg ccg ggc ace teg gtc ggg atg tac ctg tgc teg ttc ggc 960
Gly Tyr Ser Pro Gly Thr Ser Val Gly Met Tyr Leu Cys Ser Phe Gly
305 310 315 320
etc ggc tgc att tac att ttc ctg cag ttc gcc gtc age cac acg cac 1008
Leu Gly Cys lie Tyr lie Phe Leu Gin Phe Ala Val Ser His Thr His
325 330 335
ctg ccg gtg ace aac ccg gag gac cag ctg cac tgg etc gag tac gcg 1056
Leu Pro Val Thr Asn Pro Glu Asp Gin Leu His Trp Leu Glu Tyr Ala
Phoeni xτ empl8528 .tmp .txt
340 345 350
gcc gac cac acg gtg aac att age ace aag tec tgg etc gtc acg tgg 1104
Ala Asp His Thr VaI Asn lie Ser Thr Lys Ser Trp Leu VaI Thr Trp
355 360 365
tgg atg teg aac ctg aac ttt cag ate gag cac cac etc ttc ccc acg 1152
Trp Met ser Asn Leu Asn Phe Gin lie Glu His His Leu Phe Pro Thr
370 375 380
gcg ccg cag ttc cgc ttc aag gaa ate agt cct cgc gtc gag gcc etc 1200
Ala Pro Gin Phe Arg Phe Lys Glu lie Ser Pro Arg VaI Glu Ala Leu
385 390 395 400
ttc aag cgc cac aac etc ccg tac tac gac ctg ccc tac acg age gcg 1248
Phe Lys Arg His Asn Leu Pro Tyr Tyr Asp Leu Pro Tyr Thr Ser Ala
405 410 415
gtc teg ace ace ttt gcc aat ctt tat tec gtc ggc cac teg gtc ggc 1296
VaI Ser Thr Thr Phe Ala Asn Leu Tyr Ser VaI Gly His Ser VaI Gly
420 425 430
gcc gac ace aag aag cag gac tga 1320







Met Gl y Lys Gl y Se r Gl u Gl y Arg Se r Al a Al a Arg Gl u Met Thr Al a
1 5 10 15
Gl u Al a As n Gl y Asp Lys Arg Lys Thr l i e Leu l i e Gl u Gl y VaI Leu
20 25 30
Tyr Asp Al a Thr Asn Phe Lys Hi s Pr o Gl y Gl y Se r l i e l i e Asn Phe
35 40 45
Leu Thr Gl u Gl y Gl u Al a Gl y VaI Asp Al a Th r Gi n Al a Tyr Arg Gl u
50 55 60
Phe Hi s Gi n Arg Se r Gl y Lys Al a Asp Lys Ty r Leu Lys Se r Leu Pro
65 70 75 80
Lys Leu As p Al a Se r Lys VaI Gl u Se r Arg Phe Se r Al a Lys Gl u Gi n
85 90 95
Al a Arg Arg Asp Al a Met Thr Arg Asp Ty r Al a Al a Phe Arg Gl u Gl u
100 105 110
Leu VaI Al a Gl u Gl y Tyr Phe As p Pr o Se r l i e Pr o Hi s Met l i e Ty r
115 120 12 5
Phoeni xτ empl8528 .tmp .txt
Arg VaI VaI Glu lie VaI Ala Leu Phe Ala Leu Ser Phe Trp Leu Met
130 135 140
Ser Lys Ala Ser Pro Thr Ser Leu VaI Leu Gly VaI VaI Met Asn Gly
145 150 155 160
lie Ala Gin Gly Arg Cys Gly Trp VaI Met His Glu Met Gly His Gly
165 170 175
Ser Phe Thr Gly VaI lie Trp Leu Asp Asp Arg Met Cys Glu Phe Phe
180 185 190
Tyr Gly VaI Gly Cys Gly Met Ser Gly His Tyr Trp Lys Asn Gin His
195 200 205
Ser Lys His His Ala Ala Pro Asn Arg Leu Glu His Asp VaI Asp Leu
210 215 220
Asn Thr Leu Pro Leu VaI Ala Phe Asn G lu Arg VaI VaI Arg Lys VaI
225 230 235 240
Lys Pro Gly Ser Leu Leu Ala Leu Trp Leu Arg VaI Gin Ala Tyr Leu
245 250 255
Phe Ala Pro VaI Ser Cys Leu Leu lie Gly Leu Gly Trp Thr Leu Tyr
260 265 270
Leu His Pro Arg Tyr Met Leu Arg Thr Lys Arg His Met Glu Phe VaI
275 280 285
Trp lie Phe Ala Arg Tyr lie Gly Trp Phe Ser Leu Met Gly Ala Leu
290 295 300
Gly Tyr Ser Pro Gly Thr Ser VaI Gly Met Tyr Leu Cys Ser Phe Gly
305 310 315 320
Leu Gly Cys lie Tyr lie Phe Leu Gin Phe Ala VaI Ser His Thr His
330 335
Leu Pro VaI Thr Asn Pro Glu Asp Gin Leu His Trp Leu Glu Tyr Ala
340 345 350
Ala Asp His Thr VaI Asn lie Ser Thr Lys Ser Trp Leu VaI Thr Trp
355 360 365
Trp Met Ser Asn Leu Asn Phe Gin lie Glu His His Leu Phe Pro Thr
370 375 380
Ala Pro Gin Phe Arg Phe Lys Glu lie ser Pro Arg val Glu Ala Leu
385 390 395 400
Phoeni xτ empl8 528. tmp . txt
Phe Lys Arg Hi s Asn Leu Pro Tyr Tyr Asp Leu Pro Tyr Thr Se r Al a
405 410 415
VaI Se r Th r Thr Phe Al a Asn Leu Tyr Se r VaI Gl y Hi s Se r VaI Gl y
420 425 430





<213> Acanthamoeba castel l ani i
<220>
<221> CDS
<222> (1) . . (1353)
<223> Del ta- 5- Desatu rase
<400> 15
atg gcc ace gca tct gca tec aac gtt etc cgc ctg ccc gga gag gga 48
Met Al a Th r Al a Se r Al a Se r Asn VaI Leu Arg Leu Pro Gl y Gl u Gl y
1 5 10 15
etc gcg act ggc etc gag cag etc gag tgg gcc gaa gtg cag aag cac 96
Leu Al a Th r Gl y Leu Gl u Gi n Leu Gl u Tr p Al a Gl u VaI Gi n Lys Hi s
20 25 30
aac acg cgc gag age teg tgg ctg gtg att aac gac cag gtg tac gac 144
Asn Thr Arg Gl u Se r Se r Trp Leu VaI l i e Asn Asp Gi n VaI Ty r Asp
35 40 45
ate ace aac ttc ggc egg cgc cat ccc ggt ggc aag gta ate tac cac 192
l i e Thr Asn Phe Gl y Arg Arg Hi s Pro Gl y Gl y Lys VaI l i e Ty r Hi s
50 55 60
tac gcg ggt caa gat gcc acg gac teg ttt egg get ctt cac ccc gat 240
Tyr Al a Gl y Gi n Asp Al a Thr Asp Se r Phe Arg Al a Leu Hi s Pro Asp
65 70 75 80
tec gcc ctg gtg atg aag tat etc aag ccc etc etc ate ggt caa gtg 288
Se r Al a Leu VaI Met Lys Tyr Leu Lys Pro Leu Leu l i e Gl y Gi n VaI
85 90 95
gca ccc ggc tea tec ace gca gca teg att gtt gat ggc gcc cgc ccg 336
Al a Pro Gl y Se r Se r Thr Al a Al a Se r l i e VaI Asp Gl y Al a Arg Pro
100 105 110
gcg ccc teg gca ttc gta gag gaa ttc aga cag gtg cgc aaa gaa ttc 384
Al a Pro Se r Al a Phe VaI Gl u Gl u Phe Arg Gi n VaI Arg Lys Gl u Phe
115 120 12 5
gag gag cag ggc ctg ttc gag gcc age tgg tec ttc ttc ttc ggg atg 432
Gl u Gl u Gi n Gl y Leu Phe Gl u Al a Se r Trp Se r Phe Phe Phe Gl y Met
130 135 140
Phoeni xτ empl8528 .tmp .txt
ctg gcc cac ate ttc ctg etc gag get gcc gcc tac tac age ate aag 480
Leu Ala His lie Phe Leu Leu Glu Ala Ala Ala Tyr Tyr Ser lie Lys
145 150 155 160
ctg ctg ggc aac agt tgg ccc gtc tac etc etc gcc gtc ggc etc etc 528
Leu Leu Gly Asn Ser Trp Pro VaI Tyr Leu Leu Ala VaI Gly Leu Leu
165 170 175
gcc act gcc cag gca cag gcc ggc tgg etc cag cac gat tgt ggg cac 576
Ala Thr Ala Gin Ala Gin Ala Gly Trp Leu Gin His Asp Cys Gly His
180 185 190
ttg tec gtg ttc aag aag teg aag tgg aac cat tgg atg cac tac ate 624
Leu Ser VaI Phe Lys Lys Ser Lys Trp Asn His Trp Met His Tyr lie
195 200 205
gtc ate tgc cac ate aag ggc gcc teg cga gcc tgg tgg aac tgg cgt 672
VaI lie Cys His lie Lys Gly Ala Ser Arg Ala Trp Trp Asn Trp Arg
210 215 220
cac ttt gag cac cac gca aag ccc aac gtg gtg cgc aag gac ccc gac 720
His Phe Glu His His Ala Lys Pro Asn VaI VaI Arg Lys Asp Pro Asp
225 230 235 240
ate ace ttc ccc aac etc ttc ctt etc ggc gac cac ctg acg cgc aag 768
lie Thr Phe Pro Asn Leu Phe Leu Leu Gly Asp His Leu Thr Arg Lys
245 250 255
tgg gcc aag gcc aag aag gga gtg atg ccc tac aac aag cag cac etc 816
Trp Ala Lys Ala Lys Lys Gly VaI Met Pro Tyr Asn Lys Gin His Leu
260 265 270
tac tgg tgg get ttc ccc ccg etc ctg ctg ccc gtc tac ttc cac tac 864
Tyr Trp Trp Ala Phe Pro Pro Leu Leu Leu Pro VaI Tyr Phe His Tyr
275 280 285
gac aac att cga tac gtc ttc cag cac aag cac tgg tgg gac etc ttc 912
Asp Asn lie Arg Tyr VaI Phe Gin His Lys His Trp Trp Asp Leu Phe
290 295 300
tgg ate gcc acg ttc ttc gcg aag cac ttc acg etc tac ggc ccg ctg 960
Trp lie Ala Thr Phe Phe Ala Lys His Phe Thr Leu Tyr Gly Pro Leu
305 310 315 320
atg ggc ggc tgg ggc gcg ttc tgg ttc tac atg ctg gtg cgc acg gtc 1008
Met Gly Gly Trp Gly Ala Phe Trp Phe Tyr Met Leu VaI Arg Thr VaI
325 330 335
gag age cac tgg ttc aca tgg gtg ace cag atg aac cac ate ccc atg 1056
Glu Ser His Trp Phe Thr Trp VaI Thr Gin Met Asn His H e Pro Met
340 345 350
cac gtc gac aac gac cgc gag ctg gac tgg ccc ace ctg cag ggt etc 1104
His VaI Asp Asn Asp Arg Glu Leu Asp Trp Pro Thr Leu Gin Gly Leu
355 360 365
gcc acg tgc aac gtc gag ggc age etc ttc aac gac tgg ttc acg ggc 1152
Ala Thr Cys Asn VaI Glu Gly Ser Leu Phe Asn Asp Trp Phe Thr Gly
370 375 380
cac etc aac tac cag ate gag cac cac etc ttc ccc ace atg ccc cgc 1200
His Leu Asn Tyr Gin lie Glu His His Leu Phe Pro Thr Met Pro Arg
385 390 395 400
cac aac tac gcg gtg gcc aac aag aag gtc cag gcc etc tac aag aag 1248
His Asn Tyr Ala val Ala Asn Lys Lys val Gin Ala Leu Tyr Lys Lys
405 410 415
Phoeni xτ empl8528 .tmp .txt
cac ggc gtg ccg atg cag ace aag ggc etc ate gaa gcc ttc gcc gac 1296
His Gly VaI Pro Met Gin Thr Lys Gly Leu lie Glu Ala Phe Ala Asp
420 425 430
ate gtc aag teg etc gag cac tat ggt gag gtg tgg aag gag gcc tac 1344
lie VaI Lys Ser Leu Glu His Tyr Gly G lu VaI Trp Lys Glu Ala Tyr
435 440 445






<213> Acanthamoeba caste! lanii
<400> 16
Met Ala Thr Ala Ser Al a Ser Asn VaI Leu Arg Leu Pro Gly Gl u Gly
1 5 10 15
Leu Ala Thr Gly Leu Gl u Gi n Leu Gl u Trp Al a Gl u VaI Gi n Lys Hi s
20 25 30
Asn Thr Arg Gl u Ser Ser Trp Leu VaI lie Asn Asp Gi n VaI Tyr Asp
35 40 45
l i e Thr Asn Phe Gly Arg Arg Hi s Pro Gly Gly Lys VaI l i e Tyr Hi s
50 55 60
Tyr Ala Gly Gi n Asp Al a Thr Asp ser Phe Arg Ala Leu Hi s Pro Asp
65 70 75 80
Ser Ala Leu VaI Met Lys Tyr Leu Lys Pro Leu Leu lie Gly Gi n VaI
8 5 90 95
Al a Pro Gly Ser ser Thr Ala Ala ser lie val Asp Gly Al a Arg Pro
100 105 110
Al a Pro Ser Ala Phe VaI Gl u Gl u Phe Arg Gi n VaI Arg Lys Gl u Phe
115 120 125
Gl u Gl u Gi n Gly Leu Phe Gl u Ala ser Trp ser Phe Phe Phe Gly Met
130 135 140
Leu Ala Hi s lie Phe Leu Leu Gl u Ala Ala Al a Tyr Tyr Ser lie Lys
145 150 155 160
Leu Leu Gly Asn Ser Trp Pro VaI Tyr Leu Leu Ala VaI Gly Leu Leu
165 170 175
Phoeni xτ empl8528 .tmp .txt
Ala Thr Ala Gin Ala Gin Ala Gly Trp Leu Gin His Asp Cys Gly His
180 185 190
Leu Ser VaI Phe Lys Lys Ser Lys Trp Asn His Trp Met His Tyr lie
195 200 205
VaI lie Cys His lie Lys Gly Ala Ser Arg Ala Trp Trp Asn Trp Arg
210 215 220
His Phe Glu His His Ala Lys Pro Asn VaI VaI Arg Lys Asp Pro Asp
225 230 235 240
lie Thr Phe Pro Asn Leu Phe Leu Leu Gly Asp His Leu Thr Arg Lys
245 250 255
Trp Ala Lys Ala Lys Lys Gly VaI Met Pro Tyr Asn Lys Gin His Leu
260 265 270
Tyr Trp Trp Ala Phe Pro Pro Leu Leu Leu Pro val Tyr Phe His Tyr
275 280 285
Asp Asn lie Arg Tyr VaI Phe Gin His Lys His Trp Trp Asp Leu Phe
290 295 300
Trp lie Ala Thr Phe Phe Ala Lys His Phe Thr Leu Tyr Gly Pro Leu
305 310 315 320
Met Gly Gly Trp Gly Ala Phe Trp Phe Tyr Met Leu VaI Arg Thr VaI
325 330 335
Glu Ser His Trp Phe Thr Trp VaI Thr Gin Met Asn His lie Pro Met
340 345 350
His VaI Asp Asn Asp Arg Glu Leu Asp Trp Pro Thr Leu Gin Gly Leu
355 360 365
Ala Thr Cys Asn VaI Glu Gly Ser Leu Phe Asn Asp Trp Phe Thr Gly
370 375 380
His Leu Asn Tyr Gin lie Glu His His Leu Phe Pro Thr Met Pro Arg
385 390 395 400
His Asn Tyr Ala VaI Ala Asn Lys Lys VaI Gin Ala Leu Tyr Lys Lys
405 410 415
His Gly VaI Pro Met Gin Thr Lys Gly Leu lie Glu Ala Phe Ala Asp
420 425 430
lie VaI Lys Ser Leu Glu His Tyr Gly Glu VaI Trp Lys Glu Ala Tyr
435 440 445
Tyr Gly











atg act act tea ace act act gtg caa eta caa gaa gac ctg tea agt 48
Met Thr Thr Ser Thr Thr Thr VaI Gi n Leu Gi n Gl u Asp Leu Ser Ser
1 5 10 15
ggt gac cag aac gcc cac ccc agt cca age cga get act cct agt gtt 96
Gly Asp Gi n Asn Ala Hi s Pro Ser Pro Ser Arg Ala Thr Pro Ser VaI
20 25 30
ggt gat act aag gag gat gcg agg gtt gtt ate aaa eta ttt ggt aca 144
Gly Asp Thr Lys Gl u Asp Ala Arg VaI VaI l i e Lys Leu Phe Gly Thr
35 40 45
tgg gtt gat gtt aca get tgg ttg aat gac cat cct ggt ggt tct aaa 192
Trp VaI Asp VaI Thr Ala Trp Leu Asn Asp His Pro Gly Gly Ser Lys
50 55 60
gtg etc aga gca ttc aac aag aag gac gcg act gat get gtt atg gcc 240
VaI Leu Arg Ala Phe Asn Lys Lys Asp Ala Thr Asp Ala val Met Ala
65 70 75 80
atg cac act gat gaa get ate aag cgc ate ate aga ttt tea aat gtg 288
Met His Thr Asp Glu Ala lie Lys Arg lie lie Arg Phe Ser Asn VaI
85 90 95
gtc tec teg gcc ccc ate aac gcc tct att ggt gat gtc cag gtt att 336
val ser ser Ala Pro lie Asn Ala ser lie Gly Asp val Gin val lie
100 105 110
gag aaa tct eta teg aga gaa cag ttg atg tat tac aag etc cgc act 384
Glu Lys Ser Leu Ser Arg Glu Gin Leu Met Tyr Tyr Lys Leu Arg Thr
115 120 125
ctt get aga aac cag ggc tgg ttt caa age aat eta tta tac gaa gga 432
Leu Ala Arg Asn Gin Gly Trp Phe Gin ser Asn Leu Leu Tyr Glu Gly
130 135 140
gtg aaa gca atg ata gcc ttc ggt ttg etc ate ate ggg ttt get act 480
Val Lys Ala Met lie Ala Phe Gly Leu Leu lie lie Gly Phe Ala Thr
145 150 155 160
etc tac ttc gac tat ggt att tgg tea ace gca ctg ata ggt ttc get 528
Leu Tyr Phe Asp Tyr Gly lie Trp Ser Thr Ala Leu lie Gly Phe Ala
165 170 175
tgg ttt cag ctg ggg tgg ttg gga cat gac tgg tct cat cat aca get 576
Phoeni xτ empl8528 .tmp .txt
Trp Phe Gin Leu Gly Trp Leu Gly His Asp Trp Ser His His Thr Ala
180 185 190
eta cca aag tct act act aac tgt gcg aac tac aat gac tat ctt ggc 624
Leu Pro Lys Ser Thr Thr Asn Cys Ala Asn Tyr Asn Asp Tyr Leu Gly
195 200 205
tgg ctt act ggt ttg get aga ggg aat aca ctt ctg tgg tgg aaa eta 672
Trp Leu Thr Gly Leu Ala Arg Gly Asn Thr Leu Leu Trp Trp Lys Leu
210 215 220
agg cat aat act cat cac gtg ctg ace aat cag tac gag aat gat cct 720
Arg His Asn Thr His His VaI Leu Thr Asn Gin Tyr G lu Asn Asp Pro
225 230 235 240
gat ata eta act caa cca ccg ttg cat ttt ttc gag gac ttc gat gtt 768
Asp lie Leu Thr Gin Pro Pro Leu His Phe Phe Glu Asp Phe Asp val
245 250 255
ggt aat gtg aac aga tat caa get gtc tac tat eta cca atg eta act 816
Gly Asn VaI Asn Arg Tyr Gin Ala VaI Tyr Tyr Leu Pro Met Leu Thr
260 265 270
eta ctg cat eta ttt tgg ttg tac gag teg gta ttg gtt tgc ttg aga 864
Leu Leu His Leu Phe Trp Leu Tyr Glu ser val Leu val cys Leu Arg
275 280 285
caa agt aag tct att aat aga tac aac cgt atg cat gcc egg agg gat 912
Gin Ser Lys Ser lie Asn Arg Tyr Asn Arg Met His Ala Arg Arg Asp
290 295 300
ace gta get ttg gta ctt cac ata etc att gtt ggc ate ata teg tac 960
Thr val Ala Leu val Leu His lie Leu lie val Gly lie lie ser Tyr
305 310 315 320
ace agt ggt aag tat ttg etc ate ctt ctg gcc tac atg ctt agt ggc 1008
Thr Ser Gly Lys Tyr Leu Leu lie Leu Leu Ala Tyr Met Leu Ser Gly
325 330 335
ttt eta act get gtt gtt gta ttt gcc age cac tac aac gag cct agg 1056
Phe Leu Thr Ala Val Val Val Phe Ala Ser His Tyr Asn Glu Pro Arg
340 345 350
gta get tct ggt gaa tec tta tea etc gtt cgt cag aca ttg tta ace 1104
Val Ala Ser Gly Glu Ser Leu Ser Leu Val Arg Gin Thr Leu Leu Thr
355 360 365
act ate aat ata ggc tea ttc agt gat act cat tgg gag aag aag ttg 1152
Thr lie Asn lie Gly Ser Phe Ser Asp Thr His Trp Glu Lys Lys Leu
370 375 380
tgg ttc tat eta act ggt ggt ctt aat atg caa ate gag cat cat etc 1200
Trp Phe Tyr Leu Thr Gly Gly Leu Asn Met Gin lie Glu His His Leu
385 390 395 400
ttc cca aca atg ccc cgc cat aat ctt ccg aag aca act ttt ctg gtc 1248
Phe Pro Thr Met Pro Arg His Asn Leu Pro Lys Thr Thr Phe Leu Val
405 410 415
aag tea eta gcc cag gag eta gga ctg cca tac aag gaa ace aac att 1296
Lys Ser Leu Ala Gin Glu Leu Gly Leu Pro Tyr Lys Glu Thr Asn lie
420 425 430
gtc agt tta ace aag gcg gcc gtt act act ttg cat cat aat get ctg 1344
Val Ser Leu Thr Lys Ala Ala Val Thr Thr Leu His His Asn Ala Leu
435 440 445
cgt aac ate gag aga ttg ctt get agg tag 1374
Arg Asn lie Glu Arg Leu Leu Ala Arg







Met Thr Th r Se r Thr Thr Thr VaI Gi n Leu Gi n Gl u As p Leu Se r Se r
1 5 10 15
Gl y Asp G n Asn Al a Hi s Pr o Se r Pr o Se r Arg Al a Th r Pr o Se r VaI
20 25 30
Gl y Asp Th r Lys Gl u As p Al a Arg VaI VaI l i e Lys Leu Phe Gl y Th r
35 40 45
Trp VaI As p VaI Thr Al a Trp Leu Asn Asp Hi s Pr o Gl y Gl y Se r Lys
50 55 60
VaI Leu Arg Al a Phe As n Lys Lys Asp Al a Th r Asp Al a VaI Met Al a
65 70 75 80
Met Hi s Th r Asp Gl u Al a l i e Lys Ar g l i e l i e Arg Phe Se r Asn VaI
85 90 95
VaI Se r Se r Al a Pro l i e Asn Al a Se r l i e Gl y Asp VaI Gi n VaI l i e
100 105 110
Gl u Lys Se r Leu Se r Arg Gl u Gi n Leu Met Ty r Tyr Lys Leu Arg Th r
115 120 12 5
Leu Al a Arg Asn Gi n Gl y Trp Phe Gi n Se r As n Leu Leu Tyr Gl u Gl y
130 135 140
VaI Lys Al a Met l i e Al a Phe Gl y Leu Leu l i e l i e Gl y Phe Al a Th r
145 150 155 160
Leu Ty r Phe Asp Ty r Gl y l i e Trp Se r Thr Al a Leu l i e Gl y Phe Al a
165 170 175
Trp Phe Gi n Leu Gl y Trp Leu Gl y Hi s Asp Trp Se r Hi s Hi s Thr Al a
180 185 190
Leu Pr o Lys Se r Thr Thr Asn Cys Al a Asn Ty r Asn As p Tyr Leu Gl y
19 5 200 205
Trp Leu Th r Gl y Leu Al a Arg Gl y Asn Thr Leu Leu Trp Trp Lys Leu
210 215 220
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Arg His Asn Thr His His VaI Leu Thr Asn Gin Tyr G lu Asn Asp Pro
225 230 235 240
Asp lie Leu Thr Gin Pro Pro Leu His Phe Phe Glu Asp Phe Asp VaI
245 250 255
Gly Asn VaI Asn Arg Tyr Gin Ala VaI Tyr Tyr Leu Pro Met Leu Thr
260 265 270
Leu Leu His Leu Phe Trp Leu Tyr Glu Ser VaI Leu VaI Cys Leu Arg
275 280 285
Gin Ser Lys Ser lie Asn Arg Tyr Asn Arg Met His Ala Arg Arg Asp
290 295 300
Thr VaI Ala Leu VaI Leu His lie Leu lie VaI Gly lie lie Ser Tyr
305 310 315 320
Thr Ser Gly Lys Tyr Leu Leu lie Leu Leu Ala Tyr Met Leu Ser Gly
325 330 335
Phe Leu Thr Ala VaI VaI VaI Phe Ala Ser His Tyr Asn Glu Pro Arg
340 345 350
VaI Ala Ser Gly Glu Ser Leu Ser Leu VaI Arg Gin Thr Leu Leu Thr
355 360 365
Thr lie Asn lie Gly Ser Phe Ser Asp Thr His Trp Glu Lys Lys Leu
370 375 380
Trp Phe Tyr Leu Thr Gly Gly Leu Asn Met Gin lie Glu His His Leu
385 390 395 400
Phe Pro Thr Met Pro Arg His Asn Leu Pro Lys Thr Thr Phe Leu VaI
405 410 415
Lys Ser Leu Ala Gin Glu Leu Gly Leu Pro Tyr Lys Glu Thr Asn lie
420 425 430
VaI Ser Leu Thr Lys Ala Ala VaI Thr Thr Leu His His Asn Ala Leu
435 440 445





<213> Acanthamoeba caste! lanii




<223> Del ta-12/Delta-15-Desatu rase
<400> 19
atg act att act act ace cag ace ttg aac cag aag get get aag aag 48
Met Thr l e Thr Thr Thr Gi n Th r Leu Asn Gi n Lys Al a Al a Lys Lys
1 5 10 15
gga gga aag gag agg get cca att att cca aag gag aac get cca ttc 96
Gl y Gl y Lys Gl u Arg Al a Pr o l i e l i e Pro Lys Gl u As n Al a Pr o Phe
20 25 30
act ttg gga cag ate aag gga get ate cca cct cat etc ttc aag cac 144
Thr Leu Gl y Gi n l i e Lys Gl y Al a l i e Pro Pro Hi s Leu Phe Lys Hi s
35 40 45
tec atg ttg aag tct ttc tec tac ttg gga gtg gat ttg ttg gag tct 192
Se r Met Leu Lys Se r Phe Se r Ty r Leu Gl y VaI Asp Leu Leu Gl u Se r
50 55 60
ace ate tgg ttg ttc etc ate ttg tac ttg gat gga etc act aag gag 240
Thr l i e Trp Leu Phe Leu l i e Leu Tyr Leu As p Gl y Leu Thr Lys Gl u
65 70 75 80
aac ace ttg ttg aac tgg act tgc tgg gtt gca tac tgg ttg tac caa 288
Asn Thr Leu Leu Asn Trp Thr Cys T r p VaI Al a Tyr Trp Leu Ty r Gi n
85 90 95
gga ttg act tgg act gga att tgg gtg ttg get cat gag tgt gga cat 336
Gl y Leu Th r Trp Thr Gl y l i e Trp VaI Leu Al a Hi s Gl u Cys Gl y Hi s
100 105 110
gga gga ttc gtt get caa gag tgg ttg aac gat ace gtg ggt ttc att 384
Gl y Gl y Phe VaI Al a Gi n Gl u Trp Leu Asn As p Thr VaI Gl y Phe l i e
115 120 12 5
ttc cat ace gtg etc tac gtt cca tac ttc tec tgg aag ttc tct cat 4 32
Phe Hi s Th r VaI Leu Tyr VaI Pro Tyr Phe Se r Trp Lys Phe Se r Hi s
130 135 140
get aag cac cat cac tac ace aac cac atg act aag gat gag cca ttc 480
Al a Lys Hi s Hi s Hi s Tyr Thr As n Hi s Met Th r Lys As p Gl u Pr o Phe
145 150 155 160
gtg cca cat aca ate act cca gag caa agg get aaa gtg gat caa gga 528
VaI Pr o Hi s Thr l i e Thr Pr o Gl u Gi n Arg Al a Lys VaI Asp Gi n Gl y
165 170 175
gag ttg cca cat cca aac aag cca tec etc ttc get ttc tac gag aga 576
Gl u Leu Pro Hi s Pro As n Lys Pro Se r Leu Phe Al a Phe Tyr Gl u Arg
180 185 190
tgg gtg ate cca ttc gtg atg ttg ttc ttg gga tgg cca etc tac ttg 624
Trp VaI l i e Pr o Phe VaI Met Leu Phe Leu Gl y Trp Pro Leu Ty r Leu
19 5 200 205
tct ate aac get tct gga cca cca aag aag gag ttg gtt tec cac tac 672
Se r l i e As n Al a Se r Gl y Pr o Pro Lys Lys Gl u Leu VaI Se r Hi s Ty r
210 215 220
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gat cca aag get tec ate ttc aac aag aaa gat tgg tgg aag ate ttg 720
Asp Pro Lys Ala Ser lie Phe Asn Lys Lys Asp Trp Trp Lys lie Leu
225 230 235 240
etc tct gat ttg gga ttg gtt get tgg act ttg get ttg tgg aag ttg 768
Leu Ser Asp Leu Gly Leu VaI Ala Trp Thr Leu Ala Leu Trp Lys Leu
245 250 255
gga gag act ttc gga ttc gga ttg gtg get get ctt tac att cca cca 816
Gly Glu Thr Phe Gly Phe Gly Leu VaI Ala Ala Leu Tyr lie Pro Pro
260 265 270
gtg etc gtt ace aac tct tac ttg gtg get ate ace ttc ttg caa cac 864
VaI Leu VaI Thr Asn Ser Tyr Leu VaI Ala lie Thr Phe Leu Gin His
275 280 285
ace gat gat ate etc cca cat tac gat get act gag tgg act tgg ttg 912
Thr Asp Asp lie Leu Pro His Tyr Asp Ala Thr Glu Trp Thr Trp Leu
290 295 300
aga gga get ttg tgc act gtg gat aga tct ttg gga tgg ttc gga gat 960
Arg Gly Ala Leu Cys Thr VaI Asp Arg Ser Leu Gly Trp Phe Gly Asp
305 310 315 320
tac aag ace cat cac ate gtt gat act cat gtg ace cac cac ate ttc 1008
Tyr Lys Thr His His lie VaI Asp Thr His VaI Thr His His lie Phe
325 330 335
tct tac etc cca ttc tat aac get gag gag get act aag get att aag 1056
Ser Tyr Leu Pro Phe Tyr Asn Ala Glu Glu Ala Thr Lys Ala lie Lys
340 345 350
cca gtg ttg aag gag tat cac tgc gag gat aag aga gga ttc ttc cac 1104
Pro VaI Leu Lys Glu Tyr His Cys Glu Asp Lys Arg Gly Phe Phe His
355 360 365
ttc tgg tac ttg ttc ttc aag ace get get gag aac tct gtt gtg gat 1152
Phe Trp Tyr Leu Phe Phe Lys Thr Ala Ala Glu Asn Ser VaI VaI Asp
370 375 380
aac gag ace aac aag tec cca gga ate ttc tac ttc ttc agg gag gag 1200
Asn Glu Thr Asn Lys Ser Pro Gly lie Phe Tyr Phe Phe Arg Glu Glu
385 390 395 400
att aag cac gga aag get cat tga 1224





<213> Acanthamoeba caste! lanii
<400> 20
Met Thr lie Thr Thr Thr Gi n Thr Leu Asn Gi n Lys Ala Al a Lys Lys
1 5 10 15
Gly Gly Lys Gl u Arg Al a Pro lie lie Pro Lys Gl u Asn Al a Pro Phe
20 25 30
Phoeni xτempl8528 .tmp .txt
Thr Leu Gl y Gi n l i e Lys Gl y Al a l i e Pro Pro Hi s Leu Phe Lys Hi s
35 40 45
Se r Met Leu Lys Se r Phe Se r Ty r Leu Gl y VaI Asp Leu Leu Gl u Se r
50 55 60
Thr l i e Trp Leu Phe Leu l i e Leu Tyr Leu As p Gl y Leu Thr Lys Gl u
65 70 75 80
Asn Thr Leu Leu Asn Trp Thr Cys T r p VaI Al a Tyr Trp Leu Ty r Gi n
85 90 95
Gl y Leu Th r Trp Thr Gl y H e Trp VaI Leu Al a Hi s Gl u Cys Gl y Hi s
100 105 110
Gl y Gl y Phe VaI Al a Gi n Gl u Trp Leu Asn As p Thr VaI Gl y Phe l i e
115 120 12 5
Phe Hi s Th r VaI Leu Tyr VaI Pro Tyr Phe Se r Trp Lys Phe Se r Hi s
130 135 140
Al a Lys Hi s Hi s Hi s Tyr Thr As n Hi s Met Th r Lys As p Gl u Pr o Phe
145 150 155 160
VaI Pr o Hi s Thr H e Thr Pro Glu Gin Arc Ala Lys VaI Asp Gin Gly
165 17C
Glu Leu Pro His Pro Asn Lys Pro Ser Leu Phe Ala Phe Tyr Glu Arg
180 185 190
Trp val lie Pro Phe val Met Leu Phe Leu Gly Trp Pro Leu Tyr Leu
195 200 205
Ser lie Asn Ala Ser Gly Pro Pro Lys Lys Glu Leu Val Ser His Tyr
210 215 220
Asp Pro Lys Ala ser lie Phe Asn Lys Lys Asp Trp Trp Lys lie Leu
225 230 235 240
Leu Ser Asp Leu Gly Leu Val Ala Trp Thr Leu Ala Leu Trp Lys Leu
245 250 255
Gly Glu Thr Phe Gly Phe Gly Leu val Ala Ala Leu Tyr lie Pro Pro
260 265 270
Val Leu Val Thr Asn Ser Tyr Leu Val Ala lie Thr Phe Leu Gin His
275 280 285
Thr Asp Asp lie Leu Pro His Tyr Asp Ala Thr Glu Trp Thr Trp Leu
290 295 300
Phoeni xτempl8528 .tmp .txt
Arg Gly Ala Leu Cys Thr VaI Asp Arg Ser Leu Gly Trp Phe Gly Asp
305 310 315 320
Tyr Lys Thr His His lie VaI Asp Thr His VaI Thr His His H e Phe
325 330 335
Ser Tyr Leu Pro Phe Tyr Asn Ala Glu Glu Ala Thr Lys Ala lie Lys
340 345 350
Pro VaI Leu Lys Glu Tyr His Cys Glu Asp Lys Arg Gly Phe Phe His
355 360 365
Phe Trp Tyr Leu Phe Phe Lys Thr Ala Ala Glu Asn ser val val Asp
370 375 380
Asn Glu Thr Asn Lys Ser Pro Gly lie Phe Tyr Phe Phe Arg Glu Glu
385 390 395 400









<22 3> Del ta-12/Delta-15-Desatu rase
<400> 21
atg acg ate acg acg acg cag aca ctg aat cag aag gca gcc aag aag 48
Met Thr H e Thr Thr Thr Gin Thr Leu Asn Gin Lys Ala Ala Lys Lys
1 5 10 15
ggc gga aag gag cgc get ccg ate att ccc aag gag aac gcc ccc ttc 96
Gly Gly Lys Glu Arg Ala Pro lie lie Pro Lys Glu Asn Ala Pro Phe
20 25 30
act ctg ggc cag ate aag ggc gcc att cct ccg cat etc ttc aag cac 144
Thr Leu Gly Gin lie Lys Gly Ala lie Pro Pro His Leu Phe Lys His
35 40 45
age atg etc aaa tec ttc age tat ctg ggc gtg gat ctg ctg gag age 192
Ser Met Leu Lys Ser Phe Ser Tyr Leu Gly Val Asp Leu Leu Glu Ser
50 55 60
ace ate tgg etc ttc etc ate etc tac etc gac ggc etc ace aag gag 240
Thr lie Trp Leu Phe Leu lie Leu Tyr Leu Asp Gly Leu Thr Lys Glu
65 70 75 80
Phoeni xτ empl8528 .tmp .txt
aac acg etc etc aac tgg act tgc tgg gtt gcg tac tgg etc tac cag 288
Asn Thr Leu Leu Asn Trp Thr Cys Trp VaI Ala Tyr Trp Leu Tyr Gin
85 90 95
ggt ctg ace tgg act ggc att tgg gtg ctg gee cac gag tgt ggc cat 336
Gly Leu Thr Trp Thr Gly lie Trp VaI Leu Ala His G lu Cys G ly His
100 105 110
ggc ggc ttc gtg gcg cag gag tgg etc aac gac acg gtc ggc ttc ate 384
Gly Gly Phe VaI Ala Gin Glu Trp Leu Asn Asp Thr VaI Gly Phe H e
115 120 125
ttc cac ace gtc etc tac gtg ccc tac ttc teg tgg aag ttc tec cac 432
Phe His Thr VaI Leu Tyr VaI Pro Tyr Phe Ser Trp Lys Phe Ser His
130 135 140
gee aag cac cac cac tac ace aac cac atg aca aag gac gag ccc ttc 480
Ala Lys His His His Tyr Thr Asn His Met Thr Lys Asp Glu Pro Phe
145 150 155 160
gtg ccc cac ace ate ace cct gag cag agg gcc aag gtc gac cag ggc 528
VaI Pro His Thr lie Thr Pro Glu Gin Arg Ala Lys VaI Asp Gin Gly
165 170 175
gag ctg ccc cac ccc aac aag ccc tec etc ttc gcc ttc tac gaa agg 576
Glu Leu Pro His Pro Asn Lys Pro Ser Leu Phe Ala Phe Tyr Glu Arg
180 185 190
tgg gtc ate ccc ttc gtc atg etc ttc etc ggc tgg ccg etc tac ctg 624
Trp VaI lie Pro Phe VaI Met Leu Phe Leu Gly Trp Pro Leu Tyr Leu
195 200 205
tec ate aac gcc tct ggc cct ccc aag aag gag ctt gtg tec cac tac 672
Ser lie Asn Ala Ser Gly Pro Pro Lys Lys Glu Leu VaI Ser His Tyr
210 215 220
gac ccc aaa gcc age ate ttc aac aag aag gac tgg tgg aag ate ctt 720
Asp Pro Lys Ala Ser lie Phe Asn Lys Lys Asp Trp Trp Lys lie Leu
225 230 235 240
etc tct gac etc ggc ctt gtg gcg tgg ace ctg gcc etc tgg aag ctg 768
Leu ser Asp Leu Gly Leu val Ala Trp Thr Leu Ala Leu Trp Lys Leu
245 250 255
ggc gag ace ttc ggc ttc ggt etc gtg gcc gcc etc tac att ccg ccc 816
Gly Glu Thr Phe Gly Phe Gly Leu VaI Ala Ala Leu Tyr lie Pro Pro
260 265 270
gtg ctg gtg ace aac tec tac ctg gtg gcc ate ace ttc etc cag cac 864
val Leu val Thr Asn ser Tyr Leu val Ala lie Thr Phe Leu Gin His
275 280 285
ace gac gac att ctg ccc cac tac gac gcc ace gag tgg ace tgg etc 912
Thr Asp Asp lie Leu Pro His Tyr Asp Ala Thr Glu Trp Thr Trp Leu
290 295 300
agg ggt get etc tgc act gtt gat cgt teg ctg ggc tgg ttc ggc gac 960
Arg Gly Ala Leu cys Thr val Asp Arg ser Leu Gly Trp Phe Gly Asp
305 310 315 320
tac aag acg cac cac ate gtc gac ace cac gtg acg cac cac ate ttc 1008
Tyr Lys Thr His His lie Val Asp Thr His Val Thr His His lie Phe
325 330 335
teg tac ctg ccg ttc tac aac gcc gag gag gcc ace aag gcc ate aag 1056
Ser Tyr Leu Pro Phe Tyr Asn Ala Glu Glu Ala Thr Lys Ala lie Lys
340 345 350
ccc gtg etc aag gag tac cac tgc gag gac aag cgt ggc ttc ttc cac 1104
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Pro VaI Leu Lys G lu Tyr His Cys G lu Asp Lys Arg Gly Phe Phe His
355 360 365
ttc tgg tat ctg ttc ttc aag ace gcc gcc gag aac age gtt gtc gac 1152
Phe Trp Tyr Leu Phe Phe Lys Thr Ala Ala Glu Asn Ser VaI VaI Asp
370 375 380
aac gag ace aac aag age ccc ggc ate ttc tac ttc ttc egg gag gag 1200
Asn Glu Thr Asn Lys Ser Pro Gly lie Phe Tyr Phe Phe Arg Glu Glu
385 390 395 400
ate aag cac ggc aag gcc cac tag 1224





<213> Acanthamoeba caste! lanii
<400> 22
Met Thr l i e Thr Thr Thr Gi n Th r Leu Asn Gi n Lys Al a Al a Lys Lys
1 5 10 15
Gl y Gl y Lys Gl u Arg Al a Pr o l i e l i e Pro Lys Gl u As n Al a Pr o Phe
20 25 30
Thr Leu Gl y Gi n l i e Lys Gl y Al a l i e Pro Pro Hi s Leu Phe Lys Hi s
35 40 45
Se r Met Leu Lys Se r Phe Se r Ty r Leu Gl y VaI Asp Leu Leu Gl u Se r
50 55 60
Thr l i e Trp Leu Phe Leu l i e Leu Tyr Leu As p Gl y Leu Thr Lys Gl u
65 70 75 80
Asn Thr Leu Leu Asn Trp Thr Cys T r p VaI Al a Tyr Trp Leu Ty r Gi n
85 90 95
Gl y Leu Th r Trp Thr Gl y l i e Trp VaI Leu Al a Hi s Gl u Cys Gly Hi s
100 105 110
Gly Gly Phe VaI Ala Gi n Gl u Trp Leu Asn Asp Thr VaI Gly Phe lie
115 120 125
Phe Hi s Thr VaI Leu Tyr VaI Pro Tyr Phe Ser Trp Lys Phe Ser Hi s
130 135 140
Al a Lys Hi s Hi s Hi s Tyr Thr Asn Hi s Met Thr Lys Asp Gl u Pro Phe
145 150 155 160
VaI Pro Hi s Thr lie Thr Pro Gl u Gi n Arg Al a Lys VaI Asp Gi n Gly
Phoeni xτ empl8528 .tmp .txt
165 170 175
Glu Leu Pro His Pro Asn Lys Pro Ser Leu Phe Ala Phe Tyr Glu Arg
180 185 190
Trp val lie Pro Phe val Met Leu Phe Leu Gly Trp Pro Leu Tyr Leu
195 200 205
Ser lie Asn Ala Ser Gly Pro Pro Lys Lys Glu Leu Val Ser His Tyr
210 215 220
Asp Pro Lys Ala Ser lie Phe Asn Lys Lys Asp Trp Trp Lys lie Leu
225 230 235 240
Leu Ser Asp Leu Gly Leu Val Ala Trp Thr Leu Ala Leu Trp Lys Leu
245 250 255
Gly Glu Thr Phe Gly Phe Gly Leu Val Ala Ala Leu Tyr lie Pro Pro
260 265 270
Val Leu Val Thr Asn Ser Tyr Leu Val Ala lie Thr Phe Leu Gin His
275 280 285
Thr Asp Asp lie Leu Pro His Tyr Asp Ala Thr Glu Trp Thr Trp Leu
290 295 300
Arg Gly Ala Leu Cys Thr Val Asp Arg Ser Leu Gly Trp Phe Gly Asp
305 310 315 320
Tyr Lys Thr His His lie Val Asp Thr His Val Thr His His H e Phe
325 330 335
Ser Tyr Leu Pro Phe Tyr Asn Ala Glu Glu Ala Thr Lys Ala lie Lys
340 345 350
Pro Val Leu Lys Glu Tyr His Cys Glu Asp Lys Arg Gly Phe Phe His
355 360 365
Phe Trp Tyr Leu Phe Phe Lys Thr Ala Ala Glu Asn Ser Val Val Asp
370 375 380
Asn Glu Thr Asn Lys Ser Pro Gly lie Phe Tyr Phe Phe Arg Glu Glu
385 390 395 400












atg ace caa act gag gtc caa gcc gga ccg tgt aga gat ggt agg aac 48
Met Thr G n Thr Gl u val Gi n Al a Gl y Pro cys Arg Asp Gl y Arg Asn
1 5 10 15
etc aag agt gag get gat gtt aaa ggc ttc act gcg gag gag ttt act 96
Leu Lys Se r Gl u Al a Asp VaI Lys Gl y Phe Th r Al a Gl u Gl u Phe Th r
20 25 30
aag gtt ggg ccg tct gtg tgt get ata caa tea get ate ccc atg cac 144
Lys val Gl y Pro ser val cys Al a l i e Gi n se r Al a l i e Pr o Met Hi s
35 40 45
tgt cgt gat agg age ctg tea agg tct gtc eta tgc gtc ate agg gat 192
Cys Arg Asp Arg Se r Leu Se r Arg Se r Val Leu Cys Val l i e Arg Asp
50 55 60
etc etc tac ata aca gca tgt get get gtg cag tac tct ctg ttg gcg 240
Leu Leu Ty r l i e Thr Al a cys Al a Al a val Gi n Tyr ser Leu Leu Al a
65 70 75 80
tta gta ccc ccg gac tea ace etc ctg agg gca gtc etc tgg ggt gtt 288
Leu Val Pro Pro Asp Se r Thr Leu Leu Arg Al a Val Leu Trp Gl y Val
85 90 95
tac att ttc tgg caa ggc gtc ttt ttt act ggt att tgg gtg atg ggc 336
Tyr l i e Phe Trp Gi n Gl y Val Phe Phe Thr Gl y l i e Trp Val Met Gl y
100 105 110
cac gag tgc ggc cat ggg get ttt tec cct tat tct atg ctg aac gat 384
Hi s Gl u Cys Gl y Hi s Gl y Al a Phe Se r Pro Ty r Se r Met Leu Asn Asp
115 120 12 5
agt att ggt ttt gtc etc cac teg gcc etc ttg gta ccc tac ttc age 432
Se r l i e Gl y Phe Val Leu Hi s Se r Al a Leu Leu Val Pro Tyr Phe Se r
130 135 140
tgg cag tac tec cat gcg agg cac cat aag ttc ace aac cac get act 480
Trp Gi n Ty r Se r Hi s Al a Arg Hi s Hi s Lys Phe Thr As n Hi s Al a Th r
145 150 155 160
aag ggt gag age cat gtc ccc age ctg gaa agt gag atg ggc gta ttc 528
Lys Gl y Gl u Se r Hi s Val Pro Se r Leu Gl u Se r Gl u Met Gl y Val Phe
165 170 175
agt cgt ata cag aag gcc ctg gag ggt tat ggt etc gat gat gtc ttc 576
Se r Arg l i e Gi n Lys Al a Leu Gl u Gl y Ty r Gl y Leu Asp Asp Val Phe
180 185 190
cca gtc ttc cct ata gtg atg etc ctg gtt ggg tat cct gtg tat etc 624
Pr o Val Phe Pro l i e Val Met Leu Leu Val Gl y Tyr Pro Val Ty r Leu
19 5 200 205
ttc tgg aat gca tea ggt ggg cgt gtg ggc tac gat cgc cgt ccg tac 672
Phe Trp Asn Al a Se r Gl y Gl y Arg Val Gl y Ty r Asp Arg Arg Pro Ty r
Phoeni xτ empl8528 .tmp .txt
210 215 220
age gac act aag cca tct cat ttc aat ccc aac ggt ggc ctt ttc cct 720
Ser Asp Thr Lys Pro Ser His Phe Asn Pro Asn Gly Gly Leu Phe Pro
225 230 235 240
cct tat atg aga gag aaa gtc etc ctt agt gga gtt ggc tgt age ata 768
Pro Tyr Met Arg G lu Lys val Leu Leu ser Gly val Gly Cys ser lie
245 250 255
ace etc ctt att ttg gcc tat tgt get ggg agg gta ggc ctt age agt 816
Thr Leu Leu lie Leu Ala Tyr Cys Ala Gly Arg Val Gly Leu Ser Ser
260 265 270
gta ttg ttg tgg tat ggt tgt ccc tac ctt atg ace aac gcc tgg eta 864
Val Leu Leu Trp Tyr Gly Cys Pro Tyr Leu Met Thr Asn Ala Trp Leu
275 280 285
acg ctg tat ace tec eta cag cac acg cat gaa gga gtc ccc cat tat 912
Thr Leu Tyr Thr Ser Leu Gin His Thr His Glu Gly Val Pro His Tyr
290 295 300
ggc gat gag get ttc ace ttc ate aga ggt gcc tta get tct ate gat 960
Gly Asp Glu Ala Phe Thr Phe lie Arg Gly Ala Leu Ala Ser lie Asp
305 310 315 320
cgt cca ccg tat ggc att ttc tct acg cat ttt cac cac gaa att ggc 1008
Arg Pro Pro Tyr Gly lie Phe Ser Thr His Phe His His Glu lie Gly
325 330 335
ace act cat gtt ctg cac cac att gat tct agg ate ccc tgt tac cat 1056
Thr Thr His Val Leu His His lie Asp Ser Arg lie Pro Cys Tyr His
340 345 350
get aga gaa gcc act gat get ate aag cct att ctg ggg gat tac tat 1104
Ala Arg Glu Ala Thr Asp Ala lie Lys Pro lie Leu Gly Asp Tyr Tyr
355 360 365
agg gag gat ggt act cct ata gta aag gca ttt ttg aag gtc cac aga 1152
Arg Glu Asp Gly Thr Pro lie Val Lys Ala Phe Leu Lys Val His Arg
370 375 380
gag tgc aag ttc ate gga ggc etc aac ggc gtc cag ttt tac cgt cct 1200
Glu Cys Lys Phe lie Gly Gly Leu Asn Gly Val Gin Phe Tyr Arg Pro
385 390 395 400
ggg cag egg ccg cag cag cag ccc tgc ggc age aac get cgc act tct 1248









Met Thr Gi n Thr Gl u Val Gi n Ala Gly Pro Cys Arg Asp Gly Arg Asn
1 5 10 15
Phoeni xτempl8528 .tmp .txt
Leu Lys Ser Glu Ala Asp VaI Lys Gly Phe Thr Ala Glu Glu Phe Thr
20 25 30
Lys VaI Gly Pro Ser VaI Cys Ala lie Gin Ser Ala lie Pro Met His
35 40 45
Cys Arg Asp Arg Ser Leu Ser Arg Ser VaI Leu Cys VaI lie Arg Asp
50 55 60
Leu Leu Tyr lie Thr Ala Cys Ala Ala VaI Gin Tyr Ser Leu Leu Ala
65 70 75 80
Leu VaI Pro Pro Asp Ser Thr Leu Leu Arg Ala VaI Leu Trp Gly VaI
85 90 95
Tyr lie Phe Trp Gin Gly VaI Phe Phe Thr Gly lie Trp VaI Met Gly
100 105 110
His Glu Cys Gly His Gly Ala Phe Ser Pro Tyr Ser Met Leu Asn Asp
115 120 125
Ser lie Gly Phe VaI Leu His Ser Ala Leu Leu VaI Pro Tyr Phe Ser
130 135 140
Trp Gin Tyr Ser His Ala Arg His His Lys Phe Thr Asn His Ala Thr
145 150 155 160
Lys Gly Glu Ser His VaI Pro Ser Leu Glu Ser Glu Met Gly VaI Phe
165 170 175
Ser Arg lie Gin Lys Ala Leu Glu Gly Tyr Gly Leu Asp Asp VaI Phe
180 185 190
Pro VaI Phe Pro lie VaI Met Leu Leu VaI Gly Tyr Pro VaI Tyr Leu
195 200 205
Phe Trp Asn Ala Ser Gly Gly Arg VaI Gly Tyr Asp Arg Arg Pro Tyr
210 215 220
Ser Asp Thr Lys Pro Ser His Phe Asn Pro Asn Gly Gly Leu Phe Pro
225 230 235 240
Pro Tyr Met Arg Glu Lys VaI Leu Leu Ser Gly VaI Gly Cys Ser lie
245 250 255
Thr Leu Leu lie Leu Ala Tyr Cys Ala Gly Arg VaI Gly Leu Ser Ser
260 265 270
val Leu Leu Trp Tyr Gly Cys Pro Tyr Leu Met Thr Asn Ala Trp Leu
275 280 285
Phoeni xτ empl8528 . tmp . txt
Thr Leu Tyr Thr Ser Leu Gi n Hi s Thr Hi s Gl u Gly VaI Pro Hi s Tyr
290 295 300
Gly Asp Gl u Ala Phe Thr Phe lie Arg Gly Al a Leu Ala Ser lie Asp
305 310 315 320
Arg Pro Pro Tyr Gly l i e Phe Ser Thr Hi s Phe Hi s Hi s Gl u lie Gly
325 330 335
Thr Thr Hi s VaI Leu Hi s Hi s lie Asp Ser Arg lie Pro Cys Tyr Hi s
340 345 350
Al a Arg Gl u Ala Thr Asp Ala lie Lys Pro l i e Leu Gly Asp Tyr Tyr
355 360 365
Arg Gl u Asp Gly Thr Pro lie VaI Lys Ala Phe Leu Lys VaI Hi s Arg
370 375 380
Gl u Cys Lys Phe lie Gly Gly Leu Asn Gly VaI Gi n Phe Tyr Arg Pro
385 390 395 400














ggtaccatgg cgatcacgac gacgcagaca c 31
<210> 26
<211> 34




























<22 3> artificial sequence
<220>
<221> mi sc_feature




























ggagctttag ccgtagtagg cctcctt 27
<210> 31





























<22 3> artificial sequence
<220>





























ggtaccatgt cttctcttac cctcta 26





























































ggtctagact agtgggcctt gccgtgcttg atctcc 36


































<222> (I) . . (26)
<223>
<400> 43
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<400> 45
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<220>
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<400> 50
























ggtctagact acctagcaag caatctct 28
